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Chapter 1 
General Introduction 
 
Escherichia coli 
Basic Phylogeny and Biology 
Escherichia coli is a fascinatingly diverse organism. While the typical E. coli 
genome contains roughly 4800 genes, only 2000 or so are shared by every E. coli strain 
(1). In total, the full complement of E. coli genes numbers to roughly 16,000 (1, 2).  
Such genomic plasticity permits E. coli strains to colonize numerous ecological niches 
and participate in various commensal and pathogenic interactions with its mammalian 
and reptilian hosts (3, 4). E. coli is one of the first bacteria to colonize the intestinal tract 
of human infants, where it establishes a stable population of roughly 108 CFUs/g of 
feces by adulthood (4-6). As a facultative anaerobe, E. coli is well-adapted to the 
oxygen limiting intestinal tract, as it can reduce several alternate electron acceptors 
such as nitrate, fumarate, DMSO, and TMAO (7). Mice colonization studies have 
revealed that in the intestine fumarate reductase, nitrate reductase, and bd oxidase 
(high affinity oxygen cytochrome) are particularly important for E. coli fitness (8, 9). 
Pathogenesis 
By acquiring specific virulence factors, E. coli strains can colonize and cause 
disease at different sites in the human body (3). Intestinal pathogenic E. coli (IPEC) 
cause gastroenteritis by interacting with and adversely affecting intestinal epithelial cells 
(3, 10). There are a variety of IPEC subtypes, most of which can be characterized and 
identified by the presence of specific virulence genes (3). For instance, 
enteropathogenic E. coli (EPEC) harbor a pathogenicity island called the locus of 
enterocyte effacement (LEE). Included in the LEE are genes that encode a type III 
secretion system as well as various effector molecules (11, 12). EPEC is a common 
cause of infant diarrhea in developing countries as well as travelers’ diarrhea (3).  
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Enterohemorrhagic E. coli (EHEC) is a pathogenic subtype that encodes the LEE 
pathogenicity island and also produces shiga toxin (13). Shiga toxin inactivates the host 
60S ribosomal subunit, halting protein synthesis and leading to apoptosis (14). EHEC 
can cause serious gastrointestinal disease such as hemolytic uremic syndrome (HUS), 
and is a source of food poisoning outbreaks worldwide (13). There is currently no 
effective treatment for EHEC infections, and antibiotics can induce expression of shiga 
toxin, leading to exacerbation of disease symptoms (15, 16).  
Some E. coli strains have adapted to cause disease at sites in the human body 
other than the intestinal tract. Collectively, these bacteria are termed extraintestinal E. 
coli (ExPEC). ExPEC infection can lead to neonatal meningitis, sepsis, and urinary tract 
infections (UTIs), with UTIs being the most common ExPEC infection (17). Indeed, 
uropathogenic E. coli (UPEC) account for roughly 80% of the uncomplicated UTIs in the 
US (18). In contrast to IPEC, there doesn’t seem to be a unique set of virulence factors 
that are specific to UPEC. However, UPEC strains are well-adapted to the bladder 
environment (19). Specifically, urine is iron-limiting, and UPEC expresses at least 10 
iron acquisition systems (20, 21). Vaccines raised against outer-membrane iron-
receptors are effective at protecting mice against UTIs (22, 23). Zinc receptors also 
contribute to UPEC fitness in the bladder (24). 
The first step in UPEC infection is ascension up the urethra, a process that 
requires flagella (25, 26). Once in the bladder, fimbriae aid in the attachment of UPEC 
to epithelial cells. Type 1 pili are particularly important for bladder colonization. The 
FimH subunit of type 1 pili binds to mannosylated glycoprotein receptors, mediating 
UPEC attachment to uroepithelial cells (27-29). Multiple receptors for FimH have been 
reported, including uroplakins and β1 and α3 integrins (30, 31). UPEC is also able to 
invade uroepithelial cells (32). Cell invasion is first initiated by type 1 pili-mediated 
attachment (27). Entry also involves fusiform vesicles. Apical exocytosis of fusiform 
vesicles helps regulate bladder volume, and drugs that increase exocytosis can 
decrease the number of intracellular E. coli in a mouse UTI model (33). Once in the 
cytosol, UPEC can rapidly divide and form polysaccharide encased cellular aggregates 
termed intracellular bacterial communities (IBCs) (34, 35). IBC formation helps UPEC 
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evade the immune response, and can likely serve as a reservoir for recurrent infections 
(25, 36). 
Transmission 
E. coli is transmitted from host to host by the fecal-oral route. A large body of 
work exists investigating how EHEC strains, particularly EHEC O157:H7, make their 
way from environmental reservoirs to humans (37). The intestinal tract of domesticated 
cattle serves as the primary reservoir for EHEC in the United States (38, 39). Intestinal 
EHEC can contaminate meat during the slaughter process. Additionally, EHEC is shed 
in feces of contaminated animals and can survive in manure for months (38, 40-42). 
Contact with animal feces is a risk factor for spontaneous EHEC infections, and the use 
of untreated manure can result in contaminated produce (37, 43-45). While 
contaminated manure or water can directly inoculate the surface of plants, there is also 
evidence that EHEC can also invade plant tissue (44-46). 
 ExPEC transmission is not as well characterized as that of IPEC, but evidence 
suggests that ExPEC can also spread via the fecal-oral route (47). ExPEC can be found 
on food products, and outbreaks of UTIs caused by UPEC have been reported (48, 49). 
The primary source of UPEC that colonizes the urethra is a patient’s own intestinal tract 
(50). UPEC seems to be able to live in the intestine without causing any disease, and 
recent work has shown that UPEC has no fitness defects in the gut environment when 
compared with commensal E. coli strains (51).  
Once E. coli is excreted in stool there is generally a net-negative fitness cost 
compared to growth in most host environments (6, 52). However, as E. coli is constantly 
being excreted, it has been estimated that half of the E. coli cells on Earth exist outside 
the host (6). The factors influencing survival outside the host have been described most 
extensively for IPEC, namely for common EHEC strains. One major factor affecting 
persistence in the non-host environment is the production of matrix encased bacterial 
communities called biofilms. 
Biofilms 
 A biofilm is a group of surface-associated bacteria encased in a self-produced 
extracellular matrix. Biofilm formation correlates with resistance to a variety of 
environmental stresses, including antibiotics, the immune system, and predation (53). 
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Biofilms confer protection through at least two distinct mechanisms. First, the 
extracellular matrix forms a physical barrier that can resist shear stress and recognition 
and phagocytosis by immune cells (53). Secondly, bacteria within biofilms often 
assemble into subpopulations that have distinct physiological characteristics. 
Subpopulation development can be triggered by mutations, stochastic gene expression, 
or chemical gradients that develop during biofilm formation (54-57). For instance, 
bacteria at the biofilm surface are exposed to more oxygen, causing them to undergo a 
higher rate of aerobic respiration (54, 58, 59). Metabolic changes often coincide with 
resistance to different stresses (56, 60). A biofilm community with multiple 
subpopulations, each resistant to differing stresses, therefore confers a broader range 
of stress resistance to the biofilm community as a whole (54, 56, 60).  
Bacteria use varying extracellular polymers to produce the biofilm extracellular 
matrix. In general, bacteria secrete proteins, polysaccharides, and DNA as biofilm 
components. In laboratory conditions a number of components can contribute to E. coli 
aggregation. These include type 1 pili, flagella, antigen 43, β-1,6-N-acetylglucosamine 
(β-1,6-GlcNAc), capsule sugars, colonic acid, curli fibers, and cellulose (61). Curli and 
cellulose are generally co-expressed due to their mutual dependence on the 
transcriptional regulator CsgD (62-64) (Fig. 1.1). 
CsgD-mediated Biofilms 
CsgD is a FixJ/LuxR/UhpA type response regulator (62). The C-terminus of 
CsgD, like most response regulators, contains a typical helix-turn-helix DNA-binding 
domain (62). The N-terminus of response regulators gets phosphorylated by a partner 
histidine kinase, leading to altered DNA-binding capabilities (65-67). Alternately, the N-
terminus of response regulators can respond to small molecule signals (67, 68). CsgD, 
like other atypical response regulators, lacks conserved aspartic acid residues in the N-
terminal region that are necessary for phosphorylation (69, 70). However, acetyl 
phosphate can phosphorylate CsgD in vitro, and the presence of acetyl phosphate 
reduces CsgD’s ability to bind particular promoters (69).  
The expression of csgD is controlled by a large, and still-expanding, list of 
transcriptional regulators and small RNAs (71, 72). In general, low salt, low 
temperature, and the absence of glucose trigger csgD expression (62, 71, 73-75). 
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Additionally, csgD expression requires the stationary phase sigma factor RpoS (63, 76), 
and is controlled by the small molecule cyclic-di-GMP. (77). Multiple diguanylate 
cyclases or phosphodiesterases, enzymes that produce or degrade cyclic-di-GMP 
respectively, affect the levels of CsgD in the cell (78, 79). However, the mechanism by 
which cyclic-di-GMP controls CsgD is unknown. 
CsgD controls a modest regulon of roughly 13 genes/operons (62, 80-82). 
Notably, CsgD induces expression of the RpoS stabilizing protein IraP, leading to a 
relay system in which CsgD requires RpoS for expression and causes increased RpoS 
stability (81). CsgD also directly represses the flagella biosynthesis genes fliE and fliF 
(82). Finally, CsgD induces expression of two biofilm matrix components, curli and 
cellulose (Fig. 1.1). 
The Basics of Curli 
Curli were identified in both E. coli and S. enterica ser. Enteritidis as fibronectin-
binding fibers (73, 83). Curli production has since been reported in various Salmonella 
spp., Citrobacter spp. and E. coli strains (63, 84-87). It is now recognized that curli 
regulation, assembly, and operon structure is well conserved among members of the 
Enterobacteriaceae (63, 64, 88, 89). Curli biogenesis initiates with expression of csgD. 
CsgD directly activates the csgBAC operon (62, 82) (Fig. 1.1). CsgA is the major curli 
fiber subunit that polymerizes into an amyloid fiber on the cell surface (90). The minor 
fiber subunit CsgB templates fiber polymerization and, along with the accessory protein 
CsgF, helps attach curli fibers to the cell surface (91-94). Both CsgA and CsgB are 
secreted through the inner membrane via the SecYEG complex and then through the 
outer membrane via the lipoprotein CsgG (Fig. 1.2A) (95, 96). CsgG is encoded in the 
csgDEFG operon, so its expression, along with the expression of the curli accessory 
proteins CsgE and CsgF, coincides with expression of the curli subunit genes. During 
curli expression, CsgG forms discrete puncta on the cell surface that are aggregated 
around curli fibers (97).  
 Curli fibers were the first described extracellular fibers to polymerize by the 
nucleation-precipitation mechanism (91, 92, 98). CsgB provides a template on the cell 
surface that allows secreted CsgA to adopt an amyloid fold and form cell-associated 
fibers (93). A csgB mutant secretes unfolded CsgA that can polymerize on the surface 
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of a csgA mutant (which presents a surface-associated CsgB), in a process called 
‘interbacterial complementation’ (91, 98) (Fig. 1.2B). Zhou et. al. demonstrated that curli 
subunits from three different species could cross-seed in vitro. Furthermore, 
interbacterial complementation between E. coli and S. enterica ser. Typhimurium was 
observed in vivo. Interspecies curli production restored agar adherence to mixed 
species bacterial communities (88). 
Amyloid Properties of Curli 
A fascinating aspect of curli fibers is that they are biochemically defined as 
amyloid (98). -sheet amyloid fibers have long been the hallmark of human 
neurodegenerative diseases, but amyloids are increasingly appreciated as a functionally 
diverse protein fold. Amyloids are remarkably stable protein polymers that form -sheet 
rich fibers with a diameter of 5-10 nm. The amyloid fold is unique in that it is adopted by 
a variety of proteins with varying primary sequences.  
The first step in amyloid fiber formation is aggregation of monomers into 
intermediate oligomers, or seeds. Once seeds form, they nucleate rapid fiber 
elongation, with the final amyloid structure being essentially a stack of β-sheet rich 
monomers, aligned so that each β-strand is perpendicular to the fiber axis (Fig. 1.3). 
Dense hydrogen bonding between adjacent β-sheets then provides fiber stability (99-
105). Amyloidogenic proteins can polymerize in the absence of an energy source, so it 
is not surprising that amyloid fibers such as CsgA are a common component of the 
microbial extracellular matrix, where energy sources can be scarce and environmental 
conditions can wreak havoc on lesser protein folds (98, 106-110).  
 The necessary structural features of an amyloid fiber, β-sheet formation and 
hydrogen bonding between β-sheets, are partly conferred by the polypeptide backbone 
and do not require complex amino acids (111-115). These properties are proposed to 
lend themselves to the universality of the amyloid fold, and, indeed, there is a 
hypothesis that the amyloid fold, with its tendency towards elementary amino acid 
composition and resistance to harsh environmental conditions, was a fundamental 
structure in the early history of life (116). Most proteins can adopt the amyloid fold, 
although the majority of ‘non-native’ amyloids require exposure to harsh denaturing 
conditions to destabilize their native structure before they can re-organize into an 
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amyloid (117-119). Conversely, some proteins readily form amyloids. These 
polypeptides often contain specific regions that promote the amyloid fold (120-122). 
Transfer of amyloidogenic stretches of amino acids to normally non-amyloidogenic 
proteins can force amyloid formation (123, 124).  
Similarly, the amyloid fold confers common biophysical characteristics to proteins 
that might be dissimilar at the primary sequence level. For instance, a defining 
characteristic of an amyloid, regardless of primary amino acid sequence, is the ability to 
bind certain dyes such as Congo red and thioflavin T (125). Additionally, antibodies 
have been designed that recognize general epitopes of amyloid fibers or amyloid 
oligomers (108, 126-129), and small molecules have been identified that affect fiber 
formation of multiple amyloids (130).   
Amyloids have been thoroughly studied because of their historical association 
with neurodegenerative conditions such as Alzheimer’s disease. The Alzheimer’s 
amyloid β (Aβ) peptide was one of the first described disease-associated amyloids and 
is among the most thoroughly studied (131). Amyloid formation is also the hallmark of 
Parkinson’s disease (132), Huntington’s disease (133), and type II diabetes (134). 
Because amyloid fibers were identified in connection with various diseases, it was 
assumed that amyloid fibrils themselves were toxic (135). Although new data suggest 
that mature amyloid fibers are relatively inert, non-cytotoxic, and maybe even protective 
(135). Instead, amyloid-related toxicity is likely caused by small oligomers formed as an 
intermediate step in fiber polymerization (127, 135-138). Indeed, the oligomeric species 
of various disease causing amyloids have been shown to be toxic (139-141).   
How E. coli Safely Manipulates Curli Biogenesis 
Because of the toxicity inherent to amyloid proteins, a good deal of research has 
been dedicated to describing how E. coli safely wields amyloid proteins such as CsgA. 
Since small oligomers are widely considered to be the toxic species in amyloid 
formation, one mechanism for avoiding toxicity has been hypothesized to be rapid 
passage through the oligomeric stage (142). In agreement with this hypothesis, E. coli 
uses a nucleator protein, CsgB, to seed rapid polymerization of the major curli 
component, CsgA, on the cell surface (Fig. 1.1A). CsgB itself can form amyloid fibers in 
vitro and the addition of CsgB seeds allows CsgA to bypass the characteristic lag phase 
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associated with amyloid fiber formation (93, 143). Specific amino acids in CsgA mediate 
interaction between these two fiber subunits, and mutation of these residues results in a 
CsgA protein that is secreted from the cell in a soluble state (90, 144). The main 
functions of CsgB in vivo then seem to be templating extracellular CsgA amyloid 
formation and, along with the surface-exposed CsgF protein, anchoring CsgA fibers to 
the cell (93, 94), outlining a model where CsgA monomers are kept unfolded and 
soluble until they are transported across the outer-membrane where they encounter 
CsgB seeds. CsgA then rapidly folds into an amyloid fiber, potentially bypassing the 
toxic oligomeric stage.  
Perhaps the most direct mechanism for avoiding amyloid toxicity is through 
manipulation of the amyloid protein’s primary amino acid sequence. The chief 
component of curli fibers, CsgA, is able to polymerize into amyloid fibers in a wide 
variety of environmental conditions (145). These results contrast with non-native 
amyloids that need to be exposed to specific, destabilizing conditions  to aggregate 
(117, 146, 147). Investigations into the primary sequence of CsgA have revealed that 
particular residues play crucial roles in the polymerization of this amyloid-by-design. The 
amyloidogenic domain of CsgA is composed of 5 imperfect repeats (R1-R5) that share 
30% amino acid identity to each other (148, 149). The two terminal repeating subunits, 
R1 and R5, readily form amyloid fibers in vitro, while R2 and R4 do not form fibers and 
R3 forms short, fibrous aggregates (150). Wang et. al. demonstrated that R2, R3, and 
R4 contain ‘gatekeeper’ residues that inhibit the aggregative propensity of these 
peptides and therefore the entire CsgA protein (151). A CsgA mutant in which the 
gatekeeper residues were substituted with amino acids that bolster amyloid formation, 
CsgA*, polymerized more rapidly than WT CsgA in vitro and formed mislocalized fibers 
without the need for CsgB in vivo. Overexpression of CsgA* was significantly more toxic 
to the cell than overexpression of WT CsgA (151). These data indicate that the CsgA 
protein sequence has evolved specific traits to allow for manageable amyloid formation 
by the cell. Additionally, both curli fiber components, CsgA and CsgB, indeed the 
majority of secreted proteins, are composed of a disproportionate amount of 
inexpensive amino acids (152), indicating that the CsgA protein is designed for both 
safe amyloid formation and for cost-effectiveness. 
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A third mechanism to control amyloid formation is the use of cellular chaperones. 
In curli biogenesis, the role of CsgB as an outer-membrane nucleator implies that CsgA 
must be maintained in a soluble, unfolded state as it is trafficked through the cytoplasm 
and periplasm. Consistent with this hypothesis, various E. coli chaperones, including 
cytoplasmic DnaK and Hsp33 and periplasmic Spy, were demonstrated to inhibit CsgA 
aggregation (153). Once in the periplasm, CsgA encounters a specificity factor for curli 
secretion, CsgE. In addition to trafficking unfolded CsgA to the outer-membrane pore 
CsgG during secretion, CsgE has been demonstrated to inhibit CsgA polymerization in 
vitro (154, 155).  These data are consistent with a model of CsgA maintaining an 
unfolded, unstructured state on its voyage through the cytoplasm and periplasm, and it 
appears that various cellular chaperones are able to inhibit inappropriate CsgA 
aggregation before secretion. 
The Basics of Cellulose 
 Bacterial cellulose production was first described in 1887, and 
Gluconacetobacter xylinus has been a model organism for the study of cellulose 
biosynthesis for decades (156-158). It was not until 2001, however, that cellulose 
production by the Enterobacteriaceae family was described (64). Cellulose is a 
polysaccharide composed of linear chains of (1,4)-β-linked glucose monomers. Most 
non-K12 E. coli strains can produce cellulose as a component of the biofilm matrix (64, 
84-86, 159). However, K12 E. coli strains do not produce cellulose (64, 159). In the 
case of E. coli W3110, the cellulose defect is due to a mutation in bcsQ, and repairing 
bcsQ on the chromosome restores cellulose synthesis (160). CsgD modulates cellulose 
synthesis by activating transcription of adrA, and deletion of adrA ablates cellulose 
production in most E. coli and S. enterica ser. Typhimurium strains (64, 85, 159, 161) 
(Fig. 1.1). AdrA contains a GGDEF domain typical of diguanylate cyclases (161, 162). 
E. coli and S. enterica encode a number of diguanylate cyclases and 
phosphodiesterases to regulate cytoplasmic levels of cyclic-di-GMP (78, 79, 162). AdrA 
presumably activates the cellulose synthase BcsA via cyclic-di-GMP production, as 
BcsA contains a cyclic-di-GMP binding PilZ domain (163, 164) (Fig. 1.1). Some E. coli 
strains have been reported to produce cellulose independently of CsgD. At least one of 
these strains, E. coli 1094, utilizes the diguanylate cyclase YedQ in place of AdrA (159). 
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Curli and Cellulose in vivo 
Various interactions between curli and host systems have been reported. Curli 
mediate binding to and internalization by host cells (165-167), with these attributes 
being at least partly imbued by curli’s fibronectin-binding capacity (73, 168). Curli have 
also been shown to interact with major histocompatibility complex I (MHC-I), but 
whether or not the amyloid properties of curli fibers affect these interactions is unclear 
(169). 
In contrast, the amyloid properties of curli might impact human amyloidosis. 
Amyloidosis is a condition in which aberrantly folded amyloids deposit on tissues or 
organs, disrupting proper function and causing inflammation (170). AA amyloidosis 
results from the abnormal deposition of a protein fragment from the typically soluble 
serum amyloid A (SAA) protein. These aggregates can be seeded by small SAA 
fragments, and indeed by other amyloid-like fibrils, thus exacerbating the symptoms of 
amyloidosis (171-174). Lundmark et. al. showed that exogenously added amyloid-
proteins including Sup35 from Saccharomyces cerevisiae, silk from Bombyx mori, and 
either purified curli or curliated E. coli increased the occurrence of SAA aggregates in 
mice (175). Further work exploring whether there are direct interactions between SAA 
and microbial amyloids will help to clarify the role of cross-seeding in amyloidosis. 
There is strong evidence that the cross-β structure of curli fibers interferes with 
host blood clotting mechanisms (176). Fibrin, a major component of blood clots, 
displays a cross β-sheet structure and other amyloid-like characteristics (177). Fibrin 
activates the mammalian tissue-type plasminogen activator (tPA) by promoting contact 
between tPA and its substrate, plasminogen. tPA can then cleave plasminogen into the 
active serine protease plasmin, which degrades fibrin and results in blood clot 
dissolution. (178). Kranenburg et. al. showed that the cross-β structure specifically 
allows for tPA activation (177). Indeed, various other amyloid-like proteins, such as Aβ 
and IAPP (the amyloid associated with β-cell toxicity in type II diabetes) have been 
shown to effectively activate tPA and trigger the degradation either of themselves or of 
fibrin (177, 179). Curli, either purified or on the surface of E. coli or S. enterica, is both 
able to sequester tPA and plasminogen from plasma, and both of these proteins are 
functional when bound to curliated bacteria (180).  
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Curliated E. coli and Salmonella spp. are also able to interfere with the host 
contact system, which is an enzymatic cascade triggered when blood contacts surface 
material (176). As part of the contact cascade, the activated form of plasma zymogen 
Factor XII (FXII) can cleave another plasma protein, high-molecular weight kininogen 
(HK). Cleavage of HK results in the release of the peptide hormone bradykinin (BK), 
which leads to an inflammatory response. Curliated E. coli or S. typhimurium can bind 
and sequester various contact phase proteins such as FXII, HK, and fibrinogen, 
resulting in release of the pro-inflammatory signals BK and fibrinopeptides (181-184). 
Intriguingly, although the in vivo activators of FXII are not completely understood, Maas 
et al. demonstrated that various unfolded proteins, including pre-fibrillar Aβ, induce FXII 
autoactivation (185), leading to the question of the folding state of CsgA upon binding to 
FXII. Concurrent with an increase in inflammation, curliated bacteria reduced clotting in 
isolated plasma as well as in an in vivo mouse model, likely due to curli-mediated 
sequestration of blood clotting elements such as fibrinogen (182-184). Bian et. al. 
demonstrated that serum from patients diagnosed with E. coli bacteremia contained 
anti-CsgA antibodies, while no such antibodies were present in sera from healthy 
patients (186). Finally, E. coli isolated from sepsis patients is more likely to produce curli 
at high temperatures than E. coli isolated from patients without sepsis (187). 
Collectively, these results allude to the interesting hypothesis that bacteria could use 
curli, and potentially other amyloids, as a mimetic of host amyloids to trigger specific 
pathways. 
 The importance of amyloid fibers in microbial pathogenesis is further cemented 
by reports of interactions between curli and the immune system. Human macrophages 
produce increased levels of pro-inflammatory cytokines, including interleukin-8 (IL-8), 
when exposed to curliated E. coli compared to non-curliated E. coli (186). Likewise, 
mice injected with E. coli showed curli-dependent increases in expression of nitric oxide 
synthase, increases in nitric oxide levels, and decreased blood pressure (188). In 
studies with S. typhimurium, curli-mediated induction of nitric oxide and IL-8 in HEK293 
cells depends on the host toll-like receptor 2 (TLR2) (189, 190). Different bacterial 
structures are recognized by varying TLRs, either alone or in combination. For example, 
TLR2 can also bind lipoprotein, lipoteichoic acid, and peptidoglycan (191, 192). TLR4 
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recognizes LPS (193), and TLR5 recognizes flagellin (194). Once bound, a signaling 
cascade is triggered that results in an immune reponse. TLR5 is specific for flagellin, 
and cannot be activated by fibrous flagella (195). In contrast, only CsgA curli polymers 
fully stimulate TLR2 induction of HEK293 cells, while monomeric CsgA has little activity 
(190). Interestingly, another amyloid, Aβ fibers, induces IL-8 production in human 
macrophage-like (THP-1) cells in a TLR2-dependent-manner (190). The same pattern 
was observed with Nos2 mRNA production in microglia cells (190). TLR2 has 
independently been shown to recognize Aβ fibers as well as SAA, indicating that it may 
function partly as a general amyloid receptor (196-200). However, curli fiber recognition 
additionally involves TLR1 and CD14 signaling, while Aβ recognition also involves TLR4 
and TLR6, indicating that the interactions between amyloids and the immune system 
are likely complex (200-203).  
 Amyloids also interact with host-derived antimicrobial peptides (AMPs). LL-37 is 
a human AMP important for resistance to bacterial infection of the urinary tract (204), 
and curli was expressed on 59% of E. coli urinary tract infection (UTI) isolates (205). 
Expression of curli increased E. coli survival after LL-37 exposure in broth culture. 
Additionally, LL-37 was shown to bind to curli fibers and monomers by surface plasmon 
resonance and inhibit in vitro polymerization of CsgA (206), implying a dynamic 
interplay between LL-37 and CsgA within the host. In the same study, cellulose 
dampened the immune response against E. coli in a UTI mouse model (206). 
Curli and Cellulose in vitro 
In the Non-Host Environment 
In S. enterica, curli and cellulose expression provide resistance to desiccation, 
bleach, and chlorine stress (207-209). EHEC curli expression increases attachment to 
produce and abiotic surfaces (210, 211). The environmental conditions that favor csgD 
expression -- low temperatures, low salts, low sugars -- suggest that CsgD-mediated 
biofilms are important outside the host. Indeed, an expression study in S. enterica 
demonstrated that the curli promoter was not induced during passage through a mouse 
host, but was activated once the bacteria were excreted in feces (208).  
Laboratory Models of Biofilm Formation 
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In laboratory conditions, E. coli produces at least two distinct biofilm types that 
are dependent on various extracellular polymers (61, 64, 212-214). The first type relies 
on type-1-pili, Poly-β-1,6-GlcNAc, antigen 43, and flagella (212, 213, 215) (216). (Fig. 
1.4A). This type of biofilm only manifests as rings of biomass around the air-exposed 
edges of polyvinyl chloride wells.  
The second major biofilm type relies on expression of the CsgD-regulated matrix 
components curli and cellulose. Glucose, temperatures >30°C, and high salt content 
inhibit CsgD-mediated biofilms (75, 76, 212, 217). In contrast to the first type of biofilm, 
curli/cellulose-dependent biofilms can manifest in a variety of ways (Fig. 1.4). In liquid 
low-salt media at room temperature, E. coli can form ring biofilms around the edge of 
96-well polyvinyl chloride plates (212) (Fig. 1.4B). Additionally, E. coli can form pellicle 
biofilms in wells of 24-well polyvinyl chloride plates (212) (Fig. 1.4C). Pellicles are thick 
sheets of curli/cellulose-encased cells that span the entire air-liquid interface of a single 
well (212, 214, 218). While curli and cellulose are the chief components of pellicle 
biofilms, deletion of type-1-pili leads to a less-robust pellicle, demonstrating that pili are 
involved in pellicle development (214). Flagella are also required for pellicle 
development (212, 214). Finally, when grown under csgD-inducing conditions on agar 
plates, E. coli will form wrinkled, rugose colony biofilms (64, 85, 219) (Fig. 1.4D). While 
flagella are not required for the wrinkled colony morphotype, rugose biofilms contain an 
interior population of heavily flagellated cells (220). 
Rugose Biofilms 
E. coli is one of a variety of bacterial species that produce wrinkled colony 
biofilms on agar plates. The nomenclature for this phenotype varies between species, 
but common names are rugose biofilms, wrinkled colony biofilms, and red dry and rough 
(rdar) biofilms. For the purpose of this thesis all colony biofilms on agar plates will be 
referred to as rugose biofilms. The mechanics of rugose biofilm formation have been 
studied extensively in Vibrio cholerae, Pseudomonas aeruginosa, Bacillus subtilis, E. 
coli, and S. enterica ser. Typhimurium (64, 74, 77, 221-227).  
 V. cholerae displays two distinct colony variants, smooth and rugose (228). 
Rugose colony development correlates with increased production of Vibrio 
polysaccharide (VPS) and an increase in cyclic-di-GMP (229, 230). The transcriptional 
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regulators VpsR and VpsT are responsible for inducing the vps biosynthetic genes 
during rugose colony development (222, 223, 231, 232). V. cholerae rugose colony 
formation is correlated with increased resistance to stresses that could be encountered 
in the non-host environment, including chlorinated water, flagellate predation, and 
osmotic and oxidative stress (221, 230, 233).  
P. aeruginosa forms polysaccharide-dependent rugose biofilms that are finely 
tuned to the redox state of the cell. The increased surface area conferred by rugose 
colony development exposes more P. aeruginosa cells to molecular oxygen when 
terminal electron acceptors are limited (225, 234). The production of phenazines, small 
redox active electron shuttles, allows respiration to occur deeper within the biofilm and 
therefore prevents colony wrinkling (225). 
B. subtilis produces both amyloid fibers and polysaccharides in rugose biofilms 
(109), the formation of which is induced by iron and dependent on cellular redox 
balance (227). Cell death can also trigger wrinkle formation (224). The surface of B. 
subtilis rugose biofilms is very resistant to gas exchange, due to both its composition 
and shape (226). Enough evaporation happens at the surface, however, to drive liquid 
flow through individual wrinkles (235). 
Rugose Biofilms In Enterobacteriaceae 
Rugose biofilms in the Enterobacteriaceae family have been most extensively 
described in E. coli and S. enterica ser. Typhimurium. Curli and cellulose are required 
for rugose development, and are the major extracellular structures in the rugose biofilm 
matrix (64, 236). E. coli K12 strains, therefore, do not produce rugose biofilms unless 
the defect in cellulose synthesis is repaired (160). However, recent isolates of 
commensal E. coli, ExPEC, and IPEC form rugose biofilms (85, 86, 237, 238). Likewise, 
a higher proportion of Salmonella spp. clinical isolates form rugose biofilms as 
compared to domesticated lab strains (87). Indeed, repeated culturing tends to select 
for genetic suppressors of biofilm formation in a variety of bacteria (239). Curli, 
cellulose, and rugose biofilm formation has also been demonstrated in Citrobacter spp. 
(84, 85). The environmental signals leading to rugose development coincide with those 
affecting CsgD expression (77, 161). As such, cyclic-di-GMP networks play a large role 
in rugose biofilm development. (77, 79).  
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Rugose biofilms are a simple model to study various aspects of biofilm formation. 
When I started my thesis project, I was especially interested in determining how 
environmental conditions affected E. coli rugose biofilm development. My rationale was 
that insight into natural E. coli biofilm regulators would provide information about biofilm 
function. Therefore, I started my project by testing the ability of various chemicals to 
affect curli production and rugose biofilm formation in a uropathogenic E. coli isolate 
UTI89. Due to its ability to affect the polymerization of disease-associated amyloids, I 
was particularly interested in iron (240). Plating UTI89 in low iron conditions resulted in 
a smooth colony phenotype, although the bacteria still bound to Congo red, a diazo dye 
that binds to both curli and cellulose (85) (Fig. 1.5). Addition of iron resulted in typical 
rugose biofilm formation (Fig. 1.5). Throughout my thesis work, I have utilized iron and 
rugose biofilm formation to address three overarching questions. 
 
I.) Iron and Biofilm Architecture 
How does iron affect matrix production during rugose biofilm development? 
II.) Biofilm Regulation 
What regulatory pathways affect rugose biofilm formation? 
III.) Biofilm Function 
What survival advantages do curli/cellulose-mediated biofilms confer? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
16 
Figures: 
 
 
 
 
Figure 1.1 Genetics of E. coli biofilm formation 
CsgD is a transcriptional regulator that induces expression of csgBAC and adrA.  
csgBAC encodes the major and minor curli subunits CsgA and CsgB. AdrA is a  
diguanylate cyclase that produces the small molecule cyclic-di-GMP (c-di-GMP) which  
activates the cellulose synthase BcsA. Production of curli and cellulose leads to CsgD- 
dependent rugose colony biofilms on agar plates in the uropathogenic E. coli isolate  
UTI89. CsgD-dependent matrix production can also be probed for by western blotting  
for the major curli subunit CsgA. 
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Figure 1.2 Nucleation-precipitation curli fiber assembly 
(A) WT E. coli secretes soluble CsgA proteins into the extracellular milieu.  Once  
outside the cell, CsgA encounters surface-attached CsgB seeds that nucleate CsgA  
amyloid formation. (B) Inter-bacterial complementation between a CsgA expressing E.  
coli csgB mutant and a CsgB expressing S. typhimurium csgA mutant. E. coli secretes  
monomeric CsgA that can interact with CsgB nucleators on the surface of S.  
typhimurium.                    
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Figure 1.3 General schematic for amyloid polymerization 
Unfolded monomers form intermediate oligomers, some of which are toxic, during the  
lag phase of amyloid assembly.  Once the on-pathway oligomers, or seeds, have  
formed rapid fiber assembly ensues.  The lag phase can be bypassed by addition of  
pre-formed seeds to monomers. 
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Figure 1.4 UTI89 biofilm models 
(A) When grown in LB media, UTI89 can form type 1 pili-dependent biofilms around  
wells of polystyrene 96-well plates. These biofilms can be stained by crystal violet. (B)  
UTI89 can also form ring biofilms when grown in YESCA media in 96-well plates.  
However, these biofilms are dependent on curli. (C) UTI89 forms curli-dependent  
pellicle biofilms at the air/culture interface in 24-well plates. These biofilms cover the  
entire liquid surface. (D) When grown on YESCA agar plates, UTI89 forms curli- 
dependent rugose biofilms. 
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Figure 1.5 Iron induces UTI89 rugose biofilm formation 
UTI89 was grown ON in LB media, rinsed twice in low iron YESCA media, and plated  
on low iron YESCA agar plates. On the same plate, a spot of UTI89 mixed with FeCl3  
was plated. After two days of growth at 26°C, UTI89 grown in the presence of iron  
wrinkled. Post-staining with the matrix-binding dye Congo red indicated that matrix was  
being produced in both conditions. 
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Chapter 2 
Iron Induces Bimodal Population Development by Escherichia coli 
 
Abstract: 
Bacterial biofilm formation is a complex developmental process involving cellular 
differentiation and the formation of complex 3D structures. Here I demonstrate that 
exposure to ferric chloride triggers rugose biofilm formation by the uropathogenic 
Escherichia coli strain UTI89 and by enteric pathogens Citrobacter koseri and 
Salmonella enterica serovar typhimurium. Two unique and separable cellular 
populations emerge in iron-triggered, rugose biofilms. Bacteria at the air-biofilm 
interface express high levels of the biofilm regulator csgD, the cellulose activator adrA, 
and the curli subunit operon csgBAC. Bacteria in the interior of rugose biofilms express 
low levels of csgD and undetectable levels of matrix components curli and cellulose. 
Iron activation of rugose biofilms is linked to oxidative stress. Superoxide generation, 
either through addition of phenazine methosulfate or by deletion of sodA and sodB, 
stimulates rugose biofilm formation in the absence of high iron. Additionally, 
overexpression of Mn-superoxide dismutase, which can mitigate iron-derived reactive 
oxygen stress, decreases biofilm formation in a WT strain upon iron exposure. Not only 
does reactive oxygen stress promote rugose biofilm formation, but bacteria in the 
rugose biofilms display increased resistance to H2O2 toxicity. Altogether, I demonstrate 
that iron and superoxide stress trigger rugose biofilm formation in UTI89. Rugose biofilm 
development involves the elaboration of two distinct bacterial populations and increased 
resistance to oxidative stress.  
 
Introduction: 
By adopting a biofilm lifestyle, bacteria gain resistance to antibiotics, the host 
immune system, and environmental stresses (1, 2). Gene expression and metabolic 
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processes can vary drastically from cell to cell in a biofilm community (3, 4), and cellular 
differentiation within a biofilm contributes to antibiotic resistance (1). Therefore, an in-
depth understanding of biofilm formation is critical for the development of antibacterial 
agents. 
Iron is an essential nutrient for almost all bacterial species, but it is efficiently 
sequestered by the host during an infection (5) and it is largely insoluble in aerobic 
environments (6). Additionally, ferrous iron can react with H2O2 in the Fenton reaction to 
form reactive hydroxyl radicals, which can damage proteins, DNA, and lipids (7, 8). To 
counter iron scarcity and toxicity, most bacteria express efficient iron acquisition 
systems and tightly regulate intracellular iron homeostasis (6, 8). 
Iron affects biofilm formation in a variety of bacteria (9-13). In E. coli, the master 
biofilm regulator csgD appears to have several indirect ties to iron sensing, transport, 
and availability. Overexpression of csgD inhibits transcription of the iron regulator fecR 
and the outer membrane ferric-coprogen receptor fhuE (14). Furthermore, CsgD binding 
sites are present upstream of the fepDGC and entS operons, which encode 
components of a ferric enterobactin transporter and an enterobactin exporter, 
respectively (15). Finally, iron chelators promote csgD expression in Salmonella 
enterica serovar typhimurium (16, 17).  
In this study I investigated the relationship between curli expression, biofilm 
formation, and environmental iron levels in an E. coli cystitis isolate, UTI89. 
Uropathogenic E. coli (UPEC) is the predominant agent of urinary tract infections, and 
biofilm formation and the production of curli fibers contribute to UPEC pathogenesis (18, 
19). Curli fibers are functional amyloids that form an integral component of the 
extracellular matrix (20). CsgD controls E. coli biofilm formation largely through 
induction of the curli subunit operon csgBAC (21) and the cellulose activator adrA (22, 
23). Along with curli, cellulose aids cell-to-cell attachment and adherence to inorganic 
surfaces and host cells (24-26). UTI89 and a variety of other bacterial species form 
rugose biofilms (also known as rdar) on agar plates (4, 23, 27-29). In both S. 
typhimurium and E. coli, the CsgD-regulated matrix components curli and cellulose are 
necessary for development of rugose biofilms (23, 27, 30). 
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This work revealed several features of E. coli biofilms in response to iron. First, I 
observed that iron induced UTI89 rugose biofilms without increasing total matrix 
production. Within a rugose biofilm, distinct and separable bacterial populations 
emerged. Curli-production was limited to bacteria at the air/biofilm interface and non-
curli-producing bacteria filled the interior of rugose biofilm wrinkles. Furthermore, 
superoxide could activate the rugose biofilm developmental pathway in place of high 
iron, and rugose biofilm formation coincided with increased survival after H2O2 
treatment. Altogether I describe a novel biofilm pathway involving formation of a bimodal 
bacterial population and oxidative stress resistance in enteric bacteria.  
 
Results: 
Iron Triggers the Formation of csgD-dependent Rugose Biofilms 
UTI89 forms csgD-dependent rugose biofilms on YESCA agar plates (Fig. 2.1). 
To test the effect of iron levels on rugose biofilm development, I treated YESCA with 
Chelex-100, a chelating resin. WT UTI89 grown on Chelex-treated YESCA agar plates 
(referred to as low iron conditions) did not form rugose biofilms. Addition of 2 mM FeCl3 
to the cell mixture before plating (referred to as high iron conditions) restored biofilm 
formation (Fig. 2.2A). As expected, a csgD mutant was unable to form rugose biofilms in 
either low or high iron conditions (Fig. 2.2A). To determine whether iron-induced rugose 
biofilm formation coincided with increased curli fiber production, whole cell western blot 
analysis probing for the major curli subunit CsgA was performed on UTI89 grown in low 
or high iron conditions. Bacteria grown in low iron conditions unexpectedly expressed 
more CsgA than rugose-forming UTI89 grown in high iron conditions (Fig. 2.2B). 
However, rugose biofilms coincided with an increase in cell aggregation after treatment 
with a tissue homogenizer (Fig. 2.2B). Since aggregation was dependent on csgD (Fig. 
2.2B), I hypothesized that curli and cellulose were components of the aggregate. This 
could bias western blot analysis, as non-curliated, suspended bacteria would more likely 
be sampled. To prevent aggregation, I produced a UTI89 mutant that cannot synthesize 
cellulose. In most, but not all E. coli strains, csgD activates cellulose production by 
inducing transcription of adrA (23, 31). In turn, the diguanylate cyclase AdrA stimulates 
the cellulose synthase BcsA, presumably through production of cyclic-di-GMP, as BcsA 
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contains a cyclic-di-GMP binding domain (31-33). I verified that UTI89 rugose biofilm 
formation was dependent on csgD, adrA, and bcsA (22, 23, 31) (Fig. 2.1, 2.2C). No 
aggregates collected when the bcsA mutant was tissue homogenized (Fig. 2.2C). I 
therefore repeated the CsgA western blot described above in the bcsA mutant 
background and found that overall levels of CsgA remained unchanged in low vs. high 
iron conditions (Fig. 2.2D). Furthermore, β-galactosidase assays of a bcsA mutant 
transformed with plasmids encoding csgBAC-lacZ or adrA-lacZ transcriptional fusions 
revealed that expression of neither operon changed in response to iron (Fig. 2.2E). Our 
results demonstrate that iron drives rugose biofilm development and cell aggregation in 
UTI89.  However, since overall curli production does not change as a result of varying 
iron concentrations, I inferred that iron exposure may trigger clustering of curli-
producing cells within a rugose biofilm. 
To test whether ferrous iron could also induce rugose biofilm formation, I loaded 
sterile paper discs with either FeCl2 or FeCl3 on low iron plates. UTI89 was spotted next 
to the discs and incubated for 48 hours. Both types of iron were able to induce rugose 
biofilm formation (Fig. 2.3). 
Rugose Biofilms Contain Two Distinct, Separable Bacterial Populations 
Our data lead us to hypothesize that two bacterial populations are present in a 
rugose biofilm – 1) matrix-associated and 2) non-matrix-associated. To mechanically 
separate these populations, I flooded a rugose biofilm in potassium phosphate buffer pH 
7.2 (KPi) with light shaking, reasoning that a non-matrix-encased population would be 
washed into suspension. Upon shaking, the biofilm floated off the agar surface (Fig. 
2.4A). Bacteria that washed freely into suspension (washout fraction) were separated 
from the aggregated bacteria (matrix fraction), which maintained its general shape after 
loss of the washout cells (Fig. 2.4A). Aggregates only settled out of suspension after 
tissue homogenization of the matrix fraction (Fig. 2.4B), and western blot analysis 
demonstrated that CsgA was solely associated with matrix fraction bacteria (Fig. 2.4C).  
To test whether cellulose, the other major rugose biofilm component, was also 
absent in the washout fraction, I quantified binding of Congo red (CR) – a diazo dye that 
binds to both curli and cellulose (31, 34). Washout fraction bacteria bound a similar 
amount of CR as a csgBA bcsA double mutant (Fig. 2.5), indicating that they produce 
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neither curli nor cellulose (34). Consistent with the CR-binding results, β-galactosidase 
assays showed that transcription of csgDEFG, csgBAC, and adrA was significantly 
reduced in the washout fraction as compared to the matrix fraction (Fig. 2.4D). 
Therefore I were able to identify and mechanically separate matrix-encased and non-
matrix encased bacteria in a rugose biofilm.  
Curliated Bacteria are Localized to the Air-Biofilm Interface in Rugose Biofilms 
Confocal microscopy was used to locate curli-producing cells within a rugose 
biofilm. A UTI89 strain harboring a csgBAC-mCherry transcriptional fusion at the attB 
site was transformed with the IPTG-inducible GFP expressing plasmid pCKR101-eGFP. 
I reasoned that all metabolically active cells would express GFP while curli-expressing 
cells would produce both mCherry and GFP. Z-stack videos taken from a rugose biofilm 
grown on a YESCA agar plate revealed that bacteria expressing mCherry were 
localized to the biofilm surface, while a population of non-curli-producing bacteria was 
localized to the interior of the each wrinkle (35). Cross-section images of the biofilm 
midpoint, as well as 3D reconstructions of biofilm sections, further demonstrated that 
each wrinkle is filled with a population of non-curli-producing cells (Fig. 2.6A, C, D). 
After the washout assay, cells were absent from the wrinkle interiors, indicating that 
interior, non-curli-producing cells were removed as the washout fraction (Fig. 2.6B, C, 
E) (35).  
To specifically probe iron-responsive architectural changes, the csgBAC-
mCherry/pCKR101-eGFP reporter strain was grown on Chelex-treated YESCA plates 
with or without FeCl3 added to the cell mixture. In the low iron colony, GFP and mCherry 
were evenly distributed throughout, indicating no large-scale spatial separation between 
curli-expressing cells and non-curli-expressing cells except for a gradual increase in 
curli/mCherry-producing cells near the biofilm surface (Fig. 2.7A). When iron was added 
to the cell mixture before plating on Chelex-treated YESCA plates, the distribution of 
cells throughout the rugose biofilms matched that seen on YESCA plates (Fig. 2.7B, 
2.6D).  
Oxygen levels can affect folding and activity of fluorophores (36). Since oxygen 
penetration into biofilms is generally limited (3), I also imaged expression patterns of a 
UTI89 attB::csgBAC-eGFP/pCKR101-mCherry strain. In this strain, mCherry producing 
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cells were localized to the interior of the wrinkles. Bacteria expressing both mCherry 
and GFP lined the air/biofilm interface (Fig. 2.7C). Since this pattern was essentially the 
inverse of that seen in Fig. 2.6D, I concluded that both fluorophores can fluoresce in the 
biofilm interior and that the csgBAC promoter is repressed in the interior washout cells.  
Superoxide Stress Drives Rugose Biofilm Formation 
Since iron triggers rugose biofilm formation, I hypothesized that an iron 
responsive regulatory protein was involved in the rugose biofilm developmental process. 
To test this, I knocked out known iron-responsive transcriptional factors that have also 
been shown to affect biofilm formation. Our candidates included the global iron 
regulator, Fur (11, 12), the iron-sulfur cluster regulator, IscR (9), the ferric iron sensing 
two-component system, BasSR (37), and the small RNA, RyhB (10). All of the mutants 
still formed rugose biofilms in response to iron (Fig. 2.8). However, the fur mutant 
wrinkled more than WT in low iron conditions (Fig. 2.8, 2.9A). 
A fur mutant constitutively expresses various iron acquisition systems and 
accumulates toxic amounts of cytoplasmic free ferrous iron (38). To investigate the 
possibility that the increase in rugose biofilm formation in the fur mutant is due to iron-
induced toxicity, I constructed a UTI89 sodA sodB double mutant that cannot produce 
cytoplasmic superoxide dismutase. In a sodA sodB mutant, cytoplasmic superoxide 
accumulates and breaks down solvent exposed [4Fe-4s] clusters in vulnerable proteins, 
freeing ferrous iron (39-41). The sodA sodB mutant formed a rugose biofilm under low 
iron conditions in a similar manner as the fur mutant (Fig. 2.9A). I also overexpressed 
sodA in a fur mutant to see if rugose biofilm formation was dampened, as reactive 
oxygen stress in a fur mutant can be partly negated by sodA overexpression (38). 
Rugose biofilm formation was decreased under low iron conditions in both the fur 
mutant and sodA sodB mutant when sodA was overexpressed (Fig. 2.9B).  
Since accumulation of endogenous superoxide induced rugose biofilm 
development, I next tested whether superoxide-producing antibiotics can induce rugose 
biofilm formation in place of high iron levels. Pseudomonas aeruginosa along with a 
variety of other bacteria produce redox-cycling antibiotics called phenazines (29, 42). In 
susceptible bacteria such as E. coli, phenazines enter the cell and produce superoxide 
by oxidizing cytoplasmic targets and reducing molecular oxygen (43). Intriguingly, 
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exogenous phenazine methosulfate exposure resulted in rugose biofilm formation in low 
iron conditions in UTI89, albeit at a slower rate than iron induction (Fig. 2.9C). A sodA 
mutant developed a rugose biofilm more rapidly than WT in response to phenazine 
exposure (Fig. 2.9D). As both iron and superoxide can independently induce rugose 
biofilms, our next question was whether reactive oxygen stress was involved in iron-
driven rugose biofilm formation. To this end, I overexpressed sodA in WT and observed 
rugose biofilm formation on Chelex-treated YESCA plates supplemented with 10 μM 
FeCl3 (Fig. 2.9E). Overexpression of sodA decreased rugose biofilm formation after 48 
hours. Altogether, these results indicate that both iron and superoxide stress trigger 
rugose biofilm formation. Furthermore, iron-induced rugose biofilm formation is at least 
partly dependent on reactive oxygen stress. 
Lastly, I sought to determine whether induction of rugose formation was specific 
to iron.  I therefore exposed WT UTI89 to various metals on chelex-100-treated YESCA 
plates.  Among the metals tested, gallium and aluminum were the only other metals 
besides iron able to induce rugose formation to any degree (Fig. 2.10). Gallium and 
aluminum are both transition metals that demonstrate toxicity towards bacteria.  Gallium 
has a similar ionic radius as iron, but cannot redox cycle.  Therefore it can disrupt iron 
homeostasis by binding to otherwise Fe3+ specific siderophores and proteins and 
preventing proper protein function (44, 45).  The mode of aluminum toxicity is less 
understood, but like gallium, aluminum has a similar ionic radius to iron, and there is 
evidence that aluminum can also bind to iron-specific siderophores (46, 47).  Altogether, 
these results indicate that iron-induced oxidative stress triggers rugose biofilm 
formation. 
Rugose Biofilm Formation Coincides with H2O2 Resistance 
Since rugose biofilm development can be triggered by reactive oxygen stress, I 
hypothesized that a rugose biofilm would demonstrate increased resistance to H2O2. 
Therefore, UTI89 grown in low or high iron conditions was tissue-homogenized, 
normalized by OD600, and treated with H2O2. Strikingly, iron-induced rugose biofilm 
development corresponded with H2O2 resistance (Fig. 2.11A). I next tested H2O2 
resistance of the washout and the matrix fractions of rugose biofilms grown on a 
Chelex-treated YESCA plate with addition of iron. Intriguingly, washout fraction bacteria 
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were more sensitive to H2O2 than matrix fraction cells, while both fractions were more 
resistant than bacteria grown under low iron conditions (Fig. 2.11A).  
Reactive oxygen species are generated as a byproduct of aerobic metabolism 
(48, 49), and oxygen diffusion into biofilms is generally limited due to respiration by 
periphery cells (3). I hypothesized that within a rugose biofilm, interior, non-matrix 
encased bacteria would be exposed to less atmospheric oxygen than matrix-encased, 
exterior cells. Oxygen microsensor measurements of a rugose biofilm demonstrated 
that oxygen levels decrease with biofilm depth (Fig. 2.11B). Assuming equal oxygen 
penetration from both the top and the sides of a single wrinkle, I can then map oxygen 
penetration depth onto a confocal image of curli-expressing cells in a rugose biofilm 
(Fig. 2.11C). The interior, non-matrix-associated cells of a rugose biofilm are therefore 
exposed to roughly 25-70% atmospheric oxygen, depending on their proximity to the 
surface (Fig. 2.11C). Altogether these data indicate that rugose biofilm formation 
parallels H2O2 resistance. Within a rugose biofilm, interior, washout cells are partly 
shielded from oxygen and are more susceptible to reactive oxygen stress than their 
matrix-encased neighbors. 
Due to the increase in curli expression and hydrogen peroxide resistance in the 
matrix fraction, I hypothesized that RpoS levels might be increased in the matrix 
fraction. RpoS is required for csgD expression and for expression of the catalase katE 
(50, 51). Furthermore, Serra el. al. suggested that elongated, interior bacteria in rugose 
biofilms likely have decreased RpoS levels (52, 53). I directly tested catalase activity in 
each biofilm fraction by utilizing an Amplex red/Horseradish peroxidase assay (54). 
Catalase activity was equivalent in both rugose biofilm fractions in WT UTI89 (Fig. 
2.12A). However, E. coli encodes another catalase, katG, that is induced upon 
exposure to hydrogen peroxide by OxyR (54, 55), and is most likely induced during the 
course of the assay. A katG mutant revealed that katE-dependent catalase activity was 
increased in the matrix fraction (Fig. 2.12A). Furthermore, a katG rpoS mutant 
demonstrated the same catalase activity as a katG katE double mutant, demonstrating 
that katE-dependent catalase activity is increased in the shell fraction in an rpoS-
dependent manner (Fig. 2.12B). Western blots suggest that RpoS levels may in fact be 
slightly decreased in the washout fraction (Fig. 2.12C). 
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Iron Triggers Bimodal Rugose Biofilms in other Enteric Bacteria 
Lastly I wanted to determine if iron-induced rugose biofilm formation was 
widespread among enterics. To this end S. typhimurium and a clinical isolate of 
Citrobacter koseri, which form rugose biofilms on LB – salt and YESCA plates 
respectively (Fig. 2.13A), were plated on Chelex-treated agar plates with or without 
addition of FeCl3. Both strains formed rugose biofilms only when exposed to iron (Fig. 
2.13B). Furthermore, CsgA was largely localized to the matrix fractions after performing 
the washout assay (Fig. 2.13C). As in UTI89, rugose biofilm formation paralleled H2O2 
resistance in each strain (Fig. 2.13D). I conclude that iron-induced bimodal rugose 
biofilm development and the increase in H2O2 resistance as a function of rugose biofilm 
formation are common features of enteric bacteria. 
 
Discussion: 
Our results demonstrate that iron induces macroscopic architectural restructuring 
and H2O2 resistance in UTI89 biofilms (Fig. 2.2,2.11). However, total curli levels did not 
change in response to varying iron concentrations (Fig. 2.2), indicating that matrix 
production is not sufficient for rugose biofilm formation. Previous work has found that 
low iron levels can affect curli production under certain conditions, as iron chelators 
added to S. typhimurium results in lower curli expression (16, 17). However, comparing 
the Salmonella results with ours is difficult because of disparities in strains used and 
growth conditions.  Iron-dependent rugose biofilm formation has likely not been reported 
before because common laboratory media has sufficient iron to induce rugose biofilm 
formation, as is evidenced by the fact that WT UTI89, C. koseri and S. typhimurium form 
rugose biofilms on YESCA or LB - salt agar plates without the addition of iron (Fig. 
2.13A).  
Both iron availability and biofilm formation affect UPEC pathogenesis. During 
infection, UPEC ascends the urethra into the bladder. Once in the bladder, UPEC is 
able to attach to and invade urothelial cells (56). After cell invasion, UPEC forms biofilm-
like pods, termed intracellular bacterial communities (IBCs) (18), and IBC formation 
helps UPEC avoid the host immune system (18, 56, 57). Growth in urine induces 
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expression of a variety of iron acquisition systems in UPEC, demonstrating that urine is 
an iron-limiting environment (58). Additionally, IBC formation correlates with induction of 
genes involved in acquiring iron from heme and siderophores (59). As iron and biofilm 
formation both play a significant role in UPEC pathogenesis, it is tempting to speculate 
that the iron-induced biofilm formation I describe here may contribute to UPEC 
virulence. 
 Experiments with UTI89 grown in low and high iron conditions revealed that iron 
induces aggregation and rugose biofilm development. There are at least two spatially 
distinct cellular populations within rugose biofilms:  matrix-encased and non-matrix-
encased (Fig. 2, 3). Studies in S. typhimurium have previously demonstrated that levels 
of CsgD and curli can vary from cell to cell in bacterial communities (17, 60). Here I 
have demonstrated a distinct bimodal restructuring in which matrix-producing bacteria 
line the air/biofilm interface while non-matrix-producing bacteria fill the wrinkle interiors. 
Additionally, the two populations are easily separated, as expression of curli and 
cellulose imbues a rigidity to the matrix-encased cells that prevents them from being 
suspended during buffer washes. Separation via the washout assay allows for 
examination of the two distinct populations by biochemical and genetic techniques. The 
dramatic disappearance of curli and cellulose and the elevated H2O2 susceptibility in the 
washout fraction imply significant physiological differences between washout and matrix 
fractions.  
We have determined that the iron-induced rugose biofilm developmental pathway 
is triggered, at least in part, by reactive oxygen stress. However, the mechanism by 
which high extracellular iron would cause intracellular reactive oxygen stress is unclear. 
E. coli is able to maintain a steady intracellular iron pool, regardless of extracellular iron 
fluctuations, due to the efficacy of iron homeostasis regulators such as Fur and RyhB 
(6). Fur is a transcriptional regulator that binds to ferrous iron and represses expression 
of iron acquisition systems. RyhB is a small RNA that limits production of iron-containing 
proteins in low iron conditions (6, 61). Therefore high extracellular iron should not 
necessarily lead to cytoplasmic free iron stress. High iron levels could allow for rapid 
cell growth and aerobic respiration, resulting in superoxide production from the electron 
transport chain (48, 49). Additionally, it has been proposed that normal fluxes in 
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intracellular free iron through Fe-Fur cycling can lead to brief periods of iron stress (38). 
If this is the case, the summation of oxidative stress from multiple free iron cycles may 
lead to enough reactive oxygen stress to induce rugose biofilm formation. sodA 
overexpression could temper the amount of free iron stress in each cycle. Future work 
will elucidate the genetic pathways leading from oxidative stress to the development of 
rugose biofilms. 
A wide-variety of bacterial species form rugose biofilms (4, 23, 28, 29). While the 
triggers of rugose biofilm development no doubt vary between systems, the conserved 
wrinkled architecture implies a measure of commonality. Rugose biofilm formation in P. 
aeruginosa is inhibited by self-produced phenazines (29).  Intriguingly, I found that E. 
coli forms rugose biofilms when exposed to phenazines or when it is unable to 
neutralize endogenous superoxide (Fig. 2.9A, C). Furthermore, a recent study in 
Bacillus subtilis determined that localized cell death contributes to the mechanical 
buckling necessary for rugose biofilm wrinkle formation (28). It is tempting to speculate 
that superoxide stress could accelerate cell death, although I found that both the 
washout and matrix fraction cells are viable under conditions that promote rugose 
biofilm formation (Fig. 2.11A). Additionally, I would expect superoxide toxicity to 
increase with proximity to molecular oxygen, and I have demonstrated that interior 
bacteria in a rugose biofilm are exposed to less atmospheric oxygen than their surface-
exposed neighbors. 
Biofilm formation, and in particular cellular differentiation within biofilms, 
contributes to bacterial antibiotic resistance (1). The sophisticated genetic tools 
available in E. coli, the large body of literature dedicated to E. coli metabolism, and the 
prevalence of E. coli-mediated uropathogenic infections make UTI89 an attractive 
model for biofilm development. Within iron-induced rugose biofilms, two populations, 
matrix-encased and non-matrix-encased, emerge. These populations are easily 
separable due to the loose association of interior cells with the biofilm matrix. Rugose 
biofilm development also parallels tiered H2O2 resistance, with surface-exposed bacteria 
being more resistant than interior cells. Analysis of the mechanisms of dual-population 
formation and the genetic pathways involved in H2O2 resistance will provide further 
insight into a biofilm developmental pathway. 
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Materials and Methods: 
Reagents:  
Catalase from bovine liver, H2O2, FeCl3, tryptophan, and MnCl2·4H2O were obtained 
from Sigma-Aldrich.  Congo red was obtained from Acros Organics.  Casamino acids 
were obtained from Amresco. Chelex-100 was obtained from Bio-Rad.  Noble agar was 
obtained from BD. ProLong Gold Antifade Reagent was obtained from Invitrogen and 
CaCl2, MgCl2, IPTG, tryptone, yeast extract, and agar were obtained from Fisher. 
Strains, Growth Conditions, and Cloning:  
Strains and plasmids are listed in Table 2.1 and primers are listed in Table 2.2.  
Bacteria were routinely grown in LB broth at 37°C under aeration. Rugose biofilms were 
grown for 48 hours on agar plates at 26°C unless otherwise noted. UTI89 was obtained 
from Scott Hultgren (62). Salmonella enterica serovar Typhimurium strain ATCC 14028 
was obtained from the American Type Tissue Collection. Citrobacter koseri was 
obtained from the University of Michigan medical school.  Strains were routinely grown 
in LB at 37°C under aeration. The sodA sodB and fur mutants were grown without 
shaking to avoid excessive oxygen exposure. Mutations were introduced into UTI89 by 
the lambda red recombinase method as described (63). The plasmid pCKR101 (39) 
was used for all overexpression experiments. For construction of overexpression 
vectors, inserts were amplified from the UTI89 genome and cloned into the pCKR101 
vector using KpnI and XbaI restriction sites. The lacZ transcriptional fusion plasmids 
pRJ800 (empty vector), pBA14 (csgBAC promoter driving lacZ), and pD1 (csgDEFG 
promoter driving lacZ) have been described (64). pRJ800-adrA (adrA promoter driving 
lacZ) was constructed by cloning a UTI89 genomic fragment including the adrA 
promoter into pRJ800 using BamHI and XbaI. Integration of the csgBAC-mCherry 
transcriptional fusion into the UTI89 attB site was performed as described (65, 66), 
except mCherry was cloned from pAH6 (67) into pCD13psk using SpeI and SacI 
restriction sites while the csgBAC promoter was cloned into pCD13psk from the UTI89 
genome using HindIII and SpeI.  
Rugose Formation and Low Iron Media: 
For rugose biofilm development, UTI89 was grown overnight in LB, diluted to 1 OD600 
and rinsed twice with YESCA media (10 g Casamino acids, 1 g yeast extract/L). 4 μl of 
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a 1 OD600 cell mixture was spotted onto YESCA agar plates (10 g Casamino acids, 1 g 
yeast extract, 20 g agar/L).  Congo red YESCA plates included a 50 µg/mL supplement 
of Congo red. Bacteria were incubated at 26°C for 48 hours unless otherwise noted. 
Pictures were taken either with a Canon EOS Rebel XSi camera or a Leica MZ FLIII 
Stereo-Fluorescence Microscope coupled to a Leica DC480 Microscope camera. For 
low iron media, YESCA media was incubated with Chelex-100 at 5 g/100 mL for 2 hours 
at room temp with fresh resin or ON at room temp with regenerated resin. Media was 
then filtered with 0.22 µM PES bottle-top filters to separate the resin. For Chelex-treated 
agar plates, media was autoclaved with 1.4% Difco Noble Agar and supplemented with 
100 µM MgCl2, 10 µM CaCl2, and 100 µM tryptophan. FeCl3, MnCl2, and IPTG were 
also supplemented where indicated.  For typical rugose biofilm formation on Chelex-
treated plates, cells were grown ON in LB, rinsed twice with Chelex-treated YESCA 
media, and resuspended at 1 OD600. 0 μl or 2 μL of 100 mM FeCl3 (low iron vs. high iron 
conditions) was added to 100 µL of 1 OD600 cells. 4 μl dots of these mixes were plated 
on Chelex-treated plates. For paper disc assays, 5 μL of indicated chemicals was added 
to sterile paper discs after cell mixes had been plated and had dried. For 
overexpression assays IPTG was added to plates at a final concentration of 10 μM or 
50 μM as noted. Ampicillin and kanamycin were added when appropriate to final 
concentrations of 100 mg/mL and 50 mg/mL respectively. For rugose biofilm 
development, S. typhimurium was grown on LB – salt agar plates (10 g tryptone, 5 g 
yeast extract, 17 g agar /L) or Chelex-treated LB – salt agar plates for 72 hours and C. 
koseri was grown on YESCA agar plates or Chelex-treated YESCA agar plates for 48 
hours. 
Confocal Microscopy:  
4 μL of 1 OD600 cells were dotted onto Millipore 0.05 μM MF-Membrane Filters that had 
been placed on YESCA agar plates or Chelex-treated YESCA plates. For induction of 
the pCKR101-eGFP or pCKR101-mCherry plasmids, 1 mM IPTG was added to cell 
mixtures prior to plating. After 48 hours at 26°C, colonies and their underlying filter were 
cut out with a razorblade and transferred to a microscope slide. 100 μL of Invitrogen 
ProLongGold antifade reagent was added to the top of each biofilm, and a 24x60-1.5 
coverslip was placed on top. Small spacers roughly 0.3 mM in height were placed in 
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each corner of the slide before addition of the coverslip to prevent direct contact 
between the biofilm and the coverslip. Samples were analyzed the next day with a Leica 
SP5 laser scanning confocal microscope (Leica GmbH, Mannheim Germany) on a 
DM6000B microscope base using a 20x or 40x objective. A double-dichroic 488/561 
beam splitter and a 488nm argon laser (eGFP) and a 561nm DPSS laser (mCherry) 
were utilized for image capture. Images and movies were analyzed with LAS AF v2.6.3 
build 8173 software. 
H202 Viability Assays:  
For UTI89, mature biofilms or washout/matrix fractions were suspended in 50 mM KPi 
pH 7.2, tissue homogenized, and 250 μL of cells normalized to 1 OD600 were mixed with 
250 μL 1% H2O2 in 50 mM KPi pH 7.2. This mixture was incubated for 20 minutes. 500 
μL of 1 mg/mL catalase was then added to stop H2O2-induced killing, and cells were 
spun down at 12,000 rpm for 1 minute. Cells were then resuspended in 250 μL 50 mM 
KPi pH 7.2, and 4 μL dots of 10-fold serial dilutions were plated on LB plates and grown 
ON at 37°C. S. typhimurium and C. koseri viability assays were performed identically 
except S. typhimurium was mixed with 1% H2O2 for 15 minutes and C. koseri was mixed 
with 3% H2O2 for 20 minutes. 
Western Blot Analysis:  
Western blotting was performed as described (68) with modifications. Briefly, samples 
were treated with HFIP to solubilize CsgA. After HFIP was removed with a Thermo 
Savant SPD SpeedVac, samples were resuspended in SDS running buffer. Samples 
were then electrophoresed in 15% polyacrylamide gels and transferred onto a 
nitrocellulose membrane in a wet transfer apparatus in 25 mM CAPS transfer buffer pH 
11.2 with 10% methanol. Blots were blocked with 5% milk in TBST for 1 hour at room 
temp or ON at 4°C. After TBST washes, blots were incubated for 1 hour with primary 
(1:5000 Santa Cruz RNA pol σ D antibody, 1:5000 Santa Cruz RNA pol σ S Antibody, 
and 1:8500 anti-CsgA peptide antibody (64)) and secondary (horseradish peroxidase-
linked anti-mouse and anti-rabbit, both at 1:8500) antibodies in 1% BSA, 1% milk in 
TBST at room temp. 
Oxygen Microelectrode Measurements: 
 UTI89 was grown on YESCA agar plates for rugose biofilm formation. Oxygen 
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microsensor measurements were performed as described (69, 70). All microprofiles 
were performed using Clark-type oxygen micro-electrodes with outside tip diameters of 
10 µm, response time 1-3 sec and  < 2% stirring sensitivity (Unisense, A/S). 
Amplification and sensor positioning was controlled with a microsensor multi-meter 
coupled with a motor controlled micromanipulator. Data collection was aided by 
software packages, SensorTrace Pro ver.3.0.1 (Unisense. A/S). Two point calibrations 
were performed in air saturated DI water and in a 1 M NaOH, 0.1 M ascorbic acid 
solution (anoxic standard). Calibrations were repeatedly checked in the anoxic standard 
and in air saturated DI water throughout the experiments. Triplicate oxygen 
measurements (both biological and technical-position replicates) were done in one-
dimension (depth-wise) from the biofilm-air interface down in. The step size between 
measurements was 10 µm. 
Quantitative Congo Red Binding:  
Congo red (CR) binding assays were performed as described (34) with modifications. 
Mature biofilms were harvested and suspended in 50 mM KPi pH 7.2. A 300 μL 
suspension of 2 OD600 cells and 5 μg/mL CR was incubated with shaking at 37°C for 30 
minutes. Cells were then pelleted at 12,000 RPM for 1 minute, and 100 μL of the 
supernatant was assayed for absorbance at 490 nm in a Tecan infinite M200 
platereader. Absorbances were then subtracted from a CR only negative control, and 
percentage of CR removal was calculated, with the CR only control representing 0% 
removed and the KPi only control representing 100% removed. Error bars represent the 
standard deviation of three biological replicates. 
Catalase Activity:   
Hydrogen peroxide scavenging by whole cells was performed by the amplex 
red/horseradish peroxidase assay as described (71) with minor modifications.  Briefly, 
cells were diluted to .1 OD600 in 50 mM kPi pH 7.8 in 100 μL and were added to a well 
of a 96-well plate.  Hydrogen peroxide was added to 150 μM for each sample and this 
mix was incubated for 15 minutes.  25 μL of a 200 μM stock solution of amplex red (AR) 
dissolved in 50 mM kPi pH 7.8 and 25 μL of 0.02 mg/mL horseradish peroxidase 
dissolved in 50 mM kPi pH 7.8 were then added to each well and absorbance was read 
at 568 nM.  Samples were diluted when necessary, a mix of cells, AR, and HRP without 
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hydrogen peroxide was assayed and subtracted as the blank, and concentrations were 
measured by plotting on a standard curve obtained with samples of 0-50 μM hydrogen 
peroxide. 
β –galactosidase Assays:  
β –galactosidase assays were performed as described (64, 72) with modifications. 100 
μL of suspended cells were added to the wells of a 96-well plate and multiple dilutions 
were added to 90 μl reaction buffer. These reactions were incubated at 30⁰C for 30 
minutes before addition of 20 μl of 4 mg/mL ONPG. Reactions were stopped via 
addition of 50 μL 1 M Na2CO3 at a light yellow color and the time was recorded. Abs. of 
each cell suspension at 600 nm and abs. of each reaction mixture at 420 nm and 550 
nm were measured using a Tecan infinite M200 platereader. β –galactosidase assays 
were performed in triplicate on a strain carrying an empty vector (pRJ800) under each 
condition. Average Miller units from the pRJ800-carrying strains were subtracted from 
each respective strain carrying pBA14, pD1, or pRJ800-adrA. After subtracting out the 
empty vector values, averages, standard deviations, and p-values were calculated from 
biological triplicates of strains carrying pBA14, pD1, or pRJ800-adrA as noted. 
Washout Assay:  
After 48 hours of growth on agar plates, a sterile metal spatula was used to cut out and 
transfer a slab of agar containing an intact colony to a well of a Falcon Tissue-treated 
Polystyrene 24-well plate. 1 mL of sterile 50 mM KPi pH 7.2 was added to the well and 
the plate was shaken gently until the matrix fraction had completely dissociated from the 
agar surface (typically 5 minutes). The KPi buffer was removed and the ‘washout’ cells 
were spun down. Two more 5-minute washes were performed on the colony, and buffer 
from each rinse was added to the washout tube and spun down. A pipette tip was used 
to remove the ‘matrix’ fraction from the third rinse and the entire matrix was placed in a 
separate eppendorf tube with 1 mL KPi. The matrix fraction was then tissue 
homogenized. Briefly, a Fisher Scientific Tissuemiser tissue homogenizer was inserted 
into the eppendorf tube, turned to medium speed, and run for 20 seconds. Aggregates 
were allowed to settle, and suspended cells from each fraction were then assayed. 
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Figures and Tables: 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 UTI89 forms CsgD-dependent Rugose Biofilms  
WT UTI89 and mutants were plated on YESCA agar plates or Chelex-treated YESCA 
agar plates with or without the addition of CR. Strains producing either curli or cellulose 
bind CR, but a curli cellulose double mutant does not. A csgD mutant does not bind CR, 
indicating that CsgD is required for curli and cellulose production in UTI89. Both curli 
and cellulose are required for WT rugose biofilm formation. 
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Figure 2.2 Iron induces UTI89 rugose biofilm formation 
 (A) WT UTI89 or a csgD mutant were grown on Chelex-treated YESCA plates with or 
without 2 mM FeCl3 added to the cell mixture before plating. (B) After tissue 
homogenization, aggregates immediately began falling out of suspension and were fully 
settled within 10 minutes. Aggregation increased with rugose biofilm formation and was 
dependent on csgD (top of panel). Suspended cells from low iron colonies demonstrate 
an increase in CsgA protein levels by whole cell western blot compared to suspended 
cells from high iron conditions, while 70 levels remain constant (bottom of panel). (C) A 
bcsA mutant does not form rugose biofilms (left side of panel) and does not form 
aggregates after tissue homogenization (right side of panel) when grown in either low or 
high iron conditions. (D) A western blot of the bcsA mutant shows that total CsgA levels 
do not change between low and high iron conditions. (E) A UTI89 bcsA mutant strain 
carrying csgBAC (pBA14) or adrA (pRJ800-adrA) transcriptional lacZ fusion plasmids or 
an empty vector (pRJ800) were plated on Chelex-treated YESCA plates with or without 
the addition of FeCl3  
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Figure 2.3 Both ferrous and ferric iron can trigger UTI89 rugose biofilms  
WT UTI89 was plated on low iron plates next to a disc loaded with 100mM FeCl3 (ferric 
iron) or FeCl2 (ferrous iron). 
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Figure 2.4 Two separable populations, matrix producing and non-matrix-
producing, are present in a rugose biofilm (A) Washing a UTI89 rugose biofilm in 50 
mM KPi buffer after growth on a YESCA agar plate separates suspended ‘washout’ 
from aggregative ‘matrix’ bacteria. (B) Cell aggregates only collect after tissue 
homogenization of the matrix fraction. (C) Western blot analysis demonstrates that 
CsgA is localized solely to the matrix fraction bacteria. (D) WT UTI89 or a csgD mutant 
carrying csgBAC (pBA14), adrA (pRJ800-adrA), or csgDEFG (pD1) transcriptional lacZ 
fusion plasmids were grown on YESCA plates. β –galactosidase assays were 
performed on each strain before (whole) or after the washout assay, and error bars 
represent the standard deviation of biological triplicates. WT and a csgD mutant 
carrying an empty vector (pRJ800) were also assayed, and average Miller units from 
these strains were subtracted from the respective samples. Asterisks represent P 
values (*P < 0.05) evaluated using a Student’s t-test. 
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Figure 2.5 Washout bacteria do not produce curli or cellulose 
Suspended bacteria were incubated with 5 μg/mL CR in KPi buffer, spun out of 
suspension, and the percent of CR taken out of solution by the bacteria was assayed by 
abs. at 490 nm of the supernatant. A CR only control represents 0% CR binding, and a 
KPi only control represents 100% CR binding. Error bars represent the standard 
deviation of biological triplicates. 
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Figure 2.6 Confocal microscopy reveals bimodal rugose biofilm architecture 
(A) UTI89 attB::csgBAC-mcherry/pCKR101-eGFP was grown on 0.05 μM cellulose 
filters on YESCA agar plates with 1 mM IPTG added to the cell mixture before plating. 
Filter sections containing a biofilm were cut out with a razor blade, placed on a slide, 
and treated with mounting solution. A 20x confocal microscopy cross-section of a UTI89 
attB::csgBAC-mcherry/pCKR101-eGFP rugose biofilm before and (B) after the washout 
assay was imaged. (C) Average relative fluorescent intensity of five separate traces 
across the blue lines in (A,B) for each fluorophore was calculated and is graphed 
against distance along the blue line from each blue circle. (D) 3D reconstructions before 
and (E) after washout assay. White arrows indicate wrinkle openings where non-curli-
producing bacteria are present before the washout assay but not after. 
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Figure 2.7 Rugose biofilm structure in low and high iron conditions 
(A) UTI89 attB::csgBAC-mCherry/pCKR101-eGFP was grown on Chelex-treated 
YESCA plates on a cellulose filter and visualized by confocal microscopy, revealing little 
spatial separation of curli-producing and non-curli-producing bacteria. (B) UTI89 
attB::csgBAC-mCherry/ pCKR101-eGFP with FeCl3 added back to the cell mixture 
before plating on Chelex-treated YESCA plates demonstrates identical architecture as 
the same strain grown on YESCA plates. (C) A UTI89 attB::csgBAC-eGFP /pCKR101-
mCherry strain grown on a YESCA plate demonstrates mCherry-producing cells lining 
the interior of mCherry/GFP expressing surface bacteria. White arrows indicate sites 
where non-curli producing bacteria can be seen in wrinkle interiors. 
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Figure 2.8 A fur mutant wrinkles in low iron conditions 
WT UTI89 as well as iscR, basSR, fur and ryhB mutants were plated on Chelex-treated 
YESCA agar plates with or without addition of FeCl3 to the cell mixture before plating. 
Only the fur mutant demonstrated an increase in rugose biofilm formation in low iron 
conditions.  
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Figure 2.9 Iron and superoxide stress drives rugose biofilm formation 
(A) WT UTI89, a fur mutant, or a sodA sodB double mutant were grown on Chelex-
treated YESCA plates with or without the addition of FeCl3 to the cell mixture before 
plating. (B) Over-expression of sodA repressed rugose biofilm formation in the fur and 
the sodA sodB mutant compared to the empty vector (EV) controls. Strains were grown 
on chelex-treated YESCA plates supplemented with 100 μM MnCl2 and either 10 μM 
IPTG (WT and sodA sodB) or 50 μM IPTG (fur). (C) WT UTI89 was exposed to 5 μl 
H2O, 100 mM FeCl3, or 10 mM phenazine methosulfate on a sterile paper disc (1 cm to 
the left of the pictured biofilms). (D) Rugose biofilm formation in response to phenazine 
is more rapid in a sodA mutant as compared to WT. (E) Rugose biofilm formation in WT 
UTI89 grown on Chelex-treated YESCA plates supplemented with 100 μM MnCl2, 50 
μM IPTG, and 10 μM FeCl3 was repressed by overexpression of sodA. 
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Figure 2.10 Gallium and aluminum can also trigger rugose biofilm formation 
WT UTI89 grown on chelex-100 treated YESCA plates and exposed to 10 μL of 100 
mM metal salts on paper discs demonstrate that full rugose formation is specific to iron, 
while gallium and aluminum are also able to induce wrinkling to a degree. 
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Figure 2.11 Rugose biofilm formation coincides with H2O2 resistance 
(A) WT UTI89 was grown on Chelex-treated YESCA plates with or without the addition 
of FeCl3 to the cell mixture before plating. Bacteria from each iron condition, or from 
washout and matrix fractions from high iron rugose biofilms, were normalized to 1 OD600 
and exposed to 1% H2O2 for 20 minutes. Cells were serially diluted and plated on LB 
plates. (B) A 10 μm oxygen microsensor was used to measure oxygen penetration into 
WT UTI89 rugose biofilms. Each data point is an average of three technical and three 
biological replicates. A 6th order polynomial curve was fit to the data points. (C) Oxygen 
penetration depth was mapped onto a 40x confocal cross-section image of the midpoint 
of a UTI89 attB::csgBAC-mcherry/pCKR101-eGFP rugose biofilm induced with IPTG. 
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Figure 2.12 RpoS-dependent KatE activity is increased in the matrix fraction 
(A,B) The Amplex red/Horseradish peroxidase assay was utilized to determine the 
catalase activity in the washout and shell fractions of various mutants. (C) Western 
blotting for RpoS and σ70 was performed. All assays were performed after 48 hours of 
growth on YESCA agar plates at 26°C. 
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Figure 2.13 Iron-dependent rugose biofilm formation in other enterics 
(A) UTI89 and C. koseri form rugose biofilms on YESCA plates after 48 hours, and S. 
enterica forms rugose biofilms on LB - salt agar plates after 72 hours. (B) Whole cell 
western blot analysis performed on washout and matrix fractions demonstrates that 
CsgA is chiefly localized to the matrix fraction in all three strains. (C) Iron is required for 
rugose biofilm formation of UTI89 and C. koseri on Chelex-treated YESCA plates and 
for S. typhimurium on Chelex-treated LB – salt plates. (D) When grown in low iron 
conditions, all three strains were more susceptible to H2O2 treatment than after growth 
in high iron conditions. UTI89 was mixed with 1% H202 for 20 minutes as described in 
materials and methods, C. koseri was mixed with 3% H202 for 20 minutes, and S. 
typhimurium was mixed with 1% H202 for 15 minutes. 
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Table 2.1: Strains and Plasmids Used in Chapter 2 
 
Plasmid: Reference: Notes: 
pCKR101 (39)  
pCKR101-sodA This Work sodA cloned into KpnI and XbaI sites 
of pCKR101 with primers WD229 and 
WD209 from UTI89 genome 
pCKR101-eGFP This Work eGFP cloned into KpnI and XbaI sites 
of pCKR101 with primers WD263 and 
WD264 from genome of UTI89 
attB::csgBAC-eGFP 
pCKR101-mCherry This Work mCherry cloned into KpnI and XbaI 
sites of pCKR101 with primers 
WD244 and WD245 from pAH6 
pRJ800 (64) lacZ expressing plasmid with no 
promoter sequence, used as empty 
vector for β-galactosidase assays. 
pBA14 (64) csgBAC promoter driving lacZ in 
pRJ800 vector. 
pD1 (64) csgDEFG promoter driving lacZ in 
pRJ800 vector. 
pRJ800-adrA This Work adrA promoter cloned into BamHI and 
XbaI sites of pRJ800 with primers 
DH1 and DH2 from the UTI89 
genome 
pAH6  (67)  
pCD13psk  (65, 66)  
pCD13psk-mCherry This Work mCherry cloned from pAH6 into 
pCD13psk SpeI and SacI sites using 
primers WD119 and WD120 
pCD13psk-csgBAC-
mcherry 
This Work UTI89 csgBAC promoter from the 
UTI89 genome cloned into pCD13psk-
mcherry HindIII and SpeI sites using 
primers WD214 and WD215 
Strain: Reference: Notes: 
UTI89  (62)  
Citrobacter Koseri Isolate from UMich 
Medical School 
 
Salmonella enterica 
serovar typhimurium 
ATCC 14028 
Obtained from the 
ATCC 
 
UTI89 csgBA::kan This Work Red swap mutagenesis of WT UTI89 
with primers WD6 and WD7 
UTI89 csgD::kan This Work Red swap mutagenesis of WT UTI89 
with primers WD36 and WD37 
   
UTI89 bcsA::kan This Work Red swap mutagenesis of WT UTI89 
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 with primers WD349 and WD350 
UTI89 adrA::kan This Work Red swap mutagenesis of WT UTI89 
with primers WD99 and WD100 
UTI89 csgBA::flp 
bcsA::kan 
This Work Red swap mutagenesis of UTI89 
csgBA::flp with primers WD349 and 
WD350 
UTI89 attB::csgBAC-
mCherry 
This Work As described (19), except mcherry 
was cloned from pAH6 into pCD13psk 
using primers WD119 and WD120 
UTI89 attB::csgBAC-
mCherry/pCKR101-
eGFP 
This Work UTI89 attB::csgBAC-mCherry 
electroporated with pCKR101-eGFP 
UTI89 attB::csgBAC-
eGFP 
 (19)  
UTI89 attB::csgBAC-
eGFP/pCKR101-
mCherry 
This Work UTI89 attB::csgBAC-eGFP 
electroporated with pCKR101-
mCherry 
UTI89 sodA::kan This Work Red swap mutagenesis of WT UTI89 
with primers WD202 and WD203  
UTI89 sodA::flp 
sodB::kan 
This Work Red swap mutagenesis of UTI89 
sodA::flp with primers WD239 and 
WD240  
UTI89 fur::kan This Work Red swap mutagenesis of WT UTI89 
with primers WD15 and WD17  
UTI89 iscR::kan This Work Red swap mutagenesis of WT UTI89 
with primers WD18 and WD19  
UTI89 ryhB::kan This Work Red swap mutagenesis of WT UTI89 
with primers WD297 and WD79  
UTI89 basSR::kan This Work Red swap mutagenesis of WT UTI89 
with primers WD221 and WD252  
UTI89/pCKR101 This Work UTI89 electroporated with pCKR101 
UTI89/pCKR101-sodA This Work UTI89 electroporated with pCKR101-
sodA 
UTI89 sodA::flp 
sodB::kan/pCKR101 
This Work UTI89 sodA::flp sodB::kan 
electroporated with pCKR101 
UTI89 sodA::flp 
sodB::flp/pCKR101-
sodA 
This Work UTI89 sodA::flp sodB::flp 
electroporated with pCKR101-sodA 
UTI89 
fur::kan/pCKR101 
This Work UTI89 fur::kan electroporated with 
pCKR101 
UTI89 
fur::kan/pCKR101-
sodA 
This Work UTI89 fur::kan electroporated with 
pCKR101-sodA 
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Table 2.2: Primers Used in Chapter 2 
--Non-complementary regions are undercase 
Primer 
Name: 
Sequence: 
WD6 5’AAATACAGGTTGCGTTAACAACCAAGTTGAAATGATTTAATTTCTTAAGT
GTGTAGGCTGGAGCTGCTT 3’ 
WD7 5’CGAAAAAAAACAGGGCTTGCGCCCTGTTTCTTTAATACAGAGGATGTAT
ATGAATATCCTCCTTAG 3’ 
WD15 5’CACTTCTAATGAAGTGAACCGCTTAGTAACAGGACAGATTCCGCATGAT
TCCGGGGATCCGTCGACC 3’ 
WD17 5’GCAGGTTGGCTTTTCTCGTTCAGGCTGGCTTATTTGCCTTCGTGCGCG
TGTGTAGGCTGGAGCTGCTTCG 3’ 
WD18 5’TACAATAAAAAACCCCGGGCAGGGGCGAGTTTGAGGTGAAGTAAGACA
TGATTCCGGGGATCCGTCGACC 3’ 
WD19 5’CACTCCGGCCTGATTCTGAATTCTTTTTATTAAGCGCGTAACTTAACGT
CTGTAGGCTGGAGCTGCTTCG 3’ 
WD36 5’CAATCCAGCGTAAATAACGTTTCATGGCTTTATCGCCTGAGGTTATCGT
TCATATGAATATCCTCCTTA 3’ 
WD37 5’GAGGCAGCTGTCAGGTGTGCGATCAATAAAAAAAGCGGGGTTTCATCA
TGGTGTAGGCTGGAGCTGCTTC 3’ 
WD79 5’TTTGCAAAAAGTGTTGGACAAGTGCGAATGAGAATGATTATTATTGTCT
CGCGGTGTAGGCTGGAGCTGCTTC 3’ 
WD99 5’CTTCTGCCTTTAGCCCCGTCTCTATAATTTGGGAAAATTGTTTCTGAAT
GGTGTAGGCTGGAGCTGCTTC 3’ 
WD100 5’CAGCAAATCCTGATGGCTTTTGCCGGACGTCAGGCCGCCACTTCGGT
GCGCATATGAATATCCTCCTTAG 3’ 
WD119 5’ gatcactagtATGGTGAGCAAGGGCGAGGAGGATA 3’ 
WD120 5’ gatcgagctcCTACTTGTACAGCTCGTCCATGCCG 3’ 
WD202 5’AACGCCTCATTGCAGCAGGCATCAAATGATTATTTTTTCGCTGCGAAAC
GGTGTAGGCTGGAGCTGCTTC 3’ 
WD203 5’CTTACGCGGCATTAACAATCGGCCGCCCGACAACACTGGAGATGAATA
TGCATATGAATATCCTCCTTAG 3’ 
WD209 5’ gatctctagaTTATTTTTTCGCTGCGAAACGTGCC 3’ 
WD214 5’ gatcaagcttGTTTTTCCTGCTCAAAGTATCC 3’ 
WD215 5’ gatcactagtTGCGCAACAACCGCCAAAAG 3’ 
WD221 5’TACCAGGCTGCGGATGATATTCTGCAAACTTGCAGGAGAGTGAGTGAA
TGGTGTAGGCTGGAGCTGCTTC 3’ 
WD229 5’ gatcggtaccGCCGCCCGACAACACTGGAGATG 3’ 
WD239 5’AATAAGGCTATTGTACGTATGCAAATTAATAATAAAGGAGAGTAGCAAT
GGTGTAGGCTGGAGCTGCTTC 3’ 
WD240 5’TCAGATAATGTTGCATTTGCCATCAGTTATTATGCAGCGAGATTTTTCG
CCATATGAATATCCTCCTTAG 3’ 
WD244 5’ gatcggtaccTAGGGAGGTTTTAAACATGGTGAGC 3’ 
WD245 5’ gatctctagaTTACTTGTACAGCTCGTCCATGCC 3’ 
WD252 5’TTCAGCGTGCTGGTGGTCAGCAGCTTTCTTTATATCTGGTTTGCCACGT
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ACATATGAATATCCTCCTTAG 3’ 
WD263 5’ gatcggtaccGGTACCTAGAATTAAAGAGGAGAAA 3’ 
WD264 5’ gatctctagaTTATTTGTATAGTTCATCCATGCCA 3’ 
WD297 5’AACGAACACAAGCACTTCCCGAGGATAAATTGAGAACGAAAGGTCAAA
AAAAAC ATATGAATATCCTCCTTAG 3’ 
WD349 5’TGCCTGTTAAACTATTCCGGGCTGAAAATGCCAGTCGGGAGTGCATCA
TGCATATGAATATCCTCCTTAG 3’ 
WD350 5’AGAATATTTTTCTTTTCATCGCGTTATCATCATTGTTGAGCCAAAGCCTG
GTGTAGGCTGGAGCTGCTTC 3’ 
DH1 5’ gatcggatccCAAAAGATGCGCGAATGTAATAATC 3’ 
DH2 5’ gatctctagaTCAGAAACAATTTTCCCAAATTATA 3’ 
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Chapter 3 
ArcAB Modulates Escherichia coli Biofilm Formation 
 
Abstract: 
Redox-balance drives rugose biofilm formation in multiple bacterial species. 
Escherichia coli rugose biofilms are dependent on the CsgD-induced matrix 
components curli and cellulose. I have previously found that E. coli grown in low iron 
conditions produces a biofilm matrix, but does not form rugose biofilms unless exposed 
to either iron or superoxide stress. In this study, I utilized low iron conditions to probe 
redox-sensitive regulators that affect rugose biofilm formation. I found that the ArcAB 
two-component system repressed rugose biofilm formation by regulating CsgD 
expression. arcA, arcB, and arcAB mutants wrinkled in low iron conditions. 
Overexpresion of a constitutively active ArcB78-778 variant reduced rugose biofilm 
formation on high iron plates. Furthermore, overexpression of the small RNA ArcZ, 
which is repressed by ArcAB, stimulated rugose biofilm formation. In E. coli rugose 
biofilms, matrix-encased bacteria are localized specifically to the air/biofilm interface. 
Non-matrix-encased bacteria line the interior of each wrinkle. ArcAB activity, as 
determined by ArcAB-dependent promoter expression, was increased in the 
microaerobic interior of rugose biofilms. Lastly, slightly more curli were produced in the 
biofilm interior when arcA and arcB were mutated, suggesting that ArcAB may repress 
matrix expression in the biofilm interior. Altogether I present data supporting a model 
where ArcAB modulates both macroscopic and microscopic E. coli biofilm architecture 
in response to cellular redox state. 
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Introduction: 
E. coli is a facultative anaerobe that is capable of fermenting sugars and 
reducing a variety of alternative electron acceptors in anaerobic conditions (1, 2). To 
sense the environmental availability of suitable respiratory oxidants, E. coli employs an 
array of regulatory proteins. E. coli senses molecular oxygen directly via the proteins 
FNR and DosCP (3-6). O2 destroys [4Fe-4S](2+) iron-sulfur clusters bound to FNR, 
repressing the protein’s ability to bind DNA and act as a transcriptional regulator (5-7). 
The DosCP complex utilizes a heme group to directly bind O2, and in turn controls 
production and degradation of the signaling molecule cyclic-di-GMP (3, 4, 8). 
Environmental concentrations of alternative electron acceptors such as nitrate, 
fumarate, and trimethylamine-N-oxide are sensed through devoted two-component 
systems (9-11). The response regulators of these systems activate transcription of the 
appropriate reductases.  
In addition to the direct oxidant sensors, E. coli also produces a two-component 
system, ArcAB, that responds directly to the redox state of the quinone pool (12). When 
the electron transport chain is oxidized, such as in aerobic conditions, ubiquinone 
triggers oxidation of cysteine residues in dimeric, membrane-bound ArcB. The resulting 
intermolecular disulfide bonds prevent ArcB from autophosphorylating (13-16). A 
reducing quinone pool, specifically the presence of menaquinol, allows for reduction of 
ArcB cysteine residues and subsequent autophosphorylation (15, 17). ArcB 
autophosphorylation starts a cascade that results in the phosphorylation of the response 
regulator ArcA, a process that is enhanced in the presence of fermentation products 
(18, 19). The relative contribution of the quinone pool and of fermentation byproducts in 
ArcB autophosphorylation is still a matter of debate (14, 15, 20, 21). ArcA-P is a 
transcriptional regulator whose regulon mostly consists of genes involved in 
aerobic/anaerobic metabolism (12, 22).  
Several studies have demonstrated that cellular redox state is intricately linked to 
biofilm formation in Pseudomonas aeruginosa, Bacillus subtilis, and Candida albicans 
(23-26). In all three organisms, redox changes drive the formation of wrinkled or rugose 
colony biofilms. Rugose biofilm formation is correlated with the production of 
extracellular matrix components. B. subtilis controls matrix production in response to 
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redox balance via two kinases, KinA and KinB (25). KinA binds to NAD+, and KinB 
associates with the electron transport chain and responds to impaired electron flow (25). 
In response to iron, KinA and KinB induce expression of polysaccharide synthase and 
the amyloid protein TasA, leading to rugose biofilm development (25). 
 In E. coli, rugose biofilm formation is dependent on the master biofilm regulator 
CsgD. Under biofilm-inducing conditions, CsgD induces expression of the csgBAC and 
adrA promoters, which result in the production of amyloidogenic curli fibers and the 
polysaccharide cellulose, respectively (27-29). I have recently reported that iron and 
superoxide stress drive rugose biofilm formation in E. coli (30). Rugose biofilm 
development involves elaboration of a bimodal population and resistance to hydrogen 
peroxide stress (30). E. coli grown in low iron conditions therefore represents something 
of a ‘ground state’ in biofilm formation. Matrix is still expressed on low iron plates, but 
environmental signals such as reactive oxygen stress are able to drive further biofilm 
maturation (30).  
I utilized low iron conditions to screen for redox-sensitive genetic systems that 
affected E. coli biofilm development. I reasoned that knocking out redox-sensitive 
regulators that repress biofilm development would lead to rugose biofilm formation 
under low iron conditions. Conversely, knocking out redox-sensitive regulators that 
enhance biofilm development would be predicted to repress rugose biofilm formation in 
high iron conditions. Since I described a role for oxidative stress in rugose biofilm 
development (30), I included the soxRS and oxyR mutants in my screen. SoxRS and 
OxyR respond to superoxide and hydrogen peroxide stress, respectively (31). 
Additionally I evaluated the effect of two redox-sensitive proteins that modulate 
intracellular levels of the signaling molecule cyclic-di-GMP, DosCP and YfgF. Cyclic-di-
GMP levels affect the expression and activity of CsgD in both E. coli and in S. enterica 
ser. Typhimurium (32, 33). DosCP responds to molecular oxygen and YfgF contributes 
to hydrogen peroxide stress resistance (8, 34). Lastly, I included global regulators FNR 
and ArcAB in my candidate list. After testing various redox-sensitive systems, I found 
that the ArcAB two-component system is a chief redox-sensing regulator of rugose 
biofilm formation. I go on to further describe that ArcAB affects the expression of the 
major biofilm regulator CsgD, through which it affects matrix production.  
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Results: 
Screen for Redox-sensitive Rugose Biofilm Regulators 
To identify redox-responsive regulatory systems that control UTI89 rugose biofilm 
development, I made mutations of various candidate genes and plated each strain on 
low iron plates or the same plates that had been supplemented with 10-200 μM FeCl3. 
The arcAB mutant wrinkled in low iron and increased rugose biofilm formation very little 
if at all in response to iron (Fig. 3.1). All other mutants developed a flat colony 
morphology in low iron and responded to iron by wrinkling. oxyR demonstrated an 
interesting increase in colony spreading in high iron conditions, but still responded to 
iron by wrinkling. Addition of 10 μM FeCl3 was sufficient to induce colony wrinkling in all 
strains (Fig. 3.1). Low iron plates + 10 μM FeCl3 are referred to as “iron replete plates” 
for the remainder of this chapter.  
Genetic Dissection of OxyR’s Effect on Rugose Biofilm Formation 
OxyR induces expression of reactive oxygen neutralizing proteins in response to 
hydrogen peroxide (31). An OxyRA233V variant demonstrates constitutively active 
transcriptional induction activity (35). Whereas an oxyR mutant spreads more than WT 
UTI89, complementation with oxyRA233V results in bundled, unorganized wrinkling (Fig. 
3.2). Altogether these results suggest that active OxyR may enhance wrinkling 
formation in iron replete conditions, whereas inactive OxyR could contribute to colony 
spreading. 
Genetic Dissection of ArcAB’s Effect on Rugose Biofilm Formation 
Since arcAB wrinkled more than WT in low iron conditions (Fig. 3.1), I posited 
that ArcAB is a repressor of rugose biofilm formation. ArcB is a sensor kinase that 
autophosphorylates when the quinone pool is in a reduced state, triggering a 
phosphorelay that results in phosphorylation of the D54 residue of ArcA (12, 18, 36). An 
arcB mutant wrinkled in low iron conditions, and complementation with WT arcB 
restored the smooth colony morphotype (Fig. 3.3A). When the ArcB transmembrane 
domain is removed, the resulting protein, ArcB78-778, obtains constitutive ArcA kinase 
activity in vivo (37). Overexpression of arcB78-778 complemented a smooth colony 
morphotype in low iron conditions (Fig. 3.3A). Furthermore arcB78-778 expression 
decreased rugose biofilm formation on iron replete plates compared to overexpression 
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of WT arcB (Fig. 3.4A), demonstrating that active ArcB can repress rugose 
development.  
To probe the specific role of ArcA in repressing rugose biofilm formation, I made 
single arcA and arcB mutants. Both single mutants developed rugose biofilms in low 
iron conditions. Complementing each single mutant with a WT version of the respective 
gene restored the smooth colony phenotype in low iron conditions (Fig. 3.3A,B). Since 
both single mutants wrinkled in low iron conditions, I inferred that both ArcA and ArcB 
are involved in repression of rugose biofilm formation. arcB wrinkling in low iron 
conditions was not as robust as arcA or the arcAB double mutant (Fig 3.1, 3.3A,B). 
Response regulators are often able to accept a phosphate group from phosphodonors 
such as acetyl-phosphate or from other histidine kinases (38), so in the absence of 
ArcB, ArcA may still become phosphorylated and repress rugose biofilm formation.  
To determine if ArcA phosphorylation is required to inhibit rugose biofilm 
formation, I engineered an ArcAD54A mutant that renders the protein transcriptionally 
inactive (39). As expected, ArcAD54A was unable to complement wrinkling in low iron 
conditions (Fig. 3.3B), indicating that phosphorylation is essential for the ability of ArcA 
to repress rugose biofilm formation. For some response regulators, a constitutively 
active phosphomimetic version can be obtained by mutating the aspartate at the 
phosphorylation site to a glutamate (40). ArcAD54E complemented an arcA mutant in 
terms of repressing rugose development in low iron conditions (Fig. 3.3B). However, 
overexpressing ArcAD54E in an arcA mutant did not repress rugose biofilm formation on 
iron replete plates (Fig. 3.4B). This result might be explained by a study that 
demonstrated that WT ArcA-P multimerizes and binds DNA as a tetramer of 
homodimers (36). ArcAD54E is unable to accept a phosphate group from ArcB, 
oligomerize, or bind DNA (36). In all, my results suggest that phosphorylation of ArcA is 
required for its ability to repress biofilm wrinkling in low iron conditions.  
ArcB can also affect gene expression independently of ArcA by phosphorylating 
RssB (41). When phosphorylated, RssB induces RpoS degradation (41, 42). An rpoS 
mutant did not wrinkle in either iron condition, indicating that RpoS is required for 
rugose biofilm formation in UTI89 (Fig. 3.5A). However, overexpressing rpoS in low iron 
conditions had very little effect on colony wrinkling (Fig. 3.5B). Similarly, an rssB mutant 
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did not wrinkle in low iron conditions (Fig. 3.5A). rssB in high iron developed less 
coordinated wrinkling than WT (Fig. 3.5A). Therefore overexpressing rpoS or stabilizing 
RpoS by overexpression of rssB was not sufficient to induce rugose biofilm formation in 
low iron conditions.  
 ArcZ is a small RNA whose expression is repressed by active ArcAB (43). To test 
the effects of ArcZ on UTI89 rugose biofilm formation, I constructed an arcZ mutant and 
tested it for rugose biofilm formation. arcZ had a subtle defect in biofilm development 
compared to WT. After 24 hours of growth on iron replete plates, there was a small but 
notable lag in wrinkle development in the arcZ mutant (Fig. 3.6A). By 48 hours however, 
arcZ was indistinguishable from WT (Fig. 3.6A). Likewise, overexpressing arcZ from an 
IPTG-inducible promoter resulted in a small amount of structure that developed in low 
iron conditions (Fig. 3.6B). Strains carrying the pBR-lac empty vector wrinkled less than 
typical WT UTI89 in iron replete conditions, but arcZ expression restored full rugose 
development (Fig. 3.6B). These results indicate that ArcZ has a small, but reproducible 
positive effect on rugose biofilm formation. 
ArcAB modulates Rugose Biofilm Formation through CsgD 
To determine whether ArcAB exerts its control on biofilm development through 
CsgD, I constructed an arcAB csgD mutant. arcAB csgD did not wrinkle in low or high 
iron conditions (Fig. 3.7), signifying that rugose biofilm formation in an arcAB mutant is 
CsgD-dependent. To directly test the effect of ArcAB on CsgD protein levels, I 
performed CsgD western blots from WT UTI89 and an arcAB mutant grown on low iron 
plates. After 24 hours of growth, CsgD levels were increased in the UTI89 arcAB mutant 
compared to WT (Fig. 3.8A). Both WT UTI89 and the arcAB mutant demonstrated 
increased CsgD levels in iron replete conditions (Fig. 3.8A). To verify that CsgD protein 
levels corresponded to CsgD activity, I performed β-galactosidase assays using a 
UTI89 lacZ mutant with a copy of the curli subunit (csgBAC) promoter driving lacZ at the 
attB site. As expected, csgBAC promoter activity was lowest in WT in low iron 
conditions (Fig. 3.8B). Promoter activity was increased in WT UTI89 grown on iron 
replete plates and in the arcAB mutant in either iron condition (Fig. 3.8B). Altogether 
these results suggest that in low iron conditions, ArcAB represses CsgD production. 
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Next, I tested whether csgD induction could induce rugose biofilm formation in 
low iron conditions. Indeed, expression of csgD from an IPTG-inducible tac promoter 
resulted in rugose formation in low iron conditions after 72 hours of growth (Fig. 3.8C). 
WT UTI89 carrying an empty vector did not wrinkle (Fig. 3.8C). In all, I conclude that 
active ArcAB represses CsgD-mediated rugose biofilm formation in low iron conditions. 
Overexpression of csgD in low iron conditions allows for an increase in rugose biofilm 
formation. 
ArcAB Contributes to Bimodal Population Development 
During rugose biofilm development, UTI89 develops two distinct populations. 
Surface-exposed bacteria express biofilm matrix components, while a non-matrix-
expressing population lines the interior of the wrinkles (30). These two populations are 
easily separable via a washout assay, as the interior population can be suspended in 
buffer (termed washout fraction), while the matrix-encased population requires tissue 
homogenization to break apart (termed matrix fraction) (30). Consistent with previous 
results (30), the washout assay revealed that CsgD levels and csgBAC promoter activity 
were decreased in the washout fraction of both WT UTI89 and an arcAB mutant (Fig. 
3.8A,B).  
Interestingly, while total CsgD levels and csgBAC promoter activity were 
decreased in WT UTI89 compared to an arcAB mutant in low iron conditions, no such 
difference was apparent between washout fractions or between matrix fractions (Fig. 
3.8A,B). I hypothesized that this discrepancy was due to a difference in the ratio of 
washout/matrix cells within each colony. To quantify the washout/matrix ratio, I took the 
OD600 of each fraction after performing the washout assay. After 48 hours of biofilm 
development, the arcAB mutant demonstrated a washout/matrix ratio of ~0.5 in either 
iron conditions. In contrast, WT UTI89 had a ratio of ~3 in low iron conditions and of ~1 
in high iron conditions (Fig. 3.9). Therefore mutating arcAB skewed the biofilm 
architecture towards a more matrix-heavy composition. 
One explanation for a decreased washout/matrix ratio in arcAB could be an 
increase in matrix expression in the interior of the biofilm, leading to less diffusible 
washout cells. I considered that in a WT strain, ArcAB could contribute to matrix 
repression in the biofilm interior. Indeed, like in most biofilms, oxygen concentrations 
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decrease within UTI89 rugose biofilms as a function of biofilm depth (30, 44). ArcAB 
demonstrates peak activity in anaerobic/microaerophilic conditions (20, 45). Therefore, I 
hypothesized that ArcAB activity would be higher in the biofilm interior in WT UTI89. 
Indeed, ArcAB-dependent fadE promoter activity was increased in the air-exposed shell 
fraction in both low and high iron conditions (46), signifying that ArcAB is more active in 
the interior washout fraction (Fig. 3.10A).  
Since ArcAB was more active in the biofilm interior, I reasoned that washout cells 
would have reduced csgBAC promoter activity due to repression by ArcAB. To directly 
assess csgBAC promoter activity in a rugose biofilm, I utilized UTI89 attB::csgBAC-
mCherry/peGFP (30). Bimodal development could be visualized and quantified by 
tracing fluorescence within a specific area from the bottom of a rugose biofilm to the top 
(Fig. 3.10B). WT UTI89 grown in low iron conditions or iron replete conditions 
demonstrated that IPTG-induced GFP was expressed throughout the biofilm, while 
mCherry was localized specifically to the periphery of the biofilm (Fig. 3.10C,D), which 
agrees with previous results (30). In keeping with CsgD protein levels and csgBAC 
promoter activity (Fig. 3.8A,B), mCherry expression was significantly decreased in low 
iron conditions in WT (Fig. 3.10C). In low iron conditions in an arcAB mutant, mCherry 
fluorescence was restored to the high levels observed on iron replete plates (Fig. 
3.10C,D).  
After two days of growth, confocal microscopy of an arcAB mutant revealed that 
csgBAC-driven mCherry fluorescence was still largely localized to the biofilm surface in 
both low and high iron conditions (Fig. 3.10C,D). However, a small increase in mCherry 
expression was maintained deeper in the arcAB biofilm on iron replete plates (Fig. 
3.10C,D). Therefore, although ArcAB affects the levels of csgBAC promoter activity, 
another system apparently assists with matrix repression in the biofilm interior. 
Preliminary experiments with 5-day old rugose biofilms suggest that ArcAB has a larger 
impact on matrix production in the interior in older biofilms (data not shown). ArcAB may 
therefore affect bimodal population development at later states of biofilm development. 
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Discussion: 
Rugose biofilm formation in response to iron provides a unique opportunity to 
monitor genetic networks that regulate E. coli biofilm formation. Typically rugose 
biofilms are grown on YESCA or LB no salt plates, on which colonies wrinkle fully and 
rapidly (30). Therefore systems like ArcAB, which repress biofilm formation, would be 
difficult to identify in mutagenesis screens on YESCA plates, as the fully wrinkled arcAB 
biofilm would not stand out from WT biofilms. In contrast, low iron conditions produce 
UTI89 biofilms that are not fully developed. Further biofilm maturation can be induced 
by either iron addition or superoxide stress (30). Therefore my screen on low iron plates 
revealed that arcAB demonstrated a unique wrinkled colony phenotype in low iron 
conditions, where WT UTI89 does not wrinkle (Fig. 3.1).  
While rugose biofilm formation is a useful tool to study biofilm development, it 
also presents technical problems. Rugose biofilms are characterized by production of a 
thick extracellular matrix that results in aggregation when biofilms are tissue 
homogenized (30). Matrix-encased bacteria preferentially aggregate, while washout 
bacteria tend to stay in suspension, producing sampling biases (30). I have previously 
utilized a cellulose synthase mutant to bypass aggregation, with which I demonstrated 
that total curli levels were similar in low and high iron (30). However, polysaccharide 
production affects matrix expression by influencing osmotic pressure in B. subtilis, and 
matrix production can affect CsgD expression in S. enterica ser. Typhimurium (47). 
Moreover, rugose biofilm formation increases total biofilm surface area (24). Since 
matrix expression is localized to the air/biofilm interface (30), rugose biofilm formation 
likely increases total matrix production in part through biofilm wrinkling. Since a UTI89 
cellulose mutant does not wrinkle (30), no such increase in total matrix production can 
take place. Therefore using a cellulose synthase mutant to monitor curli expression is 
not ideal, so in this manuscript I analyzed only matrix-proficient strains. To minimize the 
effects of aggregation, I utilized confocal microscopy or I monitored whole colony 
gene/protein expression after 24 hours of growth, at which time less aggregation 
developed than after 48 hours of growth (data not shown).  
We took a genetic approach to analyze how each arm of the ArcAB pathway 
affected rugose biofilm formation. An arcB mutant wrinkled in low iron conditions (Fig. 
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3.3A), and overexpression of the constitutively active arcB78-778 repressed wrinkling in 
iron replete conditions (Fig. 3.4A). These results support a model where active ArcB 
suppresses rugose biofilm formation. An arcA mutant still wrinkled in low iron 
conditions, revealing that ArcA is involved in biofilm suppression (Fig. 3.3B). ArcB may 
also repress rugose biofilm formation by phosphorylating RssB, leading to RpoS 
degradation. However, neither deleting rssB nor overexpressing rpoS resulted in rugose 
biofilm development in low iron conditions, implying that RpoS on its own is not able to 
induce wrinkling (Fig. 3.5A,B). However, RpoS may still be involved in rugose biofilm 
development. In fact, OxyR induces expression of a small RNA, oxyS, which regulates 
rpoS translation (48), and OxyR affected rugose biofilm development in high iron 
conditions (Fig. 3.1, 3.2.). Alternatively, OxyR could affect rugose biofilm formation 
through regulation of Antigen-43, which affects type 1 pili-dependent E. coli biofilms (49, 
50). 
ArcZ is required for rugose biofilm formation in S. enterica ser. Typhimurium (51). 
In UTI89, an arcZ mutant demonstrated a slight delay in rugose biofilm development, 
and arcZ overexpression induced rugose biofilm development (Fig. 3.6A,B). While 
ArcZ’s effect on rugose biofilm formation is subtler in UTI89, it follows the same trend as 
was described with S. enterica ser. Typhimurium (51). Altogether, my genetic data 
suggests that ArcB controls rugose biofilm development through multiple effectors.  
 While researching the ArcAB regulon, I was struck by the number of connections 
between ArcAB and the master biofilm regulator CsgD. First of all, the stationary phase 
sigma factor RpoS is required for csgD transcription (52, 53). ArcA-P inhibits 
transcription of rpoS (52), and ArcB directly phosphorylates and activates RssB, which 
triggers the degradation of RpoS (41, 42). Futhermore, the csgD promoter region 
contains an ArcA binding site (54), implying that there is direct regulation of csgD by 
ArcA-P. Lastly, Monteiro et. al. demonstrated that ArcZ is essential for rugose biofilm 
formation in Salmonella enterica ser. Typhimurium, likely by facilitating rpoS and csgD 
translation (43, 51). Collectively these results suggest that active ArcAB could repress 
CsgD expression through multiple pathways. In most E. coli strains, including UTI89, 
rugose biofilm formation is dependent on CsgD because of its ability to induce 
expression of curli and cellulose. (28, 30, 55). However, Hufnagel et. al. (manuscript in 
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prep) recently demonstrated that mutations in the periplasmic disulfide bonding system 
(DSB) induce a CsgD-independent cellulose activation pathway. DSB mutants produce 
cellulose and form rugose biofilms without csgD. An arcAB csgD mutant did not wrinkle 
in low or high iron conditions (Fig. 3.7), suggesting that ArcAB modulates rugose biofilm 
development through CsgD.  
WT UTI89 in low iron conditions demonstrated suppressed CsgD levels and 
csgBAC promoter activity in my assays (Fig.3.8A,B). csgD overexpression induced 
rugose biofilm formation in low iron conditions (Fig. 3.8C). Altogether these data support 
a model where, in low iron conditions, active ArcAB represses rugose biofilm formation 
through repression of csgD. 
 ArcAB activity alters as a function of oxygen concentration, with peak activity 
achieved in anaerobic/microaerophilic conditions (20, 45). I previously demonstrated 
that oxygen concentrations decrease within rugose biofilms (30), leading us to 
hypothesize that ArcAB may be more active in interior biofilm cells. Indeed, activity of 
the Arc-suppressed fadE promoter was lower in the washout fraction compared to the 
matrix fraction (Fig. 3.10A). csgBAC promoter activity increased slightly in the biofilm 
interior in an arcAB mutant after two days of biofilm development, but peak activity was 
still localized to the biofilm surface (Fig. 3.10C,D). Serra et. al. showed by SEM that 
interior cells in E. coli W3110 rugose biofilms maintain an elongated shape, typical of E. 
coli cells in the logarithmic phase of growth (56). E. coli matrix production is relegated to 
cells in stationary phase, largely due to the dependence of csgD transcription on the 
stationary phase sigma factor RpoS (52, 53). At earlier time points, it is therefore likely 
that interior bacteria are still in a logarithmic state, leading to matrix repression via an 
absence of RpoS. Preliminary experiments with 5 day old biofilms suggest that an 
arcAB mutant displays a more robust increase in curliated bacteria in the biofilm interior 
(data not shown). Active ArcAB may then assume the role of repressing washout cell 
matrix production in older biofilms.  
 It has been convincingly demonstrated that P. aeruginosa wrinkles in response to 
a lack of oxidants, as a way to increase biofilm surface area and expose more biofilm 
cells to atmospheric oxygen (24, 57). However, as noted by Serra. et. al., E. coli is 
metabolically versatile in terms of its capability to ferment and utilize various alternative 
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electron acceptors (1, 2), so gaining access to oxygen might not be the chief selective 
force driving biofilm wrinkling (58). Indeed, my findings that active ArcAB repressed 
CsgD expression, and therefore rugose biofilm formation, suggests that peak wrinkling 
occurs in peak oxygenic conditions. Instead, wrinkling in E. coli might simply be due to 
mechanical buckling caused by large-scale matrix production.  
Curli and cellulose provide protection against various environmental stresses 
such as desiccation and bleach stress in S. enterica ser. Typhimurium (59). White et. al. 
also demonstrated that the csgBAC promoter only activates once S. enterica ser. 
Typhimurium is excreted in feces in a mouse pathogenesis model (60). E. coli normally 
resides in the anaerobic/microaerophilic intestinal tract of mammals and reptiles (61). 
Excretion in stool likely exposes E. coli to atmospheric oxygen and a subsequent 
increase in cellular oxidation state. I therefore propose that ArcAB generally functions to 
repress curli expression in the gut environment. Oxygen exposure in the non-host 
environment could then derepress CsgD and lead to protective biofilm formation. 
 Interestingly, curli fibers produced from S. enterica ser. Typhimurium interact 
with gut epithelial cells and can decrease epithelial permeability (62, 63). While the gut 
is generally considered anaerobic, it is clear that oxygen respiration improves E. coli’s 
fitness in the gut environment (64). Oxygen diffuses away from epithelial cells, leading 
to a small microaerobic zone that can influence bacterial gene expression (65). An 
intriguing possibility is that close proximity to epithelial cells could inactivate ArcAB and 
derepress CsgD expression, leading to curli production and subsequent curli-mediated 
interactions with epithelial cells. 
 
Materials/Methods: 
Strains, Media, Cloning, and Growth Conditions:  
All plasmids and strains used in this study are listed in Table S1, and primers are listed 
in Table S2. WT UTI89 and all mutants were routinely cultured in LB media. UTI89 
mutants were produced via the lambda red recombinase method as described (66). For 
complementation and expression studies, genes were cloned from the UTI89 
chromosome and inserted into pCKR101 using standard genetic techniques (30). Point 
mutations were introduced using synthesis by overlapping ends PCR (67). 
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Chromosomal lacZ insertions were produced using pCD13psk as described (68, 69). 
Briefly, UTI89 lacZ was cloned into the XbaI and SacI sites of pCD13psk, and UTI89 
promoter regions were introduced using BamHI and XbaI sites. pCD13psk and  variants 
were amplified in DH5α λpir+. Insertion of pCD13psk and variants into the attB site of 
lacZ UTI89 or various UTI89 mutants was performed using pINT-ts as described (68, 
69).  
Rugose Biofilm Assays:  
YESCA agar plates were used for all rugose biofilm assays (10 g Casamino Acids/Liter, 
1 g Yeast Extract/L). To produce low iron plates, YESCA media was mixed with 5 g/100 
mL Chelex-100 resin for 1 hour at room temperature. Media was then filtered to remove 
the resin. 1.5 g/Liter Noble agar was added and media was autoclaved. Before pouring 
plates, media was supplemented with 100 µM MgCl2, 10 µM CaCl2, and 10 µM 
tryptophan. Where indicated 10 or 200 µM FeCl3 was also supplemented. For biofilm 
assays, overnight cultures were rinsed 2x with low iron YESCA media. 4 µL dots of the 
indicated strains were then plated and incubated at 26°C to allow for biofilm formation. 
All pictures were taken using an Olympus DP72® camera mounted on an Olympus 
SZX16® research stereomicroscope 
Washout Assay:  
The washout assay has been previously described (30). Briefly, agar chunks including 
rugose biofilms were removed from agar plates and manually inserted into a well of a 
24-well plate. 1 mL of potassium phosphate buffer pH 7.2 (kPi) was added to the well 
and the biofilm was gently shaken for 5 minutes. When the rugose biofilm lifted off the 
surface, the cells that washed into the buffer suspension were collected and spun down. 
arcAB mutants stuck to the agar plate, and kPi was pipetted onto the biofilm edges to 
facilitate colony lift-off. The matrix fraction was washed twice more with kPi, and 
washout cells were pooled from all three washes. The matrix fraction was then moved 
into an eppendorf tube filled with 1 mL of kPi and was tissue homogenized at high 
speed for 15 seconds. 
β-galactosidase Assays:  
β-galactosidase assays were performed as previously described (30, 70), except that 
chromosomal lacZ transcriptional fusion strains were utilized instead of a plasmid-based 
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system. All β-galactosidase assays were performed in a UTI89 lacZ mutant background. 
All experiments were performed in biological triplicate, and error bars represent 
standard deviation. 
Western Blot Analysis: 
Western blot analysis was performed as previously described (30). Briefly, bacteria 
grown on agar plates were scraped off and suspended in kPi. After normalizing to 1 
OD600, 150 µL was spun down. The pellet was then suspended in 150 µL 2x SDS 
loading buffer. Samples were electrophoresed in 15% polyacrylamide gels and 
transferred onto a nitrocellulose membrane in a wet transfer apparatus in 25 mM CAPS 
transfer buffer pH 11.2 with 10% methanol. After transfer, the blot was blocked in 5% 
milk in TBST for one hour at room temperature. The blot was then incubated with anti-
CsgD primary antibody (1:5000) for 1 hour at room temperature, followed by incubation 
with 1:15000 IRDye 700CW goat anti-mouse IgG secondary antibody (Licor). Blots were 
washed with TBST and visualized on a Licor Odyssey CLX imager. 
Confocal Microscopy: 
Confocal microscopy was performed as described (30). LAS AF v2.6.3 build 8173 
software was used to trace fluorescence within a circle drawn onto a Z-stack. Traces 
represent the high point possible in each rugose biofilm, i.e. if the biofilm contained 
wrinkles, the circle was drawn so that it traces fluorescence through the center of the 
wrinkle. Each trace is an average of three separate circles from the same Z-stack.  
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Figures and Tables: 
Figure 3.1 Screening redox-regulators for rugose biofilm formation 
WT UTI89 and various mutants were spotted on low iron plates or low iron plates 
supplemented with 10 or 200 μM FeCl3. Pictures were taken after 48 hours of biofilm 
development. 
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Figure 3.2 OxyR affects colony spreading 
WT UTI89 or oxyR were transformed with pCKR101 (empty vector (EV)), pCKR101-
oxyR (poxyR), or pCKR101-oxyRA233V (poxyRA233V). Strains were then grown on YESCA 
plates, and pictures were taken after 48 hours of biofilm development. 
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Figure 3.3 Single arc mutants and complementation on low iron plates 
WT UTI89, arcB (A), and arcA (B) were transformed with pCKR101 (EV), pCKR101-
arcA (parcA), pCKR101-arcAD54A (parcAD54A), pCKR101-arcAD54E (parcAD54E), 
pCKR101-arcB (parcB) or pCKR101-parcB78-778 (parcB78-778). Strains were then grown 
on low iron plates supplemented with 25 μM IPTG. Pictures were taken after 48 hours of 
biofilm development. 
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Figure 3.4 ArcB78-778 represses rugose biofilm formation on iron replete plates 
WT UTI89, arcB (A), and arcA (B) were transformed with pCKR101 (EV), pCKR101-
arcA (parcA), pCKR101-arcAD54A (parcAD54A), pCKR101-arcAD54E (parcAD54E), 
pCKR101-arcB (parcB) or pCKR101-parcB78-778 (parcB78-778). Strains were then grown 
on low iron plates supplemented with 10 μM FeCl3 and 50 μM IPTG. Pictures were 
taken after 48 hours of biofilm development. 
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Figure 3.5 rpoS expression is required for rugose biofilm formation but is not 
sufficient to induce rugose biofilm formation 
WT UTI89 as well as rpoS, csgBA bcsA, and rssB mutants were grown on low iron 
plates or low iron plates supplemented with 10 μM FeCl3 (A). Pictures were taken after 
48 hours of biofilm development. UTI89/pCKR101 (EV) and UTI89/pCKR101-rpoS 
(prpoS) were grown on low iron plates supplemented with 50 μM IPTG for 72 hours (B).  
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Figure 3.6 ArcZ increases biofilm wrinkling 
WT UTI89 and an arcZ mutant were grown on low iron plates or low iron plates 
supplemented with 10 μM FeCl3 (A). Pictures were taken after 24 and 48 hours of 
biofilm development. UTI89/pBRlac (EV) and UTI89/pBRlac-arcZ (parcZ) were grown 
on low iron plates supplemented with 25 μM IPTG or low iron plates supplemented with 
25 μM IPTG and 10 μM FeCl3 (B). Pictures were taken after 24 and 48 hours of biofilm 
development. 
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Figure 3.7 Rugose biofilm formation in an arcAB mutant is dependent on csgD 
UTI89, arcAB, csgD, and arcAB csgD were plated on low iron plates or low iron plates 
supplemented with 10 μM FeCl3. Pictures were taken after 48 hours of biofilm 
development. 
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Figure 3.8 ArcAB represses CsgD in low iron conditions 
Western blotting for CsgD was performed in WT UTI89 and an arcAB mutant after 24 
hours of biofilm development on low iron plates or low iron plates supplemented with 10 
μM FeCl3. Whole colonies were analyzed, and the washout and matrix fractions were 
also separated via the washout assay and analyzed separately (A). B-galactosidase 
assays were performed on UTI89 lacZ attB::csgBAC-lacZ and UTI89 arcAB lacZ 
attB::csgBAC-lacZ grown on low iron plates or low iron plates supplemented with 10 μM 
FeCl3 for 24 hours (B). Whole colonies and washout and matrix fractions were 
analyzed. WT UTI89/pCKR101 (EV) and WT UTI89/pCKR101-csgD (pcsgD) were 
grown on low iron plates supplemented with 25 μM IPTG or low iron plates 
supplemented with 10 μM FeCl3 and 25 μM IPTG (C). Pictures were taken after 72 
hours of biofilm development. 
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Figure 3.9 arcAB mutant has a decreased washout/matrix ratio 
The washout assay was performed on WT UTI89 and an arcAB mutant after 24 or 48 
hours of growth on low iron plates or low iron plates supplemented with 10 μM FeCl3. 
The OD600 of each fraction was taken, and the ratio of washout OD600/matrix OD600 was 
calculated. Each bar represents biological triplicates, and error bars represent standard 
deviation.
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Figure 3.10 Effect of ArcAB on bimodal population development 
(A) β-galactosidase assays were performed on UTI89 lacZ attB::fadE-lacZ and UTI89 
arcAB lacZ attB::fadE-lacZ grown on low iron plates or low iron plates supplemented 
with 10 μM FeCl3 for 48 hours after performing the washout assay. Each bar represents 
biological triplicates, and error bars represent standard deviation. (B) A mid-Z-stack 
cross section of WT UTI89 attB::csgBAC-mcherry/pCKR101-eGFP after 48 hours of 
growth on a low iron plate supplemented with 10 μM FeCl3. Circles represent areas 
where fluorescence was traced and averaged from the bottom of the Z-stack to the top. 
Fluorescent traces of WT UTI89 attB::csgBAC-mcherry/pCKR101-eGFP and UTI89 
arcAB attB::csgBAC-mcherry/pCKR101-eGFP grown on low iron plates (C) or low iron 
plates supplemented with 10 μM FeCl3 (D). Green corresponds to IPTG-induced GFP 
expression, and red corresponds to csgBAC-induced mCherry expression. Each trace is 
an average of three separate circles drawn on the same Z-stack. 
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Table 3.1: Strains and Plasmids Used in Chapter 3 
Plasmid: Reference: Notes: 
pCKR101 (1, 2)  
pCKR101-rpoS This Work rpoS cloned into KpnI and XbaI sites of 
pCKR101 with primers WD419 and 
WD420 from UTI89 genome 
pCKR101-csgD This Work csgD cloned into KpnI and XbaI sites of 
pCKR101 with primers WD403 and 
WD404 from UTI89 genome 
pCKR101-eGFP (2)  
pCKR101-arcB This Work arcB cloned into KpnI and XbaI sites of 
pCKR101 with primers WD490 and 
WD491 from UTI89 genome 
pCKR101-arcB78-778 This Work arcB78-778 cloned into KpnI and XbaI 
sites of pCKR101 with primers WD492 
and WD491 from UTI89 genome 
pCKR101-arcA This Work arcA cloned into KpnI and XbaI sites of 
pCKR101 with primers WD514 and 
WD515 from UTI89 genome 
pCKR101-arcAD54A  This Work arcAD54A amplified in two-step PCR 
using primer pairs WD518/WD515 and 
WD519/WD514. End-joined final 
product was cloned into KpnI and XbaI 
sites of pCKR101. 
pCKR101-arcAD54E  This Work arcAD54E amplified in two-step PCR 
using primer pairs WD516/WD515 and 
WD517/WD514. End-joined final 
product was cloned into KpnI and XbaI 
sites of pCKR101. 
pCKR101-oxyR  This Work oxyR cloned into KpnI and XbaI sites of 
pCKR101 with primers WD255 and 
WD256 from UTI89 genome 
pCKR101-oxyRA233V This Work oxyRA233V amplified in two-step PCR 
using primer pairs WD257/WD256 and 
WD258/WD255. End-joined final 
product was cloned into KpnI and XbaI 
sites of pCKR101. 
pCD13psk-lacZ This Work lacZ cloned from UTI89 genome into 
XbaI and SacI site of pCD13psk using 
primers WD465 and WD466. 
pCD13psk-csgBAC-lacZ This Work UTI89 csgBAC promoter from the 
UTI89 genome cloned into pCD13psk-
lacZ BamHI and XbaI sites using 
primers WD459 and WD474 
pCD13psk-fadE-lacZ This Work UTI89 fadE promoter from the UTI89 
genome cloned into pCD13psk-lacZ 
BamHI and XbaI sites using primers 
WD540 and WD541 
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Strain: Reference: Notes: 
UTI89  (2, 3)  
UTI89 csgD::kan (2)  
UTI89 csgBA::flp 
bcsA::kan 
(2)  
UTI89 arcA::kan This Work Red swap mutagenesis of WT UTI89 
with primers WD259 and WD260 
UTI89 arcB::kan This Work Red swap mutagenesis of WT UTI89 
with primers WD376 and WD377 
UTI89 fnr::kan 
 
This Work Red swap mutagenesis of WT UTI89 
with primers WD298 and WD299 
UTI89 dosCP::kan 
 
This Work Red swap mutagenesis of WT UTI89 
with primers WD361 and WD362 
UTI89 oxyR::kan 
 
This Work Red swap mutagenesis of WT UTI89 
with primers WD216 and WD217 
UTI89 rpoS::kan This Work Red swap mutagenesis of WT UTI89 
with primers WD415 and WD416 
UTI89 rssB::kan This Work Red swap mutagenesis of WT UTI89 
with primers WD431 and WD432 
UTI89 soxRS::kan This Work Red swap mutagenesis of WT UTI89 
with primers WD131 and WD133 
UTI89 arcA::flp 
arcB::kan 
This Work Red swap mutagenesis of UTI89 
arcA::flp with primers WD376 and 
WD377 
UTI89 arcA::flp 
arcB::flp csgD::kan 
This Work Red swap mutagenesis of UTI89 
arcA::flp arcB::flp with primers WD36 
and WD37 
UTI89 lacZ::kan This Work Red swap mutagenesis of WT UTI89 
with primers WD534 and WD535 
UTI89 lacZ::kan 
attB::csgBAC-lacZ 
This Work As described (2, 4), except pCD13psk-
csgBAC-lacZ was inserted into attB site 
of UTI89 lacZ. 
UTI89 lacZ::kan 
attB::fadE-lacZ 
This Work As described (2, 4), except pCD13psk-
fadE-lacZ was inserted into attB site of 
UTI89 lacZ. 
UTI89 attB::csgBAC-
mCherry/pCKR101-
eGFP 
(2) UTI89 attB::csgBAC-mCherry 
electroporated with pCKR101-eGFP 
UTI89 arcA::flp 
arcB::kan attB::csgBAC-
mCherry  
 This Work As described (2, 4), except pCD13psk-
csgBAC-mCherry was inserted into attB 
site of UTI89 arcA::flp arcB::kan 
UTI89 arcA::flp 
arcB::kan attB::csgBAC-
mCherry/pCKR101-
eGFP 
This Work UTI89 arcA::flp arcB::kan attB::csgBAC-
mCherry electroporated with pCKR101-
eGFP 
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Table 3.2: Primers Used in this Study 
--Non-complementary regions are undercase 
Primer 
Name: 
Sequence: 
WD419 5’ gatcggtaccTGCCGCAGCGATAAATCGGC 3’ 
WD420 5’ gatctctagaTTATTCGCGGAACAGCGCTT 3’ 
WD403 5’ gatcggtacCCTGTCAGGTGTGCGATCAAT 3’ 
WD404 5’ gatctctagaTCTGCCGCCACAATCCAGCG 3’ 
WD490 5’ gatcggtaccTGAAGGAATTCCCTAATGAA 3’ 
WD491 5’ gatctctagaTCATTTTTTAGTGGCTTTTG 3’ 
WD492 5’ gatcggtaccTGAAGGAATTCCCTAATGGAGCAACTGGAGGAGTCA 
CGAC 3’ 
WD514 5’ gatcggtaccTGGCAATTTAGGTAGCAAAC 3’ 
WD515 5’ gatctctagaGACGGTGGTAAAGCCGATTA 3’ 
WD516 5’ AACCTGGTGATCATGGAAATCAATCTGCCGGGT 3’ 
WD517 5’ ACCCGGCAGATTGATTTCCATGATCACCAGTGG 3’ 
WD518 5’ AACCTGGTGATCATGGCTATCAATCTGCCGGGT 3’ 
WD519 5’ ACCCGGCAGATTGATAGCCATGATCACCAGGTT 3’ 
WD255 5’ gatcggtaccCTATCGTGGCAATGGAGGATGGATA 3’ 
WD256 5’ gatctctagaTTAAACCGCCTGTTTTAACACTTTA 3’ 
WD257 5’ CGCAACATGGTGGCGGTAGGTAGCGGGATCACT 3’ 
WD258 5’ AGTGATCCCGCTACCTACCGCCACCATGTTGCG 3’ 
WD465 5’ gatctctagaATTTCACACAGGATACAGCTATGAC 3’ 
WD466 5’ gatcgagctcTTATTTTTGACACCAGACCAACTGG 3’ 
WD459 5’ gatcggatccAACGTTCTTGTTTTTTCTCCATAC 3’ 
WD474 5’ gatctctagaTTAAGAAATTAAATCATTTCAACTT 3’ 
WD540 5’ gatcggatccAAAAGTTAGCCAGCGTTTCC 3’ 
WD541 5’ gatctctagaAACGAAAAGCCCCTTACTTG 3’ 
WD259 5’GCCGTTTTTATTGACGGTGGTAAAGCCGATTAATCTTCCAGATC
ACCGCACATATGAATATCCTCCTTAG 3’ 
WD260 5’CTTTTGTACTTCCTGTTTCGATTTAGTTGGCAATTTAGGTAGCAA
ACATGGTGTAGGCTGGAGCTGCTTC 3’ 
WD376 5’AGTATTCGCGCACCCCGGTCTAGCCGGGGTCATTTTTTAGTGG
CTTTTGCCATATGAATATCCTCCTTAG 3’ 
WD377 5’TCAGAATTGGGTATTATTGGGGCAGGTTGTCGTGAAGGAATTCC
CTAATGGTGTAGGCTGGAGCTGCTTC 3’ 
WD298 5’ACAGAAGGATAGTGAGTTATGCGGAAGAATCAGGCAACGTTAC
GCGTATGCATATGAATATCCTCCTTAG 3’ 
WD299 5’AAAAGATGTTAAAATTGACAAATATCAATTACGGCTTGAGCAGA
CCTATGGTGTAGGCTGGAGCTGCTTC 3’ 
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WD361 5’TCTTCATATTTCAGGAAAATATGGTGCAGTTAGTCGATCTCGCA
CGTTGGTGTAGGCTGGAGCTGCTTC 3’ 
WD362 5’AACCCGCGAGTGCGGGCGAGAGGAATTTATCAGATTTTCAGCG
GTAACACCATATGAATATCCTCCTTAG 3’ 
WD131 5’GCGCGGGAGTTAACGCGCGGGCAATAAAACTACAGGCGGTGG
CGATAATCCATATGAATATCCTCCTTAG 3’ 
WD133 5’CTGGAAGATGAACAAAACTAAAGCGCCACAAGGGCGCTTTAGT
TTGTTTTGTGTAGGCTGGAGCTGCTTC 3’ 
WD216 5’CTATGCTACCTATCGCCGCGAACTATCGTGGCAATGGAGGATG
GATAATGGTGTAGGCTGGAGCTGCTTC 3’ 
WD217 5’AAGCCTATCGGGTAGCTGCGCTAAATGGCTTAAACCGCCTGTTT
TAAAACCATATGAATATCCTCCTTAG 3’ 
WD534 5’GGCAGACATGGCCTGCCCGGTTATTATTATTTTTGACACCAGAC
CAACTGCATATGAATATCCTCCTTAG 3’ 
WD535 5’GAGCGAATAACAATTTCACACAGGATACAGCTATGACTATGATT
ACGGATGTGTAGGCTGGAGCTGCTTC 3’ 
WD36 5’CAATCCAGCGTAAATAACGTTTCATGGCTTTATCGCCTGAGGTT
ATCGTTCATATGAATATCCTCCTTA 3’ 
WD37 5’GAGGCAGCTGTCAGGTGTGCGATCAATAAAAAAAGCGGGGTTT
CATCATGGTGTAGGCTGGAGCTGCTTC 3’ 
415 5’TGAGACTGGCCTTTCTGACAGATGCTTACTTATTCGCGGAACAG
CGCTTCCATATGAATATCCTCCTTAG 3’ 
416 5’CTTTTGCTTGAATGTTCCGTCAAGGGATCACGGGTAGGAGCCA
CCTTATGGTGTAGGCTGGAGCTGCTTC 3’ 
WD431 5’TGGCAATAGCATGCCACTATTGAGTAAAGCCAGTCAGGGGAGA
GAACATGGTGTAGGCTGGAGCTGCTTC 3’ 
WD432 5’ATGCAAATTTAGCCCGTGTTATCGTTTGCTCATTCTGCAGACAA
CATCAACATATGAATATCCTCCTTAG 3’ 
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Chapter 4 
Biofilm Formation Protects Escherichia coli against Predation 
 
Abstract: 
Enteric bacteria such as E. coli are exposed to a variety of environmental 
stresses in the non-host environment. A key tactic E. coli employs to counter such 
stresses is CsgD-mediated biofilm formation. CsgD is a transcriptional regulator that 
induces expression of the biofilm matrix components curli and cellulose. Expression of 
curli and cellulose confers protection against various stresses such as desiccation, 
reactive oxygen species, and bleach. I found that production of the biofilm matrix 
protected E. coli against predation from the nematode Caenorhabditis elegans and the 
predatory bacteria Myxococcus xanthus. Additionally, matrix-encased bacteria at the 
air/biofilm interface exhibited roughly 40-fold increased survival after C. elegans and M. 
xanthus killing compared to interior, non-matrix-encased cells. CsgD expression is 
under complex transcriptional control, with a variety of environmental signals that 
contribute to its regulation. Here I demonstrated that non-host reservoirs of E. coli, 
including pig and cow feces and commonly contaminated foods such as beef, chicken, 
and spinach provided a nutritional environment that supports biofilm matrix production. 
Altogether I showed that common non-host reservoirs of E. coli and other 
Enterobacteriaceae supported CsgD-mediated matrix production and that biofilm 
formation protected E. coli against predation. 
 
Introduction: 
E. coli is a Gram-negative, rod-shaped, facultative anaerobe which commonly 
lives as a commensal in the mammalian gut. Through acquisition of various virulence 
factors, particular E. coli strains have gained the ability to colonize and cause disease at 
specific host sites. Enterohemorrhagic E. coli (EHEC) and enteropathogenic E. coli 
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(EPEC) are common causative agents of gastroenteritis (1-3). Additionally, 
extraintestinal pathogenic E. coli (ExPEC) occupy host niches other than the intestinal 
tract. ExPEC cause various diseases such as sepsis, neonatal meningitis, and urinary 
tract infections (UTIs). Uropathogenic E. coli (UPEC) accounts for approximately 80% of 
the acute UTIs reported in the US (3-5). ExPEC are becoming increasingly problematic 
due to a recent rise in antibiotic resistance (5, 6). 
Intestinal pathogenic E. coli (IPEC) is spread through the fecal-oral route. A 
common mechanism of transmission is shedding of bacteria in the feces of pathogen-
bearing farm animals (7-10). Indeed, contact with animal feces is a risk factor for 
sporadic infection with EHEC (11). Compared to the transmission of IPEC, the 
transmission of ExPEC strains such as UPEC is poorly understood. Recent studies 
have demonstrated that UPEC strains, although they are adapted to colonize the 
bladder, show no fitness defects in the gut (12). The intestine may serve as a reservoir 
for UPEC in patients with recurrent UTIs, and it is generally accepted that UPEC from 
the gastrointestinal tract is able to infect and colonize the urethra (13-15). UPEC 
outbreaks have been reported, with a likely cause being UPEC contamination of food, 
suggesting that ExPEC can be transmitted via the fecal-oral route (16-19).  
Compared to the host or lab setting, the physiology of E. coli in non-host 
environmental reservoirs is poorly understood. A detailed understanding of the 
mechanisms involved in non-host persistence is paramount in developing effective 
strategies to prevent contamination of food products by E. coli and other pathogenic 
Enterobacteriaceae. One important aspect of non-host persistence and survival for E. 
coli is biofilm formation (20). Biofilms are bacterial communities characterized by the 
presence of a self-produced extracellular matrix. E. coli biofilm formation has been well 
described. CsgD is the master biofilm regulator in E. coli and in other 
Enterobacteriaceae such as Salmonella enterica ser. Typhimurium (21-23). CsgD is a 
transcriptional regulator required for production of the two major extracellular matrix 
components: amyloidogenic curli fibers and the polysaccharide cellulose. CsgD directly 
induces the curli subunit operon, while cellulose is activated via CsgD induction of the 
diguanylate cyclase gene adrA (22, 24, 25). AdrA produces the second messenger 
cyclic-di-GMP (c-di-GMP), which activates the cellulose synthase BcsA (25, 26). Curli 
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and cellulose production has been correlated with increased resistance to desiccation, 
reactive oxygen species, and disinfectants (27-30). Furthermore, matrix production has 
been implicated in EHEC attachment to commonly contaminated foods such as spinach 
and to abiotic surfaces (31, 32). While curli and cellulose have various roles during 
enteric pathogenesis (20, 33), an expression study demonstrated that the curli promoter 
is relatively inactive during S. enterica ser. Typhimurium passage through a mouse 
host. However, curli expression is immediately induced once the bacteria are excreted 
in stool (29). Altogether these results suggest that biofilm formation is an important 
aspect of non-host persistence for Enterobacteriaceae such as E. coli. 
In the non-host environment, bacteria are exposed to a variety of predators. In a 
similar manner to biofilm formation inhibiting immune cell phagocytosis, biofilm matrix 
can block predator feeding. Biofilm-associated Vibrio cholerae and Pseudomonas 
aeruginosa survive protozoan grazing better than planktonic cells (34-36). Biofilm 
formation by Yersinia pestis and Staphyococcus epidermidis have been shown to 
respectively block food intake and prevent efficient digestion by the nematode C. 
elegans (37, 38). Additionally, C. elegans is less efficient at feeding on Myxococcus 
xanthus colonies that produce a more robust biofilm matrix (39). In this study I sought to 
determine whether E. coli biofilms confer protection against predators, and I assessed 
how relevant non-host environmental conditions influence E. coli biofilm formation. I first 
assessed the ability of the nematode C. elegans and the soil-dwelling bacteria M. 
xanthus to prey on biofilm-encased UPEC. As both predators require direct bacterial 
contact to efficiently kill prey cells (40-42), I hypothesized that CsgD-dependent biofilms 
would protect enteric bacteria such as E. coli against both C. elegans and M. xanthus 
predation. I also tested the ability of E. coli to produce CsgD-mediated biofilms in 
environments that mimic those encountered outside the host.  
 
Results: 
C. elegans Predation Assay 
Bacteria encounter many stressors while outside the host, including predation. 
Free-living nematodes such as the model organism C. elegans are ubiquitous bacterial 
predators that have large-scale affects on soil bacterial communities (43). To determine 
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whether E. coli biofilm formation protects against nematode predation, I developed a 
feeding assay on YESCA agar plates. Briefly, ~25 L1-L2 C. elegans worms were moved 
to the center of an agar plate on which four UTI89 strains had grown for two days in 
biofilm-inducing conditions. The four UTI89 strains that I tested were WT (curli+ 
cellulose+), bcsA (curli+ cellulose-), csgBA (curli- cellulose+) and csgBA bcsA (curli- 
cellulose-). C. elegans was then allowed to feed for 15 days at 20°C. Plates were 
harvested at three day intervals, and colony forming units (CFUs)/colony were 
determined. Each plate with C. elegans was randomly paired with a control plate with no 
C. elegans added, and percent survival was calculated.  
By day nine, C. elegans decreased the CFUs/colony of all the strains by roughly 
10-fold (Fig. 4.1). However, at day 12, there was a dramatic survival difference between 
WT UTI89 and mutants that express neither curli nor cellulose. The WT rugose colony 
was still visible, and CFUs had leveled out after their initial day 9 loss. Conversely, the 
csgBA bcsA mutant had visually disappeared from the plate, and CFU counts 
decreased precipitously compared to the no-C. elegans control (Fig. 4.1A,B). By day 15 
the CFUs of a WT UTI89 colony were reduced to 2.5% of a no-C. elegans control, while 
the csgBA bcsA mutant was decreased to 0.0082%. The bcsA mutant demonstrated a 
slight but significant survival advantage compared to the csgBA bcsA double mutant, 
indicating that curli alone provides slight predation resistance. In contrast, the csgBA 
mutant phenocopied WT through day 12 in terms of CFUs/colony, and no significant 
difference in percent survival between WT and csgBA was determined at day 15 (Figure 
4.1A, B). Cellulose is therefore the more important matrix component in regard to C. 
elegans resistance. 
I also tested WT UTI89 and a csgD mutant in a “non-competition” assay. That is, 
I spotted six WT UTI89 dots on an agar plate, added worms, and at three day intervals 
harvested a single colony from that plate for CFU counts. Separately, I dotted six UTI89 
csgD colonies on an agar plate and did a parallel assay. Each plate was spotted in 
triplicate. As with the competition assay, WT displayed a dramatic resistance phenotype 
compared to the matrix deficient mutant (Fig. 4.2).  
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C. elegans Tracking Assay 
I hypothesized that the biofilm matrix either provides a mechanical barrier to C. 
elegans feeding or that C. elegans is preferentially attracted to non-matrix-encased 
bacteria. Indeed, it has been demonstrated that P. aeruginosa polysaccharide 
production changes the feeding behavior of C. elegans (44). To determine whether 
matrix expression affected colony occupancy, a mixed population of C. elegans myo-
2::rfp ceh22::gfp was moved onto the center of a plate that contained one WT colony 
and one csgBA bcsA colony (Fig. 4.3A). At intervals, the number of worms on each 
colony was counted (Fig. 4.3B,C). At 1, 6, or 24 hours post-inoculation, no significant 
difference between the number of worms on the WT colony compared to the number of 
worms on the csgBA bcsA colony could be determined (Fig. 4.3C), favoring the 
alternate model that E. coli biofilm matrix provides a mechanical barrier to predation by 
C. elegans. 
Determining the Susceptibility of Two Biofilm Populations to C. elegans Feeding 
A key factor contributing to the resistance of biofilms to various stresses is the 
development of distinct subpopulations within a biofilm (45). Biofilm-mediated antibiotic 
resistance is mostly attributable to development of a small population of persister cells, 
which resist antibiotic killing by virtue of a reduced growth rate (46). Matrix production 
can be monitored by the formation of wrinkled or rugose biofilms on agar plates, which 
is indicative of curli and cellulose expression in a variety of species from 
Enterobacteriaceae (24, 28, 47). I have previously demonstrated that UTI89, S. enterica 
ser. Typhimurium, and Citrobacter koseri develop at least two distinct populations within 
rugose biofilms (28). A population of matrix-encased bacteria lines the air-biofilm 
interface (termed the “matrix fraction”), whereas a distinct population of non-matrix-
encased cells lines the biofilm interior (termed the “washout fraction”). These two 
populations can be separated using a washout assay, which involves suspending the 
washout fraction bacteria in buffer (28). To test whether non-matrix encased washout 
cells were more susceptible to predation, I allowed C. elegans to feed on WT UTI89 
rugose colonies for 12 days -- the amount of time required for C. elegans to reduce WT 
CFUs by ~10-fold (Figure 4.1A). At days 6 and 12, the washout assay was performed 
and CFUs/fraction were determined for WT colonies exposed to C. elegans as well as 
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WT colonies under no predation. At day 12, the washout assay could still be performed 
on WT rugose colonies (Fig. 4.4), and CFUs from each fraction were similar. The 
washout fraction contained 4.9 x 109 ± 4.7 x 108 CFUs and the matrix fraction contained 
2.4 x 109 ± 4.9 x 108 CFUs. Nematode predation led to a fragile biofilm that broke into 
small pieces when washed in buffer (Fig. 4.4). The washout assay was therefore 
performed by allowing the stable aggregates to settle to the bottom of the well. Bacteria 
from three buffer washes were collected as the washout fraction. After 12 days of 
nematode feeding, 3.9 x 106 ± 1.2 x 106 CFUs (0.074% survival) were recovered from 
the washout fraction and 7.0 x 107 ± 2.4 x 107 CFUs (3.0% survival) were recovered 
from the matrix fraction (Fig. 4.5A), indicating that even within a single biofilm, C. 
elegans is able to feed more efficiently on non-matrix-encased bacteria. Western blot 
analysis for CsgA from 12-day old rugose biofilms without nematode predation revealed 
that in WT UTI89 a bimodal population is maintained throughout the experiment (Fig. 
4.5B). 
Biofilm Integrity Analysis After Predation 
In E. coli biofilms, curli and cellulose form a dense matrix, surrounding cells in 
what appears to be an “egg in a carton” arrangement (48-50). C. elegans preys on 
bacteria by contracting and relaxing the pharynx, creating a suction that results in the 
intake of bacterial cells (40). For the biofilm matrix to act as a barrier to feeding, it is 
reasonable to speculate that the structural integrity of the biofilm would have to be 
maintained even amid predation. As a measure of biofilm integrity, I assayed the SDS-
solubility of the major curli subunit CsgA. CsgA forms amyloidogenic polymers that do 
not migrate into an SDS-PAGE gel (51). Depolymerizing amyloids such as curli requires 
pretreatment with a strong denaturant such as HFIP (52). To assay the stability of curli 
fibers after nematode predation, I tested the SDS-solubility of CsgA polymers. CsgA 
was completely SDS-insoluble, both with and without nematode predation stress, 
indicating that C. elegans was not able to decompose the amyloid component of the 
biofilm matrix (Fig 4.5B). Not enough cells could be harvested from the washout fraction 
of biofilms that had been fed on by C. elegans for western blot analysis. 
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M. xanthus Predation Assay 
In addition to predation by nematodes, which rely on mechanical suction to feed 
on bacteria, a variety of bacterial predators secrete toxins to kill prey cells. M. xanthus is 
a common saprophytic soil bacteria that uses an array of secondary metabolites to kill 
and lyse target cells (53, 54). M. xanthus can commonly be found in feces from 
herbivorous animals, so non-host interactions with E. coli or other Enterobacteriaceae 
are plausible (54). M. xanthus needs to contact prey cells to efficiently kill them (41, 42), 
so I hypothesized that the biofilm matrix would also protect E. coli against M. xanthus 
predation. To test killing by Myxococcus, YESCA agar plates were buffered to pH 7.4, 
which falls within the optimum range for M. xanthus growth (55), and which still allows 
UTI89 rugose biofilm development (Fig. 4.6A). WT UTI89 or UTI89 matrix mutants were 
spotted next to M. xanthus DK1622 on agar filled wells of a 24-well plate. After 2 days of 
biofilm development at 26°C, the plates were moved into humidity chambers within 
30°C incubators (day 0), and tracked visually.  
M. xanthus completely spread through both WT UTI89 and the matrix mutants 
after 10 days of co-incubation, with the rate of spreading being approximately equal 
(Fig. 4.6A). The rugose biofilm maintained some semblance of its original shape even 
after M. xanthus feeding (Fig. 4.6A). As with the nematode assays, percent survival was 
calculated as CFUs from M. xanthus exposed colonies/CFUs from no-M. xanthus 
controls. CFU counts from the WT colony demonstrated that biofilm formation conferred 
robust protection compared to the csgBA bcsA double mutant (Fig. 4.6B), from which no 
CFUs could be recovered. In contrast to the nematode predation results, the bcsA 
mutant (only producing curli) was the only single mutant that demonstrated M. xanthus 
resistance. No colonies could be recovered from the csgBA mutant (only producing 
cellulose). However, both matrix components conferred greater resistance than curli 
only, as WT survived to a greater degree than bcsA (Fig. 4.6B). Matrix production 
therefore confers protection against both C. elegans and M. xanthus predation. 
M. xanthus kills prey cells by secreting a variety of proteases and degradative 
enzymes (53, 56). The protective phenotype conferred by WT UTI89 and the bcsA 
mutant implies that curli fibers must resist protease-mediated degradation. Indeed, a 
general property of amyloids such as curli is protease resistance (51, 57). I tested the 
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SDS-solubility of CsgA from WT UTI89 with and without M. xanthus predation, and curli 
remained SDS-insoluble even after M. xanthus predation (Fig. 4.7). Interestingly though, 
multiple species of CsgA were visible after M. xanthus of WT UTI89 (Fig. 4.7). No 
reactive band could be detected in a M. xanthus only control or from the UTI89 csgBA 
bcsA mutant (Fig. 4.7). Even though curli remained SDS-insoluble, WT rugose biofilms 
exposed to M. xanthus were fragile and broke into pieces upon buffer washing (Fig. 
4.8). Interestingly, after M. xanthus killing, the csgBA colony remained intact upon 
washing with buffer (Fig. 4.8). Therefore it is unlikely that M. xanthus degrades the 
cellulose matrix. Tissue homogenization was required to break up both WT UTI89 
biofilms and the csgBA colony. Both the bcsA and the csgBA bcsA colony went into 
suspension freely (data not shown). 
Susceptibility of Two Biofilm Populations to M. xanthus 
Since M. xanthus required prey contact for efficient killing (41, 42, 58), matrix 
production could prevent killing by M. xanthus by blocking efficient prey recognition. 
Such a mechanism of protection could leave matrix-free, washout bacteria susceptible 
to M. xanthus killing. I therefore performed the washout assay on WT UTI89 after 10 
days of coincubation with M. xanthus. As with the nematode predation assay, matrix 
fraction cells demonstrated a robust survival phenotype compared to washout bacteria 
(Fig. 4.6C). 
Growth and Matrix Expression of Enteric Bacteria in Non-Host Environment-
Mimicking Conditions 
  Nematodes and Myxobacteria are both ubiquitous soil predators (43, 54). 
Enterobacteriacea such as E. coli would likely be exposed to such predators after 
excretion from the host. Common lab media such as LB typically inhibit curli expression 
(59) (Fig. 4.9). However, if biofilm formation by E. coli provides predation resistance in 
non-host environments, I hypothesized that non-host environmental conditions would 
induce matrix expression. Pathogenic E. coli can be shed in the dung of farm animals, 
and such fecal contamination can lead to human infection (7-10, 60). To test if animal 
dung provides the correct nutritional environment for biofilm formation, I collected pig 
dung from a local farm, filter-sterilized it, and used it as the sole nutrient source in agar 
plates. I monitored growth and curli production on dung agar plates of UTI89 as well as 
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two other pathogenic members of the Enterobacteriaceae family, S. enterica ser. 
Typhimurium and Citrobacter koseri, both of which produce curli and cellulose and form 
rugose biofilms (28). Both S. enterica ser. Typhimurium and UTI89 formed rugose 
colonies on pig dung agar plates, and no such colony structure was apparent in the 
UTI89 csgBA bcsA mutant (Fig. 4.10A). Western blot analysis of the major curli subunit 
CsgA demonstrated that UTI89, S. enterica ser. Typhimurium, and C. koseri produced 
curli on pig dung agar plates (Fig. 4.10B). As expected no CsgA was detectable in the 
UTI89 csgBA bcsA mutant (Fig. 4.10B). Curli production and rugose formation were 
enhanced at 26°C compared to 37°C (Fig. 4.10A,B), which agrees with previous 
findings (61). To further test the ability of dung to support biofilm formation, I isolated 
two E. coli strains from pig dung. When these isolates were plated on pig dung agar 
plates, they also produced CsgA (Fig. 4.10B). Cow dung was also tested for its ability to 
support biofilm formation. Although growth was very limited on cow dung agar plates, 
rugose biofilm formation was apparent in UTI89 and S. enterica ser. Typhimurium at 
26°C (Fig. 4.11). 
CsgD-mediated biofilm formation increases EHEC attachment to spinach and 
abiotic surfaces (31, 32). I next tested whether extracts from commonly contaminated 
foods provided the nutritional environment to support matrix production. UTI89, C. 
koseri, and both pig dung E. coli isolates produced curli on beef, chicken, and spinach 
agar plates (Fig. 4.12A,B,C). Curli was detected from S. enterica ser. Typhimurium on 
chicken agar plates (Fig. 4.12B). On all three food plates, incubation at 26°C supported 
more curli production than growth at 37°C (61) (Fig. 4.12A,B,C). UTI89 and C. koseri 
produced rugose biofilms on beef plates (Fig. 4.13). Intriguingly, both pig dung E. coli 
isolates produced CsgA on all three food plates (Fig. 4.12A,B,C). 
The use of untreated manure to fertilize produce can lead to EHEC 
contamination of food (7, 62, 63). Furthermore, contact with animal feces is a risk factor 
for spontaneous EHEC infections (11). I therefore tested growth and curli production of 
two EHEC O157:H7 strains, EDL933 and 86-24, on dung and food agar plates. 
Intriguingly, EDL933 produced curli on all media tested, while 86-24 produced curli on 
pig dung and spinach plates (Fig. 4.14). Also of note is that both EHEC strains showed 
growth defects on spinach plates at 37°C, but grew well at 26°C (Fig. 4.14). 
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Altogether, my results demonstrated that curli and cellulose production protected 
E. coli against predation and that biofilm formation was induced by E. coli and other 
pathogenic Enterobacteriaceae in non-host environments. 
 
Discussion: 
Various bacterial species utilize biofilms to survive the non-host environment. 
Rugose biofilm formation by V. cholerae involves synthesis of extracellular 
polysaccharides and protects the bacteria against flagellate predation, chlorinated 
water, and osmotic and oxidative stress (64-67). P. aeruginosa biofilms formation can 
likewise protect against amoebae feeding (34, 35). Y. pestis, S. epidermidis, and M. 
xanthus utilize biofilms to either inhibit feeding or digestion by C. elegans (37-39). 
Finally, CsgD-mediated biofilms protect S. enterica ser. Typhimurium against various 
non-host stresses such as desiccation and disinfectants (27, 29).  
While E. coli is one of the most studied organisms on Earth, disproportionately 
little is understood about the physiology of E. coli, or indeed any members of the 
Enterobacteriaceae, in non-host environment reservoirs besides the laboratory. Here I 
present evidence in support of a model where CsgD-mediated biofilm formation is in 
part an adaptation to the non-host branch of the E. coli lifecycle. A variety of organisms, 
including nematodes and predatory bacteria such as M. xanthus consume bacterial prey 
in the non-host environment. I hypothesized that the extracellular matrix produced 
during biofilm formation would serve as a physical barrier to predation. As my model E. 
coli strain, I chose the UPEC isolate UTI89. UTI89 provides the benefits of being 
genetically tractable as well as being a relatively recent clinical isolate. Repeated 
culturing of bacterial strains introduces selective pressure to genetically suppress 
biofilm production (68, 69), and indeed E. coli K12 strains have lost the ability to 
produce one of the two major matrix components, cellulose (50). In contrast, WT UTI89 
is able to produce both curli and cellulose and form robust rugose biofilms (28). 
Moreover, a transmission route for ExPEC strains such as UTI89 is likely through 
contaminated foods (16, 60), making their survival in the non-host environment relevant 
as a public health concern. 
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Nematodes such as C. elegans graze on bacterial prey, and intake cells by 
contraction of the pharynx (40). I hypothesized that the dense matrix present in E. coli 
biofilms would inhibit efficient nematode feeding. Indeed, my results demonstrated that 
biofilm formation provided a robust survival advantage to UTI89 when exposed to C. 
elegans. After 15 days of predation, WT matrix production increased survival by roughly 
300 fold compared to a matrix deficient mutant. Interestingly, deletions of the individual 
matrix genes revealed that cellulose is the more important component, as the cellulose 
mutant only had a slight increase in fitness over a curli and cellulose double mutant. 
SEM studies of E. coli colony and pellicle biofilms have revealed that cellulose forms 
sheet-like structures throughout the colony, while curli surrounds individual cells in an 
“egg-in-a-carton” arrangement (48-50). Curli production on its own imbues colony 
biofilms with a rigid architecture, while cellulose-only biofilms demonstrate increased 
elasticity (50). The size and movement of C. elegans likely applies substantial 
mechanical stress to the biofilm matrix. Therefore the cohesive properties of cellulose 
might provide increased resistance compared to a more brittle biofilms formed by curli. 
Indeed, the csgBA mutant maintained a cohesive biomass even after nematode 
feeding, while the bcsA mutant was more easily dispersed (Fig. 1.1B). 
Curli and cellulose provide a dense coating for cells within rugose biofilms (48, 
50, 70). I hypothesized that such an arrangement would physically protect the cells 
within the biofilm from C. elegans. However, there is precedence for matrix production 
altering the feeding behavior of C. elegans (44), so I designed a tracking assay to test 
whether C. elegans is preferentially attracted to matrix-free colonies. My results 
demonstrated that both matrix-encased and non-matrix encased bacteria attracted 
similar numbers of worms at early time points, indicating that matrix primarily acts as a 
physical barrier against nematode predation. Given that rugose biofilms contain non-
matrix-encased bacteria, my results do not conclusively demonstrate that matrix 
production has no affect on nematode behavior. The main conclusion I take from the 
tracking assay is that there is not enough of an attraction difference between WT and 
the matrix mutant to explain the dramatic survival difference. 
While C. elegans mechanically swallows prey bacteria, predators such as M. 
xanthus secrete antibacterial and lytic agents to kill their prey extracellularly (53). 
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However, as M. xanthus killing requires direct predator-prey contact (41, 42), I 
hypothesized that an extracellular matrix would protect E. coli in a Myxococcus killing 
assay. I demonstrated that biofilm formation also confers a robust survival phenotype to 
UTI89 after M. xanthus predation. Biofilm-mediated antibiotic protection is largely due to 
a subpopulation of persister cells (46). Rugose biofilm formation could potentially 
develop concurrently with the formation of a population of persisters. However, my data 
would also imply that persister formation was almost completely dependent on the 
extracellular matrix, as a csgBA bcsA mutant demonstrated a dramatically reduced 
survival phenotype. A more likely scenario is that matrix production impedes prey-
recognition by M. xanthus. Indeed direct contact is required for optimal M. xanthus 
killing, and prey density affects M. xanthus predation efficiency (41, 42, 58). Intriguingly, 
in contrast to nematode killing, curli was more important than cellulose in preventing M. 
xanthus killing. The comparatively small size of M. xanthus may allow them to 
intercalate into the E. coli biofilm matrix. However, individual M. xanthus cells need to 
contact prey bacteria to lyse them (41). Therefore the dense curli matrix that surrounds 
individual cells could provide greater protection than the more diffuse cellulose filaments 
(48, 50). It is unlikely that M. xanthus is able to degrade the cellulose matrix as the 
csgBA colony still maintains its cohesion even after M. xanthus predation (Fig. 4.8). 
Bimodal population development within rugose biofilms provides a simple model 
for analyzing cellular differentiation in biofilm communities. The matrix-associated 
fraction is easily separable from the interior, washout bacteria. Moreover, I have 
previously demonstrated that the two populations demonstrate differences in stress 
resistance, as the washout cells are more vulnerable to hydrogen peroxide killing (28). 
In light of my results showing that matrix production protected E. coli against predation, I 
hypothesized that washout cells would also be more susceptible to killing by both C. 
elegans and M. xanthus than their matrix-encased neighbors. As expected, the interior, 
loosely attached washout bacteria were more susceptible to feeding. The increased 
susceptibility of the interior, non-matrix-encased fraction of rugose colonies to oxidative 
stress as well as predation raises the question of the functional role of this population 
(28). An intriguing possibility is that washout bacteria serve as an easily disseminated 
population of the biofilm. Indeed, even gently rocking with liquid releases washout cells 
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from the biofilm community (28). A pair of elegant SEM studies has recently 
demonstrated that the interior, non-surface-exposed, bacteria of W3110 E. coli rugose 
biofilms produce flagella as an integral component of the biofilm matrix (49, 50). I have 
previously demonstrated that curli producing cells are limited to the air-interface of 
UTI89 rugose colonies (28). Such a structural division of labor, with matrix-encased 
bacteria lining the air-biofilm interface while covering a non-matrix-encased, flagellated 
population is also observed in UTI89 pellicle biofilms (48).  Intriguingly, Pseudomonas 
aeruginosa mushroom biofilms also produce a similar architecture, with polysaccharide 
production being limited to the biofilm exterior. Flagellated P. aeruginosa that lines the 
biofilm interior are considered to be the chief agents of biofilm dispersal (71). It seems 
then that the formation of a protective outer coating, surrounding an interior population 
of easily dispersed cells, is a common biofilm architecture in a variety of bacterial 
species.  
CsgD is under complex transcriptional control, but in general, environments that 
present low salts, low temperatures (<30°C), and an air-interface allow for maximal 
csgD transcription (28, 48-50, 72). I hypothesized that habitats such as dung, where E. 
coli could encounter nematode and Myxobacteria predators, would provide the 
nutritional environment for matrix production. Pathogenic Enterobacteriaceae can reside 
in the gut of cattle and pigs (7-10) and, after being shed in feces, can contaminate food 
products, particularly if untreated feces is used as manure (7, 11, 62, 63). Indeed, 
EHEC O157:H7 can survive in dung for months, and survival is generally increased 
when temperatures are <23°C (73). In this study I directly tested pig dung along with 
commonly contaminated foods for their ability to induce enteric biofilm formation. 
Intriguingly, pig dung supported rugose biofilm formation by both UTI89 and S. enterica 
ser. Typhimurium. Moreover, all strains tested produced CsgA when grown on pig dung 
plates. Beef, chicken, and spinach provided the correct nutritional environment for 
biofilm production by all tested E. coli strains and by C. koseri. Curli production was 
significantly higher at 26°C compared to 37°C, which agrees with previous data (61). 
Altogether my data support a model where E. coli and other Enterobacteriaceae 
produce a CsgD-dependent biofilm in environmental conditions commonly encountered 
outside the host. Biofilm-development involves formation of a stress-resistant, matrix-
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producing population along with an easily dispersed, but stress-susceptible interior 
population. 
 
Materials and Methods: 
Organisms, Media, and Growth Conditions:  
All Enterobacteriaceae strains used in this study were routinely passaged at 37°C in LB 
media. All UTI89 strains as well as S. enterica ser. Typhimurium and C. koseri have 
been previously described (28). EHEC O157:H7 86-24 and EDL933 were kind gifts from 
Dr. Kathryn Eaton. M. xanthus DK1622 was a kind gift from Lawrence Shimkets, and 
was routinely grown at 30°C on Casitone Yeast Extract (CYE) media (10 mM 
morpholinepropanesulfonic acid (MOPS) pH 7.6, 10 g/liter Casitone, 5 g/liter yeast 
extract, and 8 mM MgSO4) in shaking cultures or on 1.5% agar plates. C. elegans wild-
type strain Bristol N2 worms were routinely grown on OP50 E. coli on Nematode Growth 
Media (NGM) agar plates (3 g/liter NaCl, 2.5 g/liter peptone, 17 g/liter agar, 
supplemented with 25 mL of 1 M KPO4 (pH 6.0) and 1 mL each of 1 M CaCl2, 1 M 
MgSO4, and 5 mg/mL cholesterol in EtOH) at room temperature. Grass-fed cow dung 
and pig dung was obtained from a local farm. Ground beef, chicken breasts, and 
spinach were purchased from a local grocery store. Dung and food products were 
ground up in a blender, and extracts were centrifuged in 50 mL conical tubes for 10 
minutes at 7500 RPM. Supernatants were filter sterilized using a 0.5 µm filter followed 
by a 0.2 µm filter. Fecal extract was diluted 1:3 into water that had been autoclaved with 
1.5% noble agar, while food extracts were diluted 1:10. After brief stirring, plates were 
poured. All pictures were taken using an Olympus DP72® camera mounted on an 
Olympus SZX16® research stereomicroscope. Pig dung E. coli isolates were selected 
for by streaking pig dung on MacConkey agar plates. Pink colonies were resetreaked 
and candidates were verified as E. coli by sequencing of the 16s gene. In all, two E. coli 
strains were isolated. 
C. elegans predation assay:  
WT UTI89 and csgBA, bcsA, and csgBA bcsA mutants were grown in LB broth 
overnight, diluted to 1 OD600 in Yeast Extract Casamino Acids (YESCA) media (10 
g/liter casamino acids, 1 g/liter yeast extract), and 2 µL dots were spotted at the cardinal 
 
 
125 
direction points of 2% agar YESCA plates supplemented with 5 ug/mL cholesterol. The 
plates were then incubated at 26°C for 48 hours. 20-30 L1-L2 stage C. elegans worms 
grown on OP50 were then transferred into the center of the C. elegans plus plates, 
while no worms were added to the C. elegans minus plates (designated day 0). At day 0 
and at 3 day intervals thereafter, three plates with worms and three plates without 
worms were harvested. Briefly, chunks of agar containing each colony were cut out from 
the agar plate. Agar slabs containing a whole colony were placed in a well of a 24-well 
polypropylene plate. 1 mL of kPi buffer was then added to each well, and the plate was 
shaken until all cells had gone into suspension or the biofilm had lifted off the agar 
surface. For WT and the csgBA and bcsA mutants, the entire sample, including biofilm 
chunks and the kPi that had been added to the well was moved into an eppendorf tube. 
These samples were tissue homogenized for 15 seconds on high speed. The csgBA 
bcsA mutant went into suspension without homogenization. Suspensions were serially 
diluted in kPi, and then 100 µL of an appropriate dilution was plated on an LB plate and 
grown ON at 37°C for CFU quantitation. Each plate with C. elegans was randomly 
paired with a plate without C. elegans, and percent survival was calculated as CFUs 
from the plate with C. elegans/CFUs from the plate without C. elegans. All data points 
are averages of biological triplicates, and error bars represent standard deviation. A 
student’s T-test was employed to compare between strains, and asterisks represent 
P<.05. For non-competition assays, WT UTI89 and a csgD mutant were spotted on 
separate plates (six dots per plate). At day 0 and at three day intervals afterwards, one 
spot per plate was harvested for CFU counts. All data points are averages of biological 
triplicates, and error bars represent standard deviation. 
C. elegans tracking assay:  
2 µL of one WT UTI89 dot and one UTI89 csgBA bcsA dot were spotted on either end of 
a YESCA +  5 ug/mL cholesterol 2% agar plate. The plate was then incubated at 26°C 
for 48 hours to allow biofilm development. C. elegans myo-2::rfp ceh22::gfp was grown 
on OP50 NGM plates at room temp. A small chunk of agar containing worms from all 
growth stages was moved from the NGM plate to the center of each UTI89 plate. At 1, 
6, and 24 hour intervals, images were taken on an Olympus DP72® camera mounted 
on an Olympus SZX16® research stereomicroscope using brightfield or a texas red 
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filter. Worms were visible as red lines under the texas red filter. All worms within the 
image frame of each colony picture were counted for that particular strain. The percent 
of worms present on each colony was calculated (with the total number being the 
amount of worms on the WT colony + the number of worms on the csgBA bcsA colony 
for a particular plate). Worm totals for each plate at each time point fell between 200-
1200. A student’s T-test was employed to compare between strains, and asterisks 
represent P<.05. 
M. xanthus predation assays:  
M. xanthus predation assays were performed on YESCA MOPS media. To support 
UTI89 rugose biofilm development and M. xanthus growth, YESCA media was buffered 
to pH 7.4 with 10 mM MOPS. After autoclaving with 1.5% agar, 1 mL of media was 
added to each well of a 24-well plate. Plates were allowed to dry for 2-3 days at room 
temperature. 2 µL dots of UTI89 and M. xanthus were spotted roughly .5 cm apart in a 
single well. UTI89 was grown ON at 37°C in LB and M. xanthus was grown for 48 hours 
at 30°C in CYE in shaking cultures prior to dotting, and each strain was normalized to 
an OD600 of 1. After dotting, plates were incubated for two days at 26°C to allow for 
biofilm formation by UTI89 and for M. xanthus growth. Plates were moved into a 
humidity chamber at 30°C to allow M. xanthus predation (designated day 0). Pictures 
were taken every 2 days. For CFU counts at day 10, contents of each well were 
suspended in 1 mL kPi. WT UTI89, as well as csgBA and bcsA mutants, were tissue 
homogenized in eppendorf tubes along with the buffer that had been added to each 
well. The csgBA bcsA double mutants went into suspension without homogenization. 
Suspensions were serially diluted on LB agar plates, which do not support 
Myxobacterial growth (74), and E. coli CFUs were determined. As with C. elegans 
predation assays, each well with M. xanthus was randomly paired with a well without M. 
xanthus, and percent survival was calculated as CFUs from the well with M. xanthus 
/CFUs from the well without M. xanthus. All data points are averages of biological 
triplicates, and error bars represent standard deviation. A student’s T-test was 
employed to compare between strains, and asterisks represent P<.05. 
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Washout Assay:  
The washout assay was performed as previously described (28). Briefly, agar chunks 
including the colony of interest were cut out and moved into the well of a 24-well plate. 
The colony was flooded with 1 mL of kPi and shaken gently. For older colonies (>48 
hours), buffer was pipetted gently onto the edge of the colony to facilitate colony lift-off. 
The original 1 mL kPi was removed from each well, added to an eppendorf tube, and 
spun down for 1 min at 12,000 rpm. The supernatant was then aspirated off. An 
additional 1 mL kPi was added to each well and was shaken gently for 5 minutes to 
remove any residual washout cells from the matrix fraction. The matrix fraction was 
removed with a pipette tip into a new eppendorf tube with 1 mL of kPi. The remaining 
kPi in each well was used to resuspend the original washout pellet. Matrix fractions 
were tissue homogenized at high speed for 15 seconds. For CFU counts, each fraction 
was then serially diluted and an appropriate dilution was plated. For M. xanthus 
washout assays, 1 mL of kPi was added to the top of each UTI89 strain that had been 
preyed upon by M. xanthus. The plate was gently shaken and kPi was pipetted around 
the edges of the WT colonies to facilitate colony liftoff. Biofilms that had been fed on by 
C. elegans or M. xanthus broke into chunks when suspended in buffer. These chunks 
were allowed to settle and buffer was removed from the top of the well. Biofilm chunks 
were suspended and shaken in two additional 1 mL kPi washes. All three washes were 
collected as the washout fraction, and biofilm chunks were tissue homogenized after 
washing to free matrix cells. 
Western Blot Analysis:  
Western blotting for the major curli subunit CsgA was performed as previously 
described (28) with minor changes. Briefly 150 µL of a 1 OD600 suspension of each 
respective strain/fraction was spun down at 12,000 rpm for 1 minute. Pellets were 
resuspended in 150 µL of hexafluoroisopropanol (HFIP), incubated at room temperature 
for 10 minutes, and then HFIP was removed using a Thermo Savant SPD SpeedVac. 
Samples were resuspended in 150 µL of 2x SDS running buffer, boiled for 10 minutes, 
and electrophoresed in 15% polyacrylamide gels. HFIP-minus samples were directly 
suspended in 150 µL of 2x SDS running buffer. For CsgA blots, samples were then 
transferred onto polyvinylidene difluoride membranes using standard techniques. Blots 
 
 
128 
were blocked with 5% milk in TBST ON at 4°C, followed by incubation with 1:8500 anti-
CsgA peptide antibody for 1 hour at room temperature. After TBST washes, blots were 
then incubated with 1:15000 LI-COR IRDYE® 800CW Goat Anti-Rabbit IgG secondary 
antibody. For blots that also include σ70 probing, samples were transferred onto 
nitrocellulose membranes in a wet transfer apparatus in 25 mM CAPS transfer buffer pH 
11.2 with 10% methanol. After transfer, the blot was blocked in 5% milk in TBST for one 
hour at room temperature. CsgA probing was performed the same, and blots were also 
incubated with 1:5000 Santa Cruz RNA pol σ D antibody primary antibody (1:5000) for 1 
hour at room temperature, followed by incubation with 1:15000 LI-COR IRDYE® 
700CW Goat Anti-Mouse IgG secondary antibody. Blots were washed with TBST and 
visualized on a Licor Odyssey CLX imager. 
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Figures: 
Figure 4.1 Biofilm formation protects E. coli against C. elegans predation 
WT UTI89 or matrix mutants were grown on the same YESCA agar plates + cholesterol 
for two days to allow biofilm development. ~25 L1-L2 C. elegans worms were then 
added to the center of each agar plate (Day 0). At three day intervals, plates to which 
worms had been added and worm-free control plates were harvested for CFU counts. 
C. elegans minus plates were randomly paired with C. elegans plus plates, and percent 
survival was calculated as CFUs on the plus C. elegans plate divided by CFUs on the 
minus C. elegans plate for each particular strain (A). An image was taken of each strain 
at each time point from a representative plus C. elegans plate that was harvested at day 
15 (B). 
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Figure 4.2 Non-competition assay demonstrates that WT UTI89 is more resistant 
to C. elegans predation than a csgD mutant 
WT UTI89 or a csgD mutants were grown on separate YESCA agar plates + cholesterol 
for two days to allow biofilm development. ~25 L1-L2 C. elegans worms were then 
added to the center of each agar plate (Day 0). At three day intervals, plates to which 
worms had been added and worm-free control plates were harvested for CFU counts. 
C. elegans minus plates were randomly paired with C. elegans plus plates, and percent 
survival was calculated as CFUs on the plus C. elegans plate divided by CFUs on the 
minus C. elegans plate for each particular strain. 
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Figure 4.3 C. elegans is not preferentially attracted to WT or csgBA bcsA UTI89 
WT UTI89 or a csgBA bcsA mutant were spotted on opposite sides of a YESCA + 
cholesterol agar plate. After two days of biofilm development at 26°C, C. elegans myo-
2::rfp ceh22::gfp were moved onto the center of the plate by chunking (A). (B) shows a 
brightfield/texas red overlay of WT or csgBA bcsA colonies with fluorescent worms after 
6 hours of C. elegans exposure. At 1, 6, and 24 hours post-C. elegans addition, 
fluorescent images were taken and worms on each strain were counted (C). Five 
individual plates were averaged, and bars represent the number of worms on each 
strain divided by the total number of worms counted on that particular plate. Error bars 
represent standard deviations. 
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Figure 4.4 C. elegans feeding results in a fragile biofilm 
After moving an agar chunk to a well of a 24-well plate, 1 mL of kPi buffer was added to 
a WT UTI89 rugose colony biofilm that had or had not been exposed to C. elegans for 
12 days. C. elegans feeding resulted in a biofilm that was more fragile and that broke 
apart easily 
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Figure 4.5 Washout cells are more susceptible to C. elegans predation than 
matrix cells 
Three WT UTI89 dots were spotted on a YESCA + cholesterol plate. After two days of 
biofilm development, 20-30 L1-L2 C. elegans worms were moved to the center of the 
plate. Plates were incubated at 20°C, and at days 6 and 12, a dot was harvested and 
subjected to the washout assay. CFUs were counted for each fraction. The graph 
represents percent survival compared to a minus-C. elegans control plate for each 
respective fraction at each respective day (A). Each bar represents an average of 
biological triplicates, and error bars represent standard deviation. Asterisks represent a 
P-value <0.05 using the Student’s T-test. (B) shows a western blot probing for the major 
curli subunit CsgA. A control 2-day old colony demonstrates the prototypical bimodal 
population present in a rugose biofilm, which is maintained after 12 days of growth. Not 
enough cells could be harvested from the washout fraction at 12-days with nematode 
predation to allow for western blot analysis of that fraction. Sigma-70 represents a 
loading control. 
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Figure 4.6 UTI89 biofilm formation protects against M. xanthus predation 
2 µL dots of UTI89 and M. xanthus were dotted ~0.5 mm apart in an agar-filled well of a 
24-well plate. After 2 days of biofilm development, plates were moved to humidity 
chambers in a 30°C incubator for M. xanthus predation. (A) shows pictures taken at 2 
day intervals following M. xanthus feeding on WT UTI89 and UTI89 matrix mutants. 
After 10 days, CFUs were harvested from each UTI89 strain. (B) represents percent 
survival compared to M. xanthus-free UTI89 colonies. The washout assay was 
performed on WT UTI89 that had been preyed on by M. xanthus for 10 days. CFUs 
from both the washout and matrix fractions were determined, and percent survival 
compared to fractions from minus-M. xanthus UTI89 colonies subjected to the washout 
assay was calculated (C). 
  
 
 
135 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7 SDS-insoluble CsgA still present after M. xanthus predation 
WT UTI89 was incubated at 30°C for 10 days with or without M. xanthus predation. 
Western blot analysis probing CsgA was performed with or without pre-treatment with 
HFIP. M. xanthus grown on its own and a UTI89 csgBA bcsA mutant serve as controls. 
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Figure 4.8 Biofilm fragility after M. xanthus predation 
After M. xanthus feeding, 1 mL of kPi was added to WT UTI89 and the csgBA mutant. 
WT broke into large chunks upon agitation, and the csgBA colony maintained its shape 
even after washing off the agar. 
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Figure 4.9 Enterobacteriaceae curli production on YESCA and LB plates 
Western blot for the major curli subunit CsgA was performed on various 
Enterobacteriaceae strains grown on YESCA (A) or LB (B) agar plates for two days at 
26°C or 37°C.  
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Figure 4.10 Growth and curli expression on pig dung agar plates 
UTI89, S. enterica ser. Typhimurium, C. koseri, and two E. coli strains isolated from pig 
dung were grown on pig dung agar plates for two days at 26°C or 37° C. Rugose biofilm 
development was apparent by UTI89 and S. enterica ser. Typhimurium (A). Western 
blot analysis for the major curli subunit CsgA revealed that pig dung plates allow robust 
curli production from all strains (B). All western blot samples were treated with HFIP to 
depolymerize CsgA. 
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Figure 4.11 Growth on cow dung agar plates 
UTI89, S. enterica ser. Typhimurium, C. koseri, and two E. coli strains isolated from pig 
dung were grown on cow dung agar plates for two days at 26°C or 37° C. Rugose 
biofilm development was apparent by UTI89 and S. enterica ser. Typhimurium. 
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Figure 4.12 Curli production on food agar plates 
After 2 days of growth at 26°C or 37°C on beef (A), chicken (B), spinach (C) agar 
plates, western blot analysis to probe for the major curli subunit CsgA was performed. 
All western blot samples were treated with HFIP to depolymerize CsgA.  
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Figure 4.13 Growth and morphology on food agar plates 
UTI89, S. enterica ser. Typhimurium, C. koseri, and two E. coli strains isolated from pig 
dung were grown on beef (A), chicken (B), or spinach (C) agar plates for two days at 
26°C or 37° C.  
 
 
 
 
 
 
142 
Figure 4.14 EHEC growth and curli production on dung and food plates 
EHEC O157:H7 86-24 and EDL933 were grown on various agar plates at 26°C or 37°C. 
Pictures were taken after 48 hours of growth to monitor colony morphology (A). Western 
blotting for the major curli subunit CsgA was performed after 48 hours of growth (B). 
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Notes and Acknowledgements: 
I started the nematode predation project because I needed something for my 
undergraduate research assistant, David Warshaw, to do. At one point during lab 
meeting, Matt had suggested that maybe curli is hard to eat for nematodes, and testing 
that idea seemed like a good undergrad project. David and John Lee put a lot of time 
and effort into setting up the initial assays that gave us a great preliminary phenotype. 
Margarita Sifuentes was extremely helpful in teaching us basic nematode handling 
procedures and providing strains. After an interesting talk at a meeting, Maggie Evans 
suggested that I test whether biofilms also protected E. coli against M. xanthus 
predation. Another undergraduate research assistant, Vinay Saggar, developed media 
conditions that supported both UTI89 rugose biofilm development and M. xanthus 
growth and performed the initial M. xanthus predation assays. Through a failed attempt 
at getting Staphylococcus aureus to form rugose biofilms, Adnan Syed provided the 
inspiration for testing curli expression in non-host-mimicking conditions. Adnan put in a 
lot of work on the ecology side of the project. He was particularly helpful with regards to 
making food and dung agar plates and isolating bacterial strains from various sources 
and subsequently genotyping those strains. Adnan also connected me with EMMA 
Acres farm, from which we acquired cow and pig dung. EMMA Acres was extremely 
hospitable during our visit there. Dr. Lawrence Shimkets and Dr. Kathryn Eaton 
graciously donated M. xanthus and EHEC strains. 
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Chapter 5 
Discussion, Perspectives, and Future Directions 
 
Dynamics of Bimodal Population Development 
Phenotypic variation in isogenic biofilm communities can arise through multiple 
mechanisms (1). One mechanism is stochastic gene expression, which can trigger 
biofilm-related differentiation pathways independently of environmental stimuli (1, 2). 
Stochastic fluctuations are essentially noise, resulting from the cell-to-cell variation in 
the biochemical process of gene expression (2-4). Therefore, one would expect that if a 
biofilm population were to develop subpopulations based on stochastic gene 
expression, those subpopulations would develop in random positions and at random 
times.  
Secondly, mutations can trigger subpopulation development within biofilms. In 
Pseudomonas aeruginosa, RecA-mediated genetic mutations lead to phenotypic 
differences among members of the same biofilm (5). Intriguingly, these mutations are 
dependent on endogenous oxidative stress causing double strand DNA breaks (6). 
Such genetic diversity creates subpopulations that are able to resist different stresses, 
granting the biofilm community as a whole a broader stress-resistance profile. Since 
mutations drive these phenotypic changes, they are heritable (5, 6).  
Lastly, chemical gradients within biofilms develop because bacteria on the 
periphery consume nutrients, which prevents those nutrients from diffusing and being 
available to the cells on the interior of the biofilm (1). For example, oxygen consumption 
occurs so robustly at the air-exposed periphery of biofilm communities that the 
underlying bacteria are often oxygen starved (7, 8). Therefore, chemical-induced 
physiological heterogeneity in a biofilm community is initially triggered by chemical 
gradients that lead to gene expression changes and subsequent metabolic gradients. 
As such, this type of biofilm differentiation is reversible and non-inheritable (1).  
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In this dissertation, I have described two discrete bacterial populations that form 
in Escherichia coli strain UTI89 rugose biofilms. Development of these two populations 
could feasibly be triggered by mutations, stochastic gene expression, or chemical-
induced physiological heterogeneity. I consider each of these possibilities with regards 
to bimodal population development below.   
The clustering of curli producing cells to the air-biofilm interface indicates that an 
environmental signal affects bimodal population development. Stochastic gene 
expression is characterized by its independence from external stimuli (1, 3). The precise 
and large-scale localization of matrix-producing cells to the air interface suggests that, 
instead of stochastic gene changes, a signal from the environment initiates 
subpopulation development.  
Mutations can be triggered by external stimuli (9), but the repeatable 
restructuring of rugose biofilms suggests that spontaneous mutations must not be the 
trigger. Alternatively, reversible genetic alterations such as phase variation might lead to 
bimodal population development. Phase variation accounts for the transition between 
rugose and smooth colony phenotypes in V. cholerae (10-13). Furthermore, in S. 
enterica ser. Typhimurium, a CsgD-GFP translational fusion demonstrated that 
individual bacteria either produced high amounts of CsgD or very little, implying that the 
expression of CsgD might be phase variable (14). However, this work was done before 
my manuscript on bimodal population development was published, so the authors may 
have been mixing “washout” bacteria with “matrix” bacteria prior to visualization (15). 
Furthermore, a former graduate student in the Chapman lab, Dan Smith, failed to find 
evidence of recombination in the csgDEFG-csgBAC intergenic region using a PCR 
screen (Dan Smith’s thesis). Therefore, although environmentally-induced phase 
variation can trigger bimodal population development in some cases, it does not seem 
to be involved in E. coli rugose colony development. 
Thus, gene expression changes due to alterations in environmental stimuli are 
the most likely driver of bimodal population development. Such a model predicts that 
curli is induced in periphery cells because they are exposed to a different chemical 
environment than interior cells. These types of phenotypic differences are purely due to 
gene regulation, and are therefore non-heritable. Therefore, one would predict that if 
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you replated washout and matrix fraction bacteria, new rugose biofilms would develop 
at the same rate. Indeed, this is the case (Fig. 5.1).  
 If an environmental signal drives bimodal population development, two obvious 
questions emerge. 1) What is the environmental signal that drives bimodal population 
development, and 2) how is this signal interpreted so that the appropriate gene 
expression changes are manifested? The localization of curli-production to the biofilm 
exterior suggests that oxygen may affect bimodal population development. Indeed, 
anaerobic conditions suppress curli production in S. enterica ser. Typhimurium (16), and 
preliminary experiments in the lab have shown that the same is true for E. coli (Fig. 5.2). 
If oxygen is the signal, we can therefore infer that the presence of oxygen induces curli 
expression, a presumption supported by the fact that higher oxygen levels correlate with 
matrix production within a UTI89 rugose biofilm (Fig. 2.11)(15). Oxygen sensing 
systems in E. coli have been well-described (17-19), and, in Chapter 3, I created 
deletion mutants for six candidate regulators and screened for changes in rugose 
biofilm formation. An arcAB mutant wrinkled in low iron conditions (Fig. 3.1). I found that 
ArcAB suppressed CsgD production. However, an arcAB mutant demonstrated only a 
small increase in csgBAC expression in the biofilm interior in two-day-old biofilms 
(Fig.3.7, 3.9).  
Therefore, in addition to ArcAB, another system must contribute to the 
maintainance of bimodal population development at earlier stages of biofilm 
development. Due to the elongated shape of cells in the biofilm interior, Sera et. al. 
suggested that cells closer to the agar surface were younger, exposed to more nutrients 
from the agar, and therefore in logarithmic growth phase, in which curli is not expressed 
(20, 21).  However, the authors also noted that tall wrinkles, where all biofilm cells are 
far removed from the agar surface, still develop a bimodal population (20, 21). 
Furthermore, I have shown that bimodal population development is maintained at least 
as long as 14 days following initial plating (Fig. 4.5), by which time underlying cells 
should presumably have gone into stationary phase. So, although growth phase does 
not appear to be the principle driving agent of bimodal population development, I think 
that it warrants more investigation. An interesting experiment would be to track bimodal 
population development in WT UTI89 vs. an arcAB mutant over an extended period of 
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time. Without ArcAB suppression of matrix in the interior, once washout cells reach 
stationary phase they may begin to produce matrix components. 
It is possible that multiple oxygen-sensing systems coordinate to suppress matrix 
production in the biofilm interior. Fnr is a global transcriptional regulator that directly 
senses and responds to molecular oxygen (18). DosCP binds molecular oxygen and in 
response regulates intracellular concentrations of cyclid-di-GMP (17, 22, 23). Lastly, 
YfgF breaks down cyclic-di-GMP in anaerobic conditions (24). Given the roles of cyclic-
di-GMP and oxygen in CsgD expression and rugose biofilm formation (16, 25-27), it is 
tempting to speculate that one of these regulators controls curli production in biofilm 
interiors. However, preliminary confocal experiments using a csgBAC-gfp reporter in fnr, 
dosCP, and yfgF mutants suggest that they are not principle regulators of bimodal 
population development (Fig. 5.3). It is possible that multiple, redundant systems 
overlap to suppress matrix production in the interior, and the only way to see a 
phenotype would be to mutate multiple regulators. 
Iron and Rugose Biofilm Formation 
Iron is an essential nutrient for almost all bacterial species, and it affects E. coli 
gene expression, growth, and metabolism in a variety of ways (28, 29). To determine 
how iron was causing rugose biofilm formation, I first screened known iron-responsive 
regulators (Fig. 2.8). A mutant lacking fur, which encodes a global iron-responsive 
regulator, wrinkled slightly in low iron. Therefore, Fur may repress rugose biofilm 
formation. However, after finding that oxidative stress could drive rugose formation in 
place of iron, and that overexpression of sodA could repress iron-induced rugose biofilm 
formation, it became apparent that iron may not directly induce rugose biofilm formation. 
Iron likely induces rugose biofilm formation through oxidative stress. Indeed, free 
ferrous iron in the cell can participate in the Fenton reaction, resulting in DNA, lipid, and 
protein damage (29-31). However, the interpretation that, in high iron conditions, E. coli 
is exposed to substantially more oxidative stress presents logical inconsistencies. Iron 
acquisition is tightly regulated by bacteria, so high levels of exogenous iron may not 
correlate with an increase in oxidative stress (29). Furthermore, there is not a described 
regulatory system that responds directly to iron-induced reactive oxygen stress. The 
hydroxyl radical, which is the direct product of the Fenton reaction, reacts too quickly 
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with organic compounds to be adequately “sensed” (30, 32). Although superoxide can 
simulate iron-induced reactive oxygen stress, neither it nor hydrogen peroxide are 
byproducts of Fenton chemistry (30). Moreover, SoxRS and OxyR, which respond to 
superoxide and hydrogen peroxide stress, respectively (33), do not affect iron-induced 
rugose biofilm development to a large degree (Fig.3.1).  
Instead, iron might cause an increase in overall cellular oxidation state. Iron 
influences rugose biofilm formation in B. subtilis, and iron exposure in that system 
results in an increase in the NAD+/NADH ratio (34). Furthermore, Kolodkin-Gal et. al. 
demonstrated that two kinases, KinB and KinA, respond to oxidation by binding to 
components of the electron transport chain and directly to NAD+, respectively (34). The 
authors hypothesized that, since iron is required for proper cytochrome function, the 
presence of iron might affect the efficiency of the electron transport chain and 
subsequently the overall cellular redox state (34). If iron induces rugose biofilm 
formation in E. coli through an increase in cellular oxidation, the next question becomes 
what is the regulator? Screening redox-responsive systems supplied me with a good 
candidate in ArcAB (Fig. 3.1). 
It is tempting to propose that in low iron conditions, ArcAB is active due to a 
reduced cellular state, leading to repression of csgD and rugose biofilm formation. The 
presence of iron could then lead to cellular oxidation and subsequent ArcAB inactivation 
coupled to csgD derepression. Superoxide could also potentially oxidize and inactivate 
ArcB. Although I could not find a direct connection between superoxide and ArcAB 
activity in the literature, a principle source of reactive oxygen species in E. coli is NADH 
dehydrogenase II (35). Superoxide is therefore produced in close proximity to the 
membrane and the electron transport chain, so oxidation of membrane-bound ArcB by 
superoxide is not a far-fetched hypothesis. To assay ArcAB activity in low vs. high iron, I 
utilized β-galactosidase assays using two ArcAB-dependent promoters, with mixed 
results (Fig. 5.4). Both fadE and llpD are repressed by ArcA-P (36-38). llpD expression 
increased in high iron, while fadE did not (Fig. 5.4). A possible reason for this 
discrepancy is that both llpD and fadE rely on other regulators besides ArcA to control 
transcription. One of these regulators might itself be subject to iron regulation. A third 
ArcAB-dependent promoter should be analyzed to clarify this result.  
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Given the recent interest in the interplay between redox balance and biofilm 
development in a variety of organisms (34,39-41), and the major role that ArcAB 
appears to play in UTI89 rugose biofilm development, the ArcAB narrative seems to me 
to be urgent and compelling. If ArcAB is responsible for iron-driven rugose formation, it 
would agree well with the iron-driven oxidation observed in B. subtilis (34). It would also 
be novel in that the same regulator could affect biofilm architecture on the micro (curli 
expression repressed in the biofilm interior) and macro (wrinkled colony development) 
scale.  
If, however, ArcAB is not responsible for iron-induced rugose biofilm formation, 
there are multiple other explanations for what could be. A fur mutant wrinkles slightly in 
low iron conditions (Fig. 2.8), so Fur may be involved in iron-dependent rugose biofilm 
formation. When iron is plentiful, Fur binds to ferrous iron and generally acts as a 
repressor of gene expression (29). Therefore, if Fur affects biofilm development, it 
would likely repress a biofilm suppressor in high iron conditions. So far, I have not been 
able to find any data in the literature that links Fur activity to expression of biofilm 
genes. An interesting experiment would be to monitor CsgD levels in a fur mutant.  
Part of iron-induced rugose biofilm formation could also be an increased growth rate. 
Because sodAB and arcAB both wrinkle in low iron conditions, and both have growth 
defects, it is evident that increased growth is not necessary for wrinkling in low iron 
conditions. A difficult question is whether or not increased growth alone is able to cause 
wrinkling in low iron conditions. A possible experiment to test whether a particular 
growth rate or growth threshold is necessary for rugose biofilm development would be 
to subtract other nutrients besides iron from growth media and monitor rugose biofilm 
formation. However, we currently do not have a defined medium with which we can 
induce rugose biofilm formation, so these experiments might prove to be technically 
challenging.  
Iron and CsgA Polymerization 
Part of the reason we were originally interested in iron’s affect on curli was that 
iron affects the aggregation of multiple disease-associated amyloids (42-45). Iron 
induces disordered aggregation of the Alzheimer’s disease amyloid Aβ, thereby 
decreasing Aβ ordered amyloid fiber formation (44). Our initial hypotheses were that 
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iron may also bind to CsgA and influence curli amyloid formation. Furthermore, if there 
was an iron-curli complex, E. coli might use curli fibers as an extracellular iron storage 
system. I attempted to test these hypotheses in a variety of ways. Thioflavin T (ThT) 
fluoresces when it binds to amyloid fibers such as CsgA or CsgB, and therefore it can 
be used as a surrogate for assessing CsgA amyloid polymerization (46, 47). I used ThT 
assays to test whether iron affected CsgA polymerization into amyloid. Interestingly, 
preliminary ThT experiments with both CsgA and CsgB demonstrated that addition of 
.5-5mM FeCl3 decreased the typical lag phase associated with fiber polymerization (Fig. 
5.5A,B). Moreover, transmission electron microscopy (TEM) revealed that when CsgA 
polymerized in the presence of 5mM FeCl3, dark aggregates were present among the 
fibers. These aggregates were largely absent when CsgA polymerized without added 
iron (Fig. 5.6). Similarly, iron addition to Aβ polymerization assays results in shorter, 
more curved fibers (44). Together, these results suggest that environmental iron levels 
could alter biofilm morphogenesis by modulating amyloid fiber polymerization. However, 
there are multiple technical caveats that should be considered with these experiments. I 
was never successful at removing iron from buffer prior to adding CsgA or CsgB. 
Therefore, if either of those proteins binds iron, they might already be “iron-loaded” prior 
to ThT assays. Additionally, we use His6x-tagged CsgA and CsgB, and the histidine tag 
could potentially affect iron binding.  
I also attempted to measure iron binding by using the R1, R3, and R5 subunits of 
CsgA, each of which polymerizes into amyloid fibers in vitro (48). Using these subunits 
bypasses the need to purify CsgA every time you need to do experiments, and they are 
not his-tagged. However, using subunits instead of the full-length protein is not ideal, as 
any potential metal-binding motifs in CsgA might not be present in individual subunits. 
To measure metal binding to subunits, I incubated Fe-NTA complexes, which produce 
an absorbance shoulder around 250 nm (49), with polymerized subunits. I then took 
absorbance spectra before and after ultracentrifugation to remove fibers. Fig. 5.7 shows 
the raw data from one such experiment, using the R1 subunit. No decrease in Fe-NTA 
specific absorbance after incubation with subunits could be detected, indicating that R1 
does not bind Fe-NTA. Neither R3 nor R5 demonstrated a clear phenotype either (data 
not shown), indicating that CsgA subunits likely do not bind iron. 
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If curli fibers bound to iron, one might expect a curliated bacterial colony to 
absorb more iron than a non-curliated colony. To test this idea, I utilized chrome azurol 
S (CAS) agar plates. CAS agar plates appear blue/greenish, due to the absorbance of 
Fe-CAS complexes. When bacteria remove iron from the media, Fe-CAS complexes 
are depleted and a yellow halo evolves around the bacteria colonies (50). No difference 
in halo size or rate of halo evolution could be determined between WT and a curli 
mutant (Fig. 5.8), indicating that curli most likely does not help UTI89 colonies to 
acquire iron. 
Rugose Biofilm Function 
When considering the function of rugose biofilms, it is important to differentiate 
between production of biofilm matrix components and the resultant wrinkled colony 
shape. The resistance to predation I have observed between WT UTI89 and matrix 
mutants is likely dependent on the presence of the matrix itself, and not colony shape. It 
is hard to imagine a possibility where a wrinkled shape would provide protection against 
predators, unless the increased height conferred to wrinkled colonies put some cells out 
of the reach of M. xanthus. However, a csgBA mutant wrinkles to some degree and is 
completely susceptible to M. xanthus killing (Fig. 4.6). It is more likely that the dense 
curli-mediated matrix protects against recognition by M. xanthus, as was discussed in 
Chapter 4. 
What advantage then, does the rugose biofilm shape confer? It has been 
recently demonstrated that Pseudomonas aeruginosa rugose biofilm formation 
increases biofilm surface area as a means to expose more biofilm bacteria to oxygen 
(39, 40). Within their system, the authors demonstrate that a reduced cellular state 
triggers wrinkling, leading to more oxygen exposure (39). Those studies were ground-
breaking in that they introduced redox balance as a driver of rugose biofilm 
development. Work in B. subtilis, Candida albicans, and my work with ArcAB and 
superoxide stress have since demonstrated that redox balance also controls rugose 
biofilm formation in other microbial species (15, 34, 41). However, applying the same 
principle of wrinkling to increase oxygen exposure to E. coli presents some problems. 
First of all, I have shown that oxidative stress can drive rugose biofilm development. 
Oxidative stress is generated through normal oxygen respiration (33, 35), so E. coli 
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exposing itself to more oxygen in response to oxidative stress seems counterproductive. 
ArcAB-inhibition of CsgD also demonstrates that cells in an oxidized state develop into 
rugose biofilm colonies. As noted by Serra et. al., the diverse respiratory/fermentative 
metabolism of E. coli may alleviate selective pressure to develop morphologies that 
optimize oxygen exposure (20, 51, 52). In line with that idea, it is difficult to imagine an 
environmental niche where substantial air-exposure would be an adaptive advantage for 
E. coli. Indeed, the only possible niche would be the non-host environment, which is the 
only place E. coli would typically encounter an air interface. One would expect 
desiccation stress to provide counter selection against development of an increased 
surface area in the non-host environment (53). An intriguing possibility is that the rugose 
biofilm shape is optimized for a balance between an oxidant exposing surface area and 
development of a desiccation-resistant interior population. One would expect a 
desiccation-resistant structure to resist evaporation, and B. subtilis rugose colony 
biofilms have been shown to resist both wetting and gas exchange (54). 
Although it is tempting to speculate about the function of such a striking visual 
phenotype, in reality it is difficult to form testable hypotheses about the “function” of 
such a structure. It is easy enough to test if matrix components contribute to protection 
against predation or if iron-induced rugose formation correlates with oxidative stress 
resistance, but how do you test if colony wrinkling confers any fitness advantage? The 
main problem is that production of the biofilm matrix almost always coincides with 
colony wrinkling. Low iron conditions, where matrix is still produced but no rugose 
biofilms develop, could potentially be used to differentiate matrix production from rugose 
biofilm formation. For instance, if a colony grown in high iron conditions resists a 
particular stress better than a colony grown in low iron conditions, one could potentially 
attribute that stress resistance to wrinkling. However, iron undoubtedly changes many 
aspects of cellular physiology, so it would be difficult to attribute a phenotype to either 
the absence of iron or the absence of a wrinkled colony morphotype. The next best 
thing would be to model wrinkled colony structure with respect to what you would expect 
if the shape were optimized for a given purpose. Indeed, these types of models have 
been successfully employed with P. aeruginosa biofilms (39, 55). However, without an 
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increase in fitness that can be attributable to colony wrinkling, it is difficult to make solid 
conclusions about what environmental pressures shaped this morphological phenotype. 
In addition to the wrinkled colony shape, we can also conjecture about where and why 
bimodal population development has been selected for. Again, I propose that the 
“where” in this case must be the non-host environment, which presents an air-interface. 
As with the rugose biofilm shape, determining the survival advantage that a bimodal 
population confers is difficult. An interesting study in B. subtilis demonstrated that liquid 
flows freely through the “channels” formed under each wrinkle (56). These results agree 
well with what I and others have observed as far as matrix production being limited to 
the biofilm exterior (15, 21). The authors concluded that the hollow areas under wrinkles 
develop to allow nutrient diffusion within the biofilm to occur more efficiently. Perhaps E. 
coli suppresses interior matrix production to allow for similar nutrient channels to 
develop. Additionally, as discussed in chapter 4, the flagellated interior cells or E. coli 
rugose biofilms may allow for the generation of an easily dispersed population within a 
biofilm. 
In total, this thesis provides a framework for understanding the dynamics of 
rugose biofilm formation in E. coli. The techniques I developed, including analysis of 
biofilm formation under low iron conditions, the washout assay, confocal microscopy of 
rugose biofilms, and predation assays, will hopefully be of use to researchers interested 
in further probing E. coli biofilms and E. coli/predator relationships. In a broader sense, 
the ubiquity of rugose biofilm formation implies that my results may be applied to other 
bacterial systems, adding to what is becoming a dynamic and unifying field in bacterial 
biofilm research. 
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Figures: 
 
 
 
 
 
 
Figure 5.1 Each rugose biofilm fraction is able to form new rugose biofilms 
UTI89 was grown on a YESCA agar plate for 48 hours. The washout assay was then 
performed, and 4 μL dots of a 1 OD600 suspension of each fraction were plated on a 
new YESCA agar plate. Concurrently, a new UTI89 culture was dotted. Rugose biofilm 
development was tracked at 24 and 48 hours post-dotting. 
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Figure 5.2 UTI89 curli expression is repressed in anaerobic conditions 
UTI89 or a csgBA mutant were grown on YESCA plates aerobically for 2 days or 
anaerobically for 20 days. Western blot analysis revealed that CsgG and CsgA are only 
expressed aerobically. 
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Figure 5.3 Bimodal population development in fnr, dosCP, and yfgF mutants 
csgBAC-gfp promoter fusions were inserted into the attB site of WT UTI89 and fnr, 
dosCP, and yfgF mutants. After growth for 2 days at 26°C on YESCA agar plates, 
colonies were visualized by confocal microscopy. A single cross-section image from the 
center of each biofilm suggests that in each strain, curli production is limited to the 
biofilm periphery. 
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Figure 5.4 ArcAB-dependent promoter expression in low and high iron 
UTI89 lacZ attB::fadE-lacZ and UTI89 lacZ attB::llpD-lacZ were grown on low iron plates 
or low iron plates supplemented with 10 μM FeCl3. After 24 hours of growth, β-
galactosidase assays were performed. Bars represent biological triplicates and error 
bars represent standard deviation. 
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Figure 5.5 CsgA and CsgB polymerization with addition of iron 
20.8 μM CsgA (A) and CsgB (B) were incubated with thioflavin T. Various 
concentrations of FeCl3 were added to the reaction mixtures to monitor how iron affects 
polymerization. 
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Figure 5.6 Effect of iron on CsgA fiber morphology 
CsgA from Fig. 5.5 that polymerized with no additional iron (A) or with 5 mM FeCl3 (B) 
was visualized under transmission electron microscopy (TEM). 
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Figure 5.7 CsgA subunit iron-binding assays 
CsgA R1 fibers were incubated with Fe3+-NTA complexes and then subjected to 
ultracentrifugation. Fe3+-NTA demonstrates an absorbance peak around 250 nm, which 
was used to determine whether spinning down fibers could also remove Fe3+-NTA from 
solution. 
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Figure 5.8 Iron uptake visualization with chrome azurol S 
WT UTI89 + pLR2 (EV), UTI89 csgA + pLR2 (EV), or UTI89 csgA + pLR5 (WT csgA 
under the csgBA promoter) were plated on YESCA chrome azurol S agar plates and 
incubated for 2 days at 26°C. Iron uptake can be visualized by a yellow halo that 
evolves around the dots. 
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Materials and Methods: 
Anaerobic Growth:  
For anaerobic growth assays, UTI89 was spotted on YESCA agar plates that had been 
supplemented with 20 mM NaNO3 and 100 μM MgCl2 10 μM CaCl2, 10 μM tryptophan. 
Plates were then placed in anaerobic chambers with 1 GasPak™ EZ anaerobe 
container system with indicator sachet and incubated at 26°C for 20 days. Aerobic cells 
were grown for 2 days at 26°C. 
β-galactosidase Assays: 
β-galactosidase Assays were performed as described (15). Agar plates for UTI89 lacZ 
attB::lldP-lacZ was supplemented with 1mM calcium lactate. Each bar represents an 
average of biological triplicates, and error bars represent standard deviation. 
Confocal Microscopy: 
Engineering of GFP-reporter strains and confocal microscopy was performed as 
described (15).  
Protein Purification, ThT Assays, and TEM: 
Purification of CsgA and CsgB, as well as ThT polymerization assays and TEM were 
performed as described (57). 
CsgA subunit binding to Fe+3-NTA: 
.3mM Fe+3-NTA was mixed with .3mM R1 subunit that had polymerized in water in 1 
mL total volume. The sample was incubated for 2 hours on a benchtop rotator, followed 
by ultracentrifugation at 40,000 rpm for 1 hour at 4°C. Along with controls, 150 μL of 
sample from the top of the centrifuge tube was then analyzed on a spectrophotometer. 
Chrome azurol S plates: 
Chrome azurol S agar plates were essentially created as described (58), with minor 
modifications. Briefly, 60.5mg of chrome azurol S powder was dissolved in 50 mL water. 
10 mL of a 1 mM FeCl3, 10 mM HCl solution was mixed in. While stirring, this solution 
was slowly added to 72.9 mg HDTMA dissolved in 40 mL water. This solution was then 
autoclaved. Separately, a solution of 900 mL water, 30.24 g pipes, 10 g Casamino 
acids, and 1 g yeast extract was pH’d to 6.8, mixed with 15 g agar, and autoclaved. 
After both solutions were autoclaved, the chrome azurol S solution was slowly added to 
the nutrient mixture under stirring, and agar plates were poured. 
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